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Abstract

UTILIZATION OF STRUCTURAL & BIOCHEMICAL CUES TO ENHANCE PERIPHERAL
NERVE REGENERATION.
By Balendu Shekhar Jha, PMP, PT

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2011
Major Director: David G. Simpson, Ph.D.
Associate Professor, Department of Anatomy and Neurobiology

This study examines the prospects of using the electrospinning process to fabricate tissue
engineering scaffolds targeting a variety of regenerative applications, with a primary focus on the
production of nerve guides for the treatment of long-defect nerve injuries in the peripheral
nervous system. A basic overview of the conventional electrospinning process is provided, and
the utility of this fabrication scheme in the production of collagen-based tissue engineering
scaffolds is demonstrated. Next, a novel modification of the basic electrospinning process is

xi
presented. This process, called two pole air gap electrospinning, was developed to produce nerve
guides that exhibit an anisotropic structure that mimics the extracellular matrix of native
peripheral nerve tissue. This electrospinning process makes it possible to produce macroscopic
nerve guides that are cylindrical in shape and composed of dense arrays of nano- to micron-scale
diameter fibers. Unlike, conventional hollow core nerve guides, these electrospun constructs lack
a central lumen, hence the designation 3D (for three-dimensional) nerve guide. The fibers are
nearly exclusively arrayed in parallel with the long axis of the construct. This architectural
feature provides thousands of individual channels, and aligned fibers that provide guidance cues
that are designed to drive regenerating axons to grow in a highly directed fashion down the
longitudinal axis of the guide. To supplement the structural cues provided by the fibrillar arrays
of the electrospun 3D nerve guides, an alginate-based platform designed to deliver therapeutic
reagents was developed and characterized. This platform makes it possible to fabricate gradients
of therapeutic reagents within the fibrillar arrays of an electrospun nerve guide. Functional and
structural analyses of these constructs supplemented with or without a gradient of NGF, in a
long-defect nerve injury in the rodent sciatic nerve indicate that the 3D design is superior to the
gold standard treatment, the autologous nerve graft.

Animals treated with the 3D grafts

recovered motor and sensory function faster and exhibited far higher nerve-to-nerve and nerveto-muscle signal amplitudes in electrophysiological studies than animals treated with autologous
grafts or conventional hollow core cylindrical grafts.

CHAPTER 1

Chapter 1. Overview

The central hypothesis of this study states that tissue regeneration after injury can be
maximized by identifying and recapitulating key features of the native extracellular matrix
(ECM) [1]. In this study the central role that scaffold structure and composition play in the tissue
engineering paradigm is explored. Tissue engineering is an evolving multidisciplinary field that
has the potential to revolutionize medical practice and improve the health and quality of life for
millions of people worldwide by restoring the structure and function to diseased or damaged
tissues and organs. As a science, tissue engineering encompasses a broad range of potential
applications including the repair, augmentation, or replacement of body tissues such as bone,
muscle, skin, blood vessels, nerve, cartilage, and other connective tissues such as ligaments and
tendons. Fundamental to nearly all tissue engineering processes is the scaffold used to establish
the three-dimensional space necessary for cell attachment and growth at the injury site

[1]

.

Typically, these scaffolds biodegrade or integrate themselves into the host tissue as the nascent
ECM regenerates at the injury site. In effect, the scaffolds represent a template that act to guide
the regenerative process and in most applications these structures are designed to be remodeled
and completely replaced by native tissues. These scaffolds may or may not be supplemented with
various types of cells designed to promote the reconstitution of functional tissue.
A primary assumption of the tissue engineering paradigm is the notion that functional
tissue will develop if the proper biological, guidance and or positional cues are provided by the
tissue engineering scaffold [1]. It is becoming increasingly clear that each specific tissue requires
its own unique set of these signals. The cues to be used in any specific application may be driven
by biological, clinical, commercial and / or regulatory considerations. In the example of

1

peripheral nervous tissue, it may be guidance and / or positional cues that are paramount in
design of the regenerative template.

Superimposed on these basic considerations are the

processing limitations that limit the ability to fabricate different materials into scaffolds with the
features suitable to function as a regenerative template for the reconstruction of organs and
tissue.
Tissue engineering scaffolds, fabricated by the process of electrospinning, can be
produced with fibers that closely resemble the size range of fibrils found in native ECM

[1]

, and

thus, have been presented as a potential avenue to the development of physiologically relevant
scaffolds for the fabrication of tissue engineered organs and tissues, wound dressings, and drug
delivery platforms. Electrospun polymers, natural, synthetic, and blends of natural and synthetic
polymers, have been explored as tissue engineering scaffolds

[1]

. This study will examine how

the composition and architecture of electrospun materials interact to define the functional
properties of this unique class of nano-materials.
Chapter 2 of this thesis provides a primer to the fundamentals of the electrospinning
process. This chapter examines how the electric field effect is exploited in the fabrication of
electrospun scaffolds. Chapter 3 provides a consideration of how the molecular organization and
composition of a scaffold interact to dictate its biological and functional properties. This chapter
was published as a review

[1]

, and represents the culmination of several studies and specifically

describes the use scaffolds produced from electrospun collagen in various tissue engineering
applications. The results presented in this particular paper underscore the critical roles that
scaffold composition and the molecular organization of electrospun fibers of collagen, play in
many tissue engineering applications.

2

Chapter 4 is also a published manuscript, and it describes the use of a novel
electrospinning strategy called two pole air gap electrospinning that was developed in our
laboratory to produce scaffolds that mimic the anisotropic structure of the native ECM present in
peripheral nerves

[2]

. In this tissue engineering application, the development of a regenerative

scaffold with potent guidance cues, sufficient material strength, and the appropriate architectural
features is critical to the success of any implant used to reconstruct a damaged segment of
peripheral nerve. This manuscript is a comprehensive analysis of the variables that impact the
alignment of electrospun fibers in the two pole air gap electrospinning system. Preliminary in
vitro and in vivo observations reported in this chapter provide evidence that scaffolds produced
by this electrospinning process recapitulate key architectural features of the native sciatic nerve
and are very efficient at supporting the regeneration of damaged peripheral nerve.
Chapter 5 discusses the development of a sustained release platform for the delivery of
growth factor gradients within a nerve graft. In long gap nerve injuries bridged with a nerve
guide, neurotrophic factors and various biochemical cues released from the cells present in the
native tissues adjacent to the implant site may be insufficient to fully drive regeneration. This is
especially true in the rodent sciatic nerve after introducing a 15 mm gap in this tissue; the
remaining nerve stumps adjacent to the injury site are quite small in area in comparison to the
area of the implanted graft. The alginate delivery system described in Chapter 5 was developed
to overcome this potential limitation. The alginate polymer can be polymerized and used to trap
therapeutic reagents; this carbohydrate is highly biocompatible and can be fabricated into a
variety of shapes and configurations. It undergoes gradual dissolution under physiological
conditions, making it suitable for use as carrier for the sustained release and delivery of growth
factors and other therapeutic reagents at precise locations.

3

Chapter 6 is a study that builds on the results reported in Chapter 4. It provides a more in
depth analysis of the grafts produced by two pole air gap electrospinning in the reconstruction of
peripheral nerve injuries. This study compares the efficacy of this unique design with respect to
the performance of autologous grafts and the more classic hollow core graft design presently in
clinical use. In this comparative study, the 3D nerve guides characterized in Chapter 4 are
supplemented with or without a gradient of Nerve Growth Factor (NGF) using the alginate
system discussed in Chapter 5. A battery of functional and structural metrics is used to evaluate
the performance of each graft design.
The discussion provided in Chapter 6 synthesizes the results of the individual chapters
presented in this thesis into a coherent whole and discusses some potential avenues for future
research.

4

CHAPTER 2

5

Chapter 2. Introduction to Electrospinning

ELECTROSPINNING PROCESS

Electrospinning is a non-mechanical process that uses an electrical field to induce the
formation of nano- to micron-scale diameter fibers from a charged polymer solution or a polymer
melt

[3-5]

. In practice, fibers produced by electrospinning are targeted to deposit onto an

oppositely charged target or collector to form a scaffold. Figure 2.1 illustrates a schematic of the
process of electrospinning.
In a typical bench scale electrospinning setup, a polymer solution is placed into a syringe
that has been installed into a syringe pump. While in many electrospinning systems, the pump is
not necessary, one is usually used to promote more uniform fiber formation through the constant
delivery of material to the tip of the electrospinning needle

[6]

. The electrospinning needle,

usually blunt tipped, is attached to an electrode of a high voltage power supply (for this thesis,
unless mentioned, it will be assumed that the needle is attached to the positive electrode, as in the
illustration on the next page). The negative electrode is attached to a collecting surface (or placed
behind a collecting surface in some cases). Electrospinning voltages vary with the polymer and
solvent system to be processed, in routine spinning, 16-22 kV is a commonly used range of
voltages [3-7].

6

Figure 2.1: Schematic of the process of electrospinning. In this image, the polymer solution in
the syringe is positively charged with a high voltage, low amperage power supply. The injection
of this charge leads to formation of a liquid jet that dries to form fibers which are deposited onto
a negatively charged collector. The nature of the polymer(s) to be spun determines the polarity
of the system.

7

In electrospinning, there are three forces that can be identified acting on the polymer
solution at the tip of the needle: (i) the surface tension of the polymer solution which holds the
solution at the tip of the needle in a spherical shape; (ii) the viscoelastic forces of the polymer
solution; and (iii) Coulomb forces of charge repulsion which originate with the positively
charged ions in the polymer solution. As noted, surface tension tends to give the polymer
solution a spherical shape at the tip of the needle. The electrostatic Coulombic forces counter the
surface tension to some extent and distort the spherical shape of the polymer drop at the needle
tip, thereby increasing the surface area of the droplet [3, 7].
When an electric charge is injected into the polymer solution via the positive electrode
placed onto the needle, the stray ionic charges present in the solution are neutralized (e.g.
injection of a positive charge neutralizes negative ions). With the application of increased
electric potential the Coulombic forces begin to dominate the surface tension forces and the
polymer droplet collapses to assume a conical shape, this structure is referred to as the Taylor
cone

[8, 9]

. Once the electrostatic forces exceed the surface tension forces, a jet of the polymer

solution is ejected from the tip of the syringe and towards the grounded target. In the theoretical
electrospinning setup under discussion, the electric potential created by the negatively charged
collector that is placed in front of the positively charged needle attracts the positively charged
polymer jet. Viscoelastic forces, which are a product of the polymer chain entanglements present
in the electrospinning solution, resist the distorting electrostatic force and serve to maintain a
smooth continuous polymer jet

[9]

. As the jet travels to the collecting target the solvent

evaporates and a fiber is formed, the fiber deposits on the surface of the collector in the form of a
non-woven mat [3, 7, 9].

8

The configuration of the grounded target array determines the gross architectural
organization of the resulting scaffold. Simple to complex shapes can be produced in a seamless
fashion. For example, if the ground target is stationary flat surface the spun fibers will collect on
that surface as a flat sheet. Spinning onto a slowly rotating mandrel can be used to produce
cylindrical and or rectangular constructs. As the rate of rotation of these targets is increased
varying degrees of fiber alignment in can be induced in the spun scaffolds

[10, 11]

. Overall, the

electrospinning process is directly related to the more familiar electrostatic painting processes
used in many industries, such as processes used in the automobile industry to paint car bodies.
The fundamental difference lies in the use of polymers with chain entanglements that result in
the formation of a fiber instead of a charged droplet.
The forces that dictate the path of the polymer jet from the needle tip to the collector play
a critical role in fiber formation and the pattern in which they deposit onto the ground target. At
electrostatic equilibrium, the electric field inside a conducting fluid is zero. Once sufficient
charge has been injected into an electrospinning system to form a Taylor cone and a charged jet,
the Coulombic repulsion forces within the jet cause the like charged ions to radiate towards and
against the surface of the jet [9], as shown in Figure 2.2A.

9

Figure 2.2A: Effect of Coulombic repulsion forces. The injection of a positive electric charge
into the syringe of an electrospinning system neutralizes the negative ions present in a polymer
solution. This leads to a charge imbalance and the formation of Coulombic repulsive forces. The
Coulombic forces cause the positively charged ions to migrate towards the surface of the
polymer solution, once sufficient force is present to overcome the intrinsic surface tension of the
solution a charged jet is formed and ejected from the syringe tip.

Figure 2.2B: Coiling of the electrospun jet. As the charged polymer jet travels some distance
away from the needle tip, its diameter decreases because of drying. This leads to an increased
concentration of the repulsive ionic charge forces (F1, F2, F3, and so on) inside the polymer jet.
The net resultant repulsive force (Fr) is in the direction perpendicular to the orientation of the jet.
The cumulative effect of these perpendicular perturbations results in fiber coiling, fiber whipping
and fiber elongation. (Adapted from Reneker and Yarin, 2008 [9].)
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As the charged jet travels away from the Taylor cone, its diameter decreases because of
the simultaneous effects of the jet stretching against the surface tension and the evaporation of
the electrospinning solvent [3]. This decrease in jet diameter further increases the repulsive charge
density. After a small straight segment, bending perturbations and many other forces leading to
instabilities

[9]

result in the formation of polymer jet. As shown in Figure 2.2B, there are many

repulsive forces in the jet in varied directions (F1, F2) with the resultant summation of all the
forces Fr, being in the radial direction to the straight jet

[9]

. This radial force ultimately results in

a three-dimensional coiled trajectory of the jet with the coil diameter growing larger as the jet
moves away from the Taylor cone. This process is largely driven by the increased charge density
associated with the constantly decreasing jet diameter. Reductions in jet diameter are produced
though the processes of solvent evaporation and fiber stretching. Together, these forces result in
the formation of nano- to micron-scale diameter fibers.
Motion along the straight axis of the trajectory from the Taylor cone towards the collector
is driven by the potential difference between the positively charged needle tip and the negatively
charged or grounded collector. After several turns of the coiled trajectory, the elongation stops,
usually as a consequence of the solidification of the polymer fiber jet. The position where
solidification occurs, essentially “flash-lyophilization”, largely determines the placement of the
collector on which non-woven mat / scaffold of polymer fibers are to be deposited. Placing the
collecting target in a position where it collects the charged polymer jet prior to its solidification
process results in the deposition of wet fibers and solvent welding (partial melting of fibers
against one another).

11

REGULATING ELECTROSPINNING – TWEAKING ITS VARIABLES

The morphology and diameter of an electrospun fiber is modulated by a variety of
electrospinning parameters, including the intrinsic properties of the polymer solution, the
electrospinning setup, and environmental variables.
The intrinsic properties of a polymer include the polymer concentration and the viscosity
of the solution, the extent of chain entanglements, the surface tension of the solvent/polymer
solution, and overall electrical conductivity of the solution (or melt). In practice, the relationship
between polymer concentration (solution viscosity which increases with polymer concentration)
and fiber diameter is relatively simple. At very low polymer concentrations, i.e. below the
electrospinning threshold, aerosol droplets will form in the electrospinning field. As the
concentration of polymer increases the droplets transition into fibers; increasing the polymer
concentration still further will result in ever larger diameter fibers

[2, 5, 10, 12]

. Once the

concentration of polymer becomes too high, the surface tension of the system cannot be
overcome. The charged jet becomes more inelastic, the Taylor cone becomes unstable and the
polymer may be ejected as short fragmented fibers or beads. Increasing the polymer
concentration still further results in the extrusion of the polymer from the needle tip as a large
diameter thread which fragments; the mass of this material may be too large for it to reach the
collecting target and it drops off the needle. These relationships assume that sufficient chain
entanglements exist within the electrospinning solution to allow fiber formation to take place. In
the absence of chain entanglements, fiber formation is non-existent or very limited. Spinning is
precluded for some polymers if they are present in a very high molecular weight form that has
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extensive chain entanglements; this results in a solution with a very high surface tension and the
electrospinning jet may be too inelastic to support fiber formation.
The conductivity of the spinning solution may originate from the charge properties of the
polymer and solvent and or from any stray “contaminating” ions that are present in the system.
Manipulating the conductivity of the solution can make it possible to produce fibers from a given
polymer that may otherwise not be possible to produce. For example, for some polymer systems
it can be difficult to produce very small diameter fibers (e.g. < 100-200 nm). At low polymer
concentrations the intrinsic charge of the solution may be insufficient to drive fiber formation,
under these conditions an aerosol, rather than a fiber, may form in the electrospinning field.
Alternatively, fibers with bead defects can also develop; these scaffolds look as if they are
composed of fibers interspersed with beads (commonly resembles a fiber composed of “beads on
a string”). These structures can compromise the mechanical properties of the scaffold. For many
polymer systems, these limitations can be compensated for by simply adding exogenous salts to
increase the charge density present in the electrospinning solution [12].
The surface tension of the polymer solvent solution is intrinsic to the specific system in
use. Altering the solvent of a system can be used to manipulate this property under some
circumstances; however, the solvent system to be used is largely dictated by the solubility
properties of the polymer to be spun. This may limit the selection of solvents that are available
for the spinning process. If it is not possible to change solvent system it may be possible to alter
surface tension by adding or mixing additional solvents into the electrospinning solutions to alter
the surface tension; in general a reduction in surface tension favors the formation of fibers over
droplets [12].
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The physical arrangement of the electrospinning setup also can be varied to modulate
fiber diameter and scaffold properties. For example, increasing the flow rate of the syringe pump
can increase the diameter of the resulting fibers. Conversely, and within limits, a decrease in
flow rate, a manipulation that “starves” the electrospinning field of polymer (effectively reducing
“polymer concentration” in the electrospinning field) results in a reduction in fiber diameter.
Similar effects can be achieved, again within limits, by altering the electric forces that drive the
spinning process. Here, increasing the voltages used in the spinning process results in the
accelerated depletion of polymer from the Taylor cone. This will usually result in a decrease in
fiber diameter. If a high voltage is required for electrospinning because of the intrinsic properties
of the polymer solution, one way to overcome the reduction in fiber diameter normally observed
in response to increased electrospinning voltages is to increase the delivery of polymer into the
electric field. This can be achieved by increasing the rate at which the polymer is delivered to the
syringe tip (increasing the rate of the pump).
It should be noted that changes in the flow rate and the electric field are usually limited in
nature and by extension are also limited in the extent to which they can impact fiber formation.
These electrospinning variables are tightly linked in a fundamental manner and the constraints
placed on manipulating these processing variables are perhaps best illustrated by theoretical
examples. At one extreme it is obvious if there is zero flow rate of polymer to the syringe tip no
electrospinning can take place! Once sufficient polymer is delivered and the resulting fibers lack
“bead defects” further increases in the flow rate will tend to drive fiber diameter somewhat
larger. This process is limited in nature because increasing the flow rate too high results in the
formation of very wet fibers and solvent welding (occurs when fibers wet with solvent collect on
the target and the excess solvent literally melts adjacent fibers together). Increasing the electric
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field decreases fiber diameter. If this is taken to an extreme, the polymer is depleted from the
Taylor cone so quickly that an aerosol spray forms or fiber defects in the guise of beads may
appear. Counteracting this effect by increasing flow rate may, once again, result in wet fibers and
a solvent welded scaffold. In some systems the evolving solvent vapors may be present at such a
high concentration that fiber formation is completely inhibited. Together, these observations
underscore the interconnected nature of the variables that drive the electrospinning process.
Decreasing the distance between syringe needle and the collector can increase the fiber
diameter. Reducing this distance reduces the interval of time that a fiber can undergo whipping
and elongation within the electric field. As with changes in the strength of the electric field and
or polymer flow rates there are limits to the extent to which this manipulation can be effective.
Moving the target too close to the electrospinning source will not allow the fibers to fully dry
prior to collecting on the target, once again resulting in solvent welding. Moving the target
further way can allow for additional fiber thinning during the flight path of the jet-fiber thinning
will cease once the fiber is dry. However, moving the target too far beyond the site in the
trajectory where fiber drying occurs reduces the efficiency of fiber collection.
Environmental variables like temperature and humidity also affect fiber diameter. For
example, increasing the temperature of the local environment will increase the rate at which
solvent evaporates from the electrospinning jet while increasing the humidity can be expected to
retard the loss of solvent from the jet.
Owing to the coiling and bending instabilities present within the charged polymer jet as it
travels towards a static collecting plate (literally a flat sheet of material in this circumstance),
electrospun fibers are typically deposited as coils of randomly oriented fibers. This type of
scaffold is suitable for many applications where the native extracellular matrix appears to be
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composed of random elements. However, a variety of tissue engineering applications ostensibly
require scaffolds composed of fibers deposited into parallel arrays. Examples of where such
anisotropic features might be desirable include tissue engineered ligaments, muscle and
substrates for nerve growth. Efforts to induce alignment have generally focused on using some
type of rotating target mandrel

[5, 13, 14]

. In a simple system a rotating cylindrical, rectangular or

square mandrel can be used to induce fiber alignment. Once sufficient surface velocity has been
achieved with the collecting mandrel, the coils of the charged electrospinning jet are caught and
pulled onto the rotating surface. This allows for the collection of aligned, parallel segments of
electrospun fibers that are oriented along the circumferential direction of the rotating target.
While this method is effective at inducing anisotropy, it has inherent limitations. The extent to
which fibers can be aligned is somewhat limited and larger diameter fibers can be induced to
align more readily and more uniformly than smaller diameter fibers in this type of system.
In contrast to the above mentioned method of conventional electrospinning using a
rotating target mandrel to deposit aligned fibers, our laboratory has develop of novel technique
of electrospinning highly aligned fibers in a cylindrical construct with fibers oriented along the
longitudinal axis of the construct [2]. This method will be discussed in detail in Chapter 4.
By regulating the various, above mentioned, electrospinning parameters, the fibers of the
electrospun scaffold can be tailored as per the requirements of specific tissue engineering
applications. The following chapters will elaborate on some of the applications of the tissue
engineered electrospun scaffolds and how the electrospinning variables can be regulated to
fabricate such scaffolds.
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Chapter 3. Electrospun Collagen: A Tissue Engineering Scaffold with Unique
Functional Properties in a Wide Variety of Applications

Preface: The following manuscript appeared in the Journal of Nanomaterials, Volume 2011

[1]

.

The work included demonstrates the exploitation of the biological and functional properties of
electrospun scaffolds for various tissue engineering applications. As noted there are a variety of
electrospinning variables that can be manipulated to fabricate scaffolds with distinct
characteristics. This chapter explores how the identity of the starting polymer solution,
variations in electrospinning conditions and post electrospinning manipulations can be used to
regulate and or alter the functional properties of electrospun scaffolds. Aspects of the materials
and methods section of this published manuscript have been augmented with additional details.
The functional properties of electrospun collage are explored; the native form of this
polymer represents the most abundant extracellular protein of the mammalian system. This
protein functions to establish the basic architectural organization of the structural body tissues.
Collagen in the form of sponges has long been used in tissue engineering applications for the
reconstruction of skin injuries. The results of our experiments indicate that fibers of electrospun
collagen mimic many of the structural and functional properties of the native collagen fiber.
And, as a result appear to represent a superior form of the protein for tissue engineering
products. The quality of starting collagen polymer solution, electrospinning variables, and the
post processing manipulations used to prepare this natural polymer for use in tissue engineering
applications, all effect the structure and function of the resulting scaffold. This chapter
demonstrates how these distinct properties, caused by slight process-modifications, can be
exploited to develop distinct and potentially clinically relevant products.
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ABSTRACT

Type I collagen and gelatin, a derivative of Type I collagen that has been denatured, can
each be electrospun into tissue engineering scaffolds composed of nano- to micron-scale
diameter fibers. We characterize the biological activity of these materials in a variety of tissue
engineering applications, including endothelial cell-scaffold interactions, the onset of bone
mineralization, dermal reconstruction, and the fabrication of skeletal muscle prosthetics.
Electrospun collagen (esC) consistently exhibited unique biological properties in these functional
assays. Even though gelatin can be spun into fibrillar scaffolds that resemble scaffolds of esC,
our assays reveal that electrospun gelatin (esG) lacks intact α chains and is composed of
proinflammatory peptide fragments. In contrast, esC retains intact α chains and is enriched in
the α 2(I) subunit. The distinct fundamental properties of the constituent subunits that make up
esC and esG appear to define their biological and functional properties.
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INTRODUCTION

Electrospinning has been used to fabricate a variety of polymers, including natural
proteins

[4, 15, 16]

, sugars [17], synthetic polymers [18], and blends of native and synthetic polymers

[13, 19, 20]

into tissue engineering scaffolds composed of nano- to micron-scale diameter fibers, a

size-scale that approaches the fiber diameters observed in the native extracellular matrix (ECM).
The physical, biochemical, and biological properties of these unique biomaterials can be
regulated at several sites in the electrospinning process. As this technology has matured, it has
become apparent that many electrospun nanomaterials exhibit unusual, and often surprising,
properties.
For many polymers, physical properties, including fiber diameter, pore dimension, and
degree of scaffold anisotropy, can be regulated by controlling the composition of the
electrospinning solvent, the air gap distance, accelerating voltage, mandrel properties, and/or the
identity, concentration, and degree of chain entanglements (viscosity) present in the starting
solutions

[10, 11, 21]

. The ability to directly manipulate these fundamental variables can have a

dramatic impact on the structural and functional properties of electrospun materials. This is
especially true when considering native proteins and blends of synthetic polymers and native
proteins.
Collagen represents the most abundant protein of the mammalian ECM. As such, this
natural polymer has long been used as a biomaterial in a variety of tissue engineering
applications. This crucial ECM protein, as well as a variety of other native proteins, can be
electrospun into fibers that resemble the native state

[4]

. Not surprisingly, the fibers of

electrospun collagen do not appear to fully reconstitute the structural or mechanical properties of
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the parent material [21]. Simultaneously, it is unclear to what extent the electrospun analog “must”
recapitulate the native material to be a functional tissue engineering scaffold. The nature of the
electrospun collagen fiber is the subject of debate and there are conflicting reports in the
literature concerning its structural and functional properties

[19, 21-24]

. In this study, we compare

and contrast the functional characteristics of electrospun collagen and electrospun gelatin
(denatured collagen) in a variety of tissue engineering applications. We then explore how the
procedures used to isolate and prepare collagen for the electrospinning process might ultimately
impact its functional profile once it has been processed into a tissue engineering scaffold. We
believe that it is essential to develop a more complete functional map of these novel materials to
fully exploit them in the development of clinically relevant products.
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MATERIALS AND METHODS

Collagen Preparation
Collagen was isolated at 4°C. Calfskin corium (Lampire Biologics, Pipersville, PA) was
cut into 1 mm2 blocks and stirred for 24 hr in acetic acid (0.5 M), processed in a blender into a
slurry, and stirred for an additional 24 hr. Solutions were filtered through cheesecloth,
centrifuged at 10,000× g for 12 hr; supernatant was recovered and dialyzed three times in tenfold volume ice cold (4 ºC), ultra-pure 18 MΩ-cm water. Collagen isolates were frozen at -70 ºC
and lyophilized. Bovine gelatin Type B isolated from skin was purchased from Sigma-Aldrich
(75 or 225 bloom).

Electrospinning: Collagen and Gelatin
Materials were purchased through Sigma-Aldrich unless noted. Lyophilized collagen (at
55 mg mL-1) and gelatin (225 bloom at 110 mg mL-1) were solubilized for 12 hr in 1,1,1,3,3,3hexafluoro-2-propanol (HFP) and electrospun

[4, 10, 19]

. Conditions were adjusted to produce

scaffolds composed of fiber diameters that were nominally 1 μm in cross-sectional diameter.
Solutions were charged to 22 kV and delivered (3–7 mL hr-1) across a 25 cm air gap onto various
target arrays. Electrospun samples, designated “recovered” electrospun collagen (rEC) or
“recovered” electrospun gelatin (rEG) were produced by dissolving uncross-linked electrospun
scaffolds immediately after spinning in ice cold (4 ºC), 18 MΩ-cm water; the final protein
concentration was adjusted in these solutions to 1.5 mg mL-1. In some experiments collagen and
gelatin starting electrospinning concentrations were manipulated to produce fibers of varying
diameters. Where indicated, scaffolds were vapor cross-linked (1–12 hr) in glutaraldehyde,
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blocked in 0.1 M glycine, rinsed in Phosphate buffered saline (PBS), and disinfected in 70%
alcohol prior to culture experimentation or implantation.

Cell Culture: Endothelial Cells
Electrospun scaffolds were cut into 12 mm diameter circular disks using a punch and
cross-linked. A sterile 6 mm diameter glass cloning ring was placed on top of each disk and the
inner portion of the disks were supplemented with 3,000 adult human microvascular endothelial
cells (Invitrogen, C-011-5C) in a total volume of 100 μL. After 20 min the culture dishes were
flooded with media to ensure that the cells were fully immersed. Cloning rings were removed
after 24 hr of culture. The rings serve to confine the cells to a known surface area volume and
help to insure a more uniform plating density across all treatment groups.

Cell Culture: Osteoblasts
Type I collagen and gelatin were electrospun across a 25 cm gap and directed at a
grounded 6 inch diameter circular steel plate. Tissue culture dishes were placed between the
source electrospinning solutions and the grounded target to directly collect fibers on the culture
surfaces. After cross-linking, equal numbers of osteoblasts (Clonetics, CC-2538) were plated
onto each surface and cultured for 10 days in OBM basal media (CC-3208). As controls, cells
were plated onto native tissue culture plastic or random gels composed of Type I collagen
(Vitrogen: Cohesion Technologies) after the methods of Simpson et al. [25]. For scanning electron
microscope (SEM) imaging, osteoblasts were cultured directly on 6 mm diameter × 500 μm thick
circular disks of electrospun collagen or gelatin (conditions optimized for 1 μm diameter fibers).
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Dermal Reconstruction
Adult guinea pigs (Dunkin Hartely guinea pig; Harlan laboratories) were brought to a
surgical plane, fur was shaved and skin swabbed in betadine. Four 1 cm2 full-thickness dermal
injuries (complete removal of the dermis and hypodermis and bordered by the superficial fascia
of the panniculus adiposus) were prepared on the dorsum of each animal. Injuries were treated
with scaffolds composed of electrospun Type I collagen or electrospun gelatin (electrospinning
conditions adjusted to produce scaffolds composed of fibers ranging from 250 nm to > 2000 nm
in average cross-sectional diameter). Scaffolds were vapor cross-linked to varying degrees as
noted in the body of this study. Each wound was treated with a candidate scaffold and covered
with a piece of silver gauze that was sutured in place. Silver gauze remained in place for 5–7
days. Animals recovered on a warming pad after surgery and were provided with pain mitigation
(Buprenorphine 0.05 mg kg-1 SQ every 12 hours). Injuries were photographed at intervals. Data
on wound closure was expressed as the percent injury surface area observed at the time of
implantation. Representative samples were recovered for histological evaluation.

Muscle Fabrication
Three-day-old neonatal rats (Harlan laboratories) were decapitated, skin was removed.
Skeletal muscle was removed from the limbs and body wall, minced into 1 mm2 pieces in sterile
PBS and rinsed until clear of blood. Tissue was incubated in a sterile flask supplemented with
0.25% trypsin (Invitrogen) in a shaking (100 RPM) 37 °C water bath. At 10 min intervals, tissue
was cannulated and allowed to settle, and supernatant was removed and centrifuged at 800× g for
6 min. Cell pellets were pooled in DMEM plus 10% Fetal Bovine Serum (FBS) and 1.2%
Antibiotic/Antimycotic (Invitrogen, 15240). A 60 min interval of differential adhesion to tissue
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culture plastic was used to reduce fibroblast contamination in the pooled samples. Myoblasts
were cultured for 3–5 days under conditions that minimized cell to cell contacts. In cell labeling
assays, myoblast cultures were incubated in DiO (Invitrogen, L-7781) overnight according to
manufacturer’s recommendations.
Electrospun scaffolds were prepared on a 4 mm diameter round mandrel. With conditions
optimized to produce 1 μm diameter fibers, cylindrical constructs were fabricated with a wall
thickness of 200–400 μm [26]. Scaffolds were cross-linked, blocked and rinsed as described under
the materials and methods section of this study discussing the electrospinning of collagen and
gelatin. Myoblasts were trypsinized from the culture dishes and rinsed 2× in PBS by
centrifugation (800× g, 6 min). Disinfected electrospun cylinders of collagen and gelatin were
sutured shut on one end (5-0 silk) and suspended myoblasts were injected into the lumen of the
constructs. Once the cylinders were supplemented with the cells, the constructs were sutured
shut. Adult 150–180 g Sprague Dawley rats (Harlan laboratories) were brought to a surgical
plane. Fur on the hind limb was shaved and skin was swabbed in betadine. In short-term studies
(3 wks), a 4 mm × 15 mm long cylinder supplemented with cells was inserted directly into a
channel (“intramuscular” position) prepared in the vastus lateralis muscle after the methods of
Telemeco et al.

[19]

. In long term studies, a hemostat was passed deep to the quadriceps muscle

group; engineered tissue (4 mm × 40 mm) was passed under the existing muscle mass and
sutured (in an extramuscular position) to the proximal and distal tendons of origin and insertion
for the quadriceps. Incisions were repaired, skin was stapled, and animals recovered on a
warming pad.
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Electrospinning: Nylon
To separate the fiber-forming properties of the different protein fractions from their
fundamental biological properties, we applied acid soluble collagen and gelatin fractions to
electrospun scaffolds composed of nylon 66 (Ambion). Nylon 66 as supplied by Ambion is
engineered and designed for protein and nucleic acid blotting assays. Processing this material
into electrospun fibers yields a unique blotting platform. Electrospun nylon has a high surface
area and as a result exhibits high protein binding capacity. Nylon was spun after the methods of
Manis et al.

[26]

. Conditions were optimized to produce charged nylon fibers ranging 1.0–1.5 μm

in diameter.

Cell Culture: Adult Human Dermal Fibroblasts
Dermal fibroblasts (HDF), (Cascade Biologics: C-013-5C) were passaged 3–5 times in
basal dermal fibroblast medium 106 supplemented with a low serum growth kit (Cascade
Biologics, S-003-K) prior to experimentation.

Cell Adhesion Assays
Electrospun nylon scaffolds were immersed in 20% methanol/phosphate buffered saline
(PBS)

[26]

, rinsed 3× in PBS and installed in a dot blotter manifold (Topac Model DHM-48).

Wells were supplemented with 50 μL of acid soluble calf skin collagen (control samples or
fractions thermally denatured at 50, 60, 70, 80 or 90 ºC for 1 hr) or gelatin fractions containing
equal amounts of protein. Samples of collagen were thermally denatured by incubating and
holding acid soluble fractions in aliquots at various temperatures in a calibrated heating block.
After 5 min of exposure to the electrospun nylon, solutions were sucked through the membrane
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using a vacuum pump. Scaffolds coated with 1% bovine serum albumin (BSA) were used as
controls. All wells were blocked with 100 μL of 1% BSA solution for 5 min and rinsed in PBS
prior to use. In each assay, 3000 HDFs were suspended in 100 μL of media and applied to each
surface for 1 hr at 37 ºC (dot blotter was used as a culture vessel; no vacuum was applied to the
cell suspensions).
After the plating interval, the dot blotter was inverted to remove non-adherent cells;
scaffolds were removed, rinsed in PBS, and fixed in ice cold methanol (20 min). For analysis,
scaffolds were rinsed 5× in PBS plus 0.5% Triton x-100, and incubated overnight at 4 ºC in
primary goat anti-rabbit GAPDH antibody (Sigma-Aldrich # G9545, 1:5000). All antibodies
were diluted in LiCor Odyssey Blocking Buffer (L-OiBB), and L-OiBB plus 0.1% Tween-20
was used in all rinses. Cultures were rinsed 5× in L-OiBB, counter-stained with goat anti-rabbit
IRDye 800 secondary antibody (LiCor 1:1000) for 1 hr and rinsed 5×. Data sets were captured at
a line resolution of 169 μm using a Li-Cor Odyssey Infrared Imager. Adhesion was expressed as
“Integrated Intensity” (signal-mm2). Integrated intensity values were extrapolated to cell number
using a standard curve of cells plated in parallel on 96 well culture dishes with the unknowns.
Data sets were screened by one-way ANOVA (p < 0.01), Dunn’s Method (p < 0.05), and a
Mann-Whitney Rank Sum test (p < 0.001) was used in post hoc analysis. In cyclic RGD
competition experiments, HDFs (10,000 cells per treatment) were incubated for 15 min at 37 ºC
with 0.01, 0.1, or 1 μg mL-1 cyclic RGD peptide (Bachem, H-2574) or 1 μg mL-1 control RGD
peptide (Bachem, H-4088). The cells were then plated for 1 hr on the different surfaces and were
processed to image GAPDH as described.
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Alpha Chain Analysis
Collagen samples were diluted to 0.15 mg protein mL-1 in Laemmli sample buffer
(63 mM Tris HCL, 10% glycerol, 2% SDS, 0.0025% Bromophenol blue; pH 6.8) and separated
by SDS interrupted gel electrophoresis using 10% polyacrylamide gels. Gels were run under
non-reducing conditions until the dye front reached the base of the stacking gel, 1 mL of
Laemmli buffer supplemented with 20% β-mercaptoethanol was added to the gel stacker and
incubated for 30 min at room temperature. The separation run was then completed. Gels were
stained with Coomassie brilliant blue overnight, de-stained and photographed. Densitometric
analysis was conducted with the ImageJ software.

Cross-Linking Assays
See Newton et al.

[21]

for details of this colorimetric assay. In this assay samples were

incubated in 2 mL of a solution of 4.0% (w/v) of sodium bicarbonate and 0.5% 2,4,6trinitrobenzenesulfonic acid (TNBS) prepared in distilled water and incubated for 2 hr at 40 ºC.
At the conclusion of this incubation samples were supplemented with 1.5 mL of 6 M HCl and
held for 1.5 hr at 60 ºC. Aliquots of equal volume were placed into 96-well plates and read at
345 nm using a Spectramax Plus microplate spectrophotometer (Molecular Devices). Percent
cross-linking was calculated from the formula
⁄
⁄
where AbsC = absorbance of the controls at 345 nm; massC = mass of controls in mg.
AbsNC = absorbance of the unknowns at 345 nm; massNC = mass of unknowns in mg. All data
is expressed as percent of cross-linking observed in dry, unprocessed electrospun scaffolds
(controls) that have not been exposed to cross-linking reagents.
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Scanning Electron Microscopy
Samples were fixed in 2% glutaraldehyde (Sigma) overnight, rinsed in PBS and dried for
imaging with hexamethyldisilazane (Electron Microscopy Sciences). Samples were sputtercoated with gold for 2 min and imaged with a Zeiss EVO 50 XVP scanning electron microscope
(SEM) equipped with digital image acquisition. Average fiber diameter and pore area data was
determined from representative samples using ImageTool (UTHSCSA version 3.0). All fiber
diameter measurements were taken perpendicular to the long axis of electrospun fibers [10].

Transmission Electron Microscopy
Samples were immersed in 2% glutaraldehyde prepared in 0.1 M Cacodylate buffer for
12 hr at 4 ºC. They were washed 3× in 0.1 M Cacodylate buffer and post-fixed in 1.0% osmium
plus or minus 2.5% potassium ferricyanide for 1 hr [2, 19]. All samples were subjected to a graded
series of alcohol dehydration (starting with 50% ethanol for 15 min, then 70% ethanol for 15
min, next 95% ethanol for 15 min, then 100% ethanol 2× for 15 min). Samples were next
embedded in 1:1 Poly/Bed(Polysciences):Propylene oxide for 2 hr, followed by embedding in
2:1 Poly/Bed:Propylene oxide overnight in dessicator.

Histological Studies
Unless stated, for light microscopic histological studies the samples were stained with a
solution of 0.1% Toluidine Blue, 0.1% Methylene Blue, 0.1% Azure II in 1% sodium borate.
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RESULTS

Functional Performance of Electrospun Collagen
To compare and contrast the biological properties of electrospun collagen and
electrospun gelatin, we conducted a series of in vitro and in vivo functional assays.

Endothelial Cell Growth
Critical to the bioengineering paradigm is the development of tissue engineering
scaffolds that can support the proliferation and penetration of vascular elements. To evaluate this
characteristic in vitro, we plated microvascular endothelial cells onto electrospun scaffolds of
Type I collagen and electrospun gelatin composed of varying fiber diameters. During the initial
plating phase, and over time in culture, cell shape, on both surfaces (collagen and gelatin), was
modulated by the fiber size (and likely the pore characteristics that “travel” with the fiber size
that is present in the electrospun scaffolds

[10]

) (Figure 3.1). Electrospun scaffolds of collagen

and gelatin composed of small diameter fibers induced the expression of a highly flattened and
stellate cell shape. This cell shape was retained throughout the culture interval on both surfaces
(e.g., Figure 3.1 compare (a) = day 1 with (b) = day 7 as well as (i) and (j)). With increasing fiber
diameter, the cells assumed a more rounded and elongated phenotype. After 10 days,
microvascular endothelial cells cultured on collagen- or gelatin-based scaffolds with average
cross-sectional fiber diameter less than about 1.0–1.50 μm remained on the dorsal surfaces of the
constructs (Figure 3.1 (q), (r), (u) and (v)). As fiber size exceeded this threshold value and pore
size increased to about 10,000 nm2, the cells began to penetrate into the scaffolds (Figure 3.1 (s),
(t), (w) and (x)). These results suggest that the physical arrangement of fibers (i.e., the pore
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characteristics) plays a role in regulating the infiltration of endothelial cells into an electrospun
scaffold.
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Figure 3.1: Endothelial interactions with electrospun collagen and gelatin.
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(x)

Figure 3.1: Endothelial interactions with electrospun collagen ((a)–(h)) and gelatin ((i)–(p)).
Endothelial cell shape varied as a function of increasing fiber diameter on both electrospun
collagen (Day 1: (a), (c), (e), (g) & Day 7: (b), (d), (f), (h)) and electrospun gelatin (Day 1: (i),
(k), (m), (o) & Day 7: (j), (l), (n), (p)). Cell shape established during the early stages of plating
persisted throughout the entire culture interval (e.g., for each scaffold cells at day 1 appeared to
exhibit a similar cell shape after 7 days of culture). Cells expressed and retained a highly
flattened and stellate shape when plated onto scaffolds composed of fibers less than 1,500 nm
((a)–(l)). At larger fiber sizes the cells exhibited a more elongated phenotype, this was especially
evident on the collagen-based scaffolds ((e), (f), (g) and (h)). Penetration into the scaffolds was
primarily regulated by average fiber diameter and pore size. TEMs of cross-sectional images of
cells plated onto electrospun collagen ((q)–(t)) and electrospun gelatin ((u)–(x)) for 10 days.
Average fiber diameters for collagen (a) & (q) = 449 ± 122 nm, (c) & (r) = 1,187 ± 297 nm, (e) &
(s) = 1,886 ± 513 nm and (g) & (t) = 2,756 ± 855 nm. In gelatin (i) & (u) = 198 ± 50 nm, (k) &
(v) = 491 ± 114 nm, (m) & (w) = 1,252 ± 302 nm, and (o) & (x) = 1,619 ± 414 nm (all fiber
measurements from dry scaffolds prior to processing for cross-linking). Note that penetration
was not evident until a nominal average fiber diameter of about 1,800 nm was achieved in the
scaffolds (arrows in (r), (t), (x) indicate fibers in cross section). Scale bar in (a) for
(a-p) = 20 μm, scale bar in (x) for (q-x) = 5 μm.
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Osteoblast Differentiation
The 67 nm banding pattern typical of native Type I collagen is associated with the
formation of nucleation and binding sites critical to the mineralization process in bone

[27]

.

Superficially, electrospun fibers of collagen exhibit a similar structural motif. To examine the
potential functional consequences of this motif, we plated osteoblasts onto surfaces coated with
electrospun collagen and electrospun gelatin. Cultures plated onto surfaces coated with
electrospun collagen exhibited low rates of proliferation and failed to form a confluent cell layer,
even after 8 days. Phase bright crystals were present throughout these cultures (Figure 3.2). Cells
plated onto surfaces coated with electrospun gelatin, Type I collagen gels, or native tissue culture
plastic proliferated and formed a confluent cell layer over this same culture interval. Phase bright
crystals were infrequently observed in any of these cultures. These data suggest electrospun
collagen contains structural motifs necessary and sufficient to induce osteoblast differentiation
and subsequent formation of hydroxyapatite crystals.
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Figure 3.2: Osteoblast interactions with electrospun collagen and electrospun gelatin.
Human osteoblasts plated for 1 (a)–(d) or 8 days (e)–(h). Cells plated on electrospun collagen
((a), (e)), electrospun gelatin ((b), (f)), collagen gel ((c), (g)), or tissue culture plastic ((d), (h)).
Cells plated onto electrospun collagen remain sub-confluent after 8 days of culture (e) and
accumulated phase bright crystals. At the ultrastructural level, osteoblasts plated onto
electrospun gelatin expressed a rounded cell shape (i); when plated onto electrospun collagen,
the cells were covered with elaborate arrays of plate-like structures typical of hydroxyapatite
crystals ((j), (k)). Scale bar in (a) for (a-h) = 10 μm.
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Dermal Reconstruction
From an architectural standpoint, tissue engineering electrospun scaffolds are
theoretically very well suited for applications in dermal reconstruction. These constructs are
deposited as nonwoven, fibrillar structures that exhibit an extensive void volume and pores that
are completely interconnected with one another. To evaluate the efficacy of using electrospun
collagen as a dermal template, we treated full thickness dermal injuries with various
permutations of this material. To track the healing process, we measured total wound surface
area as a function of treatment and time. We have used this metric because interventions that
reduce wound contraction (as measured by an increased retention of wound surface area once the
injury is healed) are associated with less scarring and more complete tissue regeneration [28].
In the first series of experiments, we treated wounds (1 cm2) with dermal templates
fabricated from electrospun collagen under conditions that produced fibers ranging 750–
1,000 nm. These scaffolds were post processed to cross-link approximately 50% of the available
sites. Wound closure took place in 16 days with these constructs (Figure 3.3(a)). When the extent
of cross-linking was increased to 70% in these constructs, wound healing was delayed modestly
and wound surface area was dramatically increased, a feature indicative of increased
regeneration (Figures 3.3(a) and 3.3(c)). Histological examination of the tissue reconstituted with
templates composed of electrospun collagen consistently revealed a smooth continuum of
infiltrating cells. There were no overt signs of inflammation or fibrosis along the interface of the
implanted templates and the adjacent uninjured tissue, regardless of the fiber diameter
composition present in electrospun constructs of Type I collagen (Figures 3.4(a)–3.4(c)). Our
tissue culture experiments demonstrated that the intrinsic architectural features present in an
electrospun scaffold can modulate the extent to which endothelial cells can penetrate into these
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constructs. We observed a similar trend in our dermal reconstruction experiments. Injuries
treated with templates composed of fibers less than 500 nm in diameter were less densely
populated than templates composed of fibers greater than 750–1000 nm in diameter (Figure 3.4).
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Figure 3.3: Dermal Reconstruction. Rates of wound closure in lesions treated with
electrospun collagen (a) or electrospun gelatin (b). Note that increasing the extent of crosslinking has a modest effect on slowing wound closure and greatly increases total wound surface
area in animals treated with electrospun collagen (a) and (c). Rates of wound closure were
similar when injuries were treated with a wide variety of gelatin-based constructs (b) and (d).
Panel (c) depicts the typical wound healing course for injuries treated with electrospun collagen
in which approximately 70% of the available sites are cross-linked. Note the retention of wound
surface area in this example. Panel (d) depicts the typical wound healing course for injuries
treated with electrospun gelatin in which approximately 70% of the available sites are crosslinked. Note the classically X-shaped wound typical of a lesion that has undergone contraction.
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Figure 3.4: Dermal Reconstruction. Healing response to electrospun collagen and
electrospun gelatin as a function of fiber diameter and pore dimension.
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Figure 3.4: Dermal Reconstruction. Healing response to electrospun collagen (a)–(c) and
electrospun gelatin (d)–(f) as a function of fiber diameter and pore dimension. Collagenbased implants exhibited a smooth continuum of cells at the interface of the lesion and the
surrounding tissue. In each of the images depicted in this figure, native, uninjured tissue appears
to the left of each data image (delineated by the large blue staining collagen bundles in the
histological preparations, arrows (b) and (c)). Gelatin based-scaffolds were consistently less
heavily infiltrated and exhibited evidence of an inflammatory response and accumulated foreign
body giant cells (arrow head (d)). (a) and (d) average fiber diameter = 240–280 nm, average pore
dimension =1500–2000 nm2, (b) and (e) average fiber diameter 500–600 nm, average pore
dimension 3000–5000 nm2, (c) and (f) average fiber diameter 800–1000 nm, average pore
dimension 4000–5000 nm2. Scale bar in (f) for (a-f) = 20 µm.
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In parallel experiments conducted with a wide variety of electrospun scaffolds composed
of gelatin (average fiber diameters ranging from 250 nm to approximately 3000 nm), we were
unable to replicate these results. Wounds treated with electrospun gelatin consistently healed in
the classic X shaped configuration (Figure 3.3(d)) that develops in response to wound
contraction, this feature developed regardless of the fiber diameter or the degree of cross-linking
present in the gelatin-based scaffolds. These scaffolds were consistently infiltrated by foreign
body giant cells (multi-nucleated macrophages), indicating an inflammatory response to the
implanted electrospun gelatin (Figures 3.4(d)–3.4(f)). These data indicate that architectural
features and the biochemical identity of an electrospun scaffold composed of collagen interact to
define its unique functional characteristics.

Muscle Engineering
To evaluate the efficacy of using electrospun collagen in a cell-based tissue engineering
application, we used an in situ strategy to fabricate skeletal muscle prosthetics. In these
experiments, we electrospun Type I collagen onto a rotating 4 mm diameter mandrel; this
resulted in the formation of a hollow cylinder with walls composed of 1 μm diameter fibers of
electrospun collagen. These cylinders were then supplemented with myoblasts and implanted
directly into the vastus lateralis muscle. After 3 weeks, tissue fabricated with electrospun
collagen was densely populated with cells. Nascent myotubes and functional blood vessels were
evident throughout these implants (Figure 3.5). As with the dermal-templates, we observed a
smooth continuum between the surrounding tissue and the engineered muscle with no evidence
of fibrosis. In contrast to these results, tissue fabricated with gelatin based materials was
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necrotic, exhibited extensive fibrosis at the tissue interface and a massive infiltration of
lymphocytes.
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Figure 3.5: Muscle Fabrication: 3 Weeks.
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Figure 3.5: Muscle Fabrication: 3 Weeks. (a) Cross-section through the wall of cylindrical
construct placed within the tissue of the rat vastus lateralis. M = endogenous host muscle tissue,
TZ = transitional zone occupied by the wall of the electrospun construct. Note the lack of a
fibrotic capsule. ((b), (c)) Sections taken from within the lumen of the tissue, dense cell
populations are evident as are nascent myotubes (*). Scattered vascular elements are apparent
and intermingle with the surrounding cell population. (d) TEM cross-section of developing
myotube with forming myofibrillar elements (arrows). (e) Cell labeling experiments (with DiO)
indicate that few cells migrate out of the implanted tissues (arrowhead). The bulk of the labeled
cells are retained within the lumen of the electrospun constructs. (f) Tissue fabricated from
gelatin undergoes necrosis and develops a fibrotic capsule (FC). CC = central core of implant.
Scale bar in (a) = 100 µm, (b) = 50 µm, (c) & (f) = 10 µm, (d) = 5 µm, and (e) = 25 µm.
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Given these results, we next prepared engineered muscle tissue fabricated with
electrospun collagen and directly sutured the constructs to the tendons of origin and insertion for
the quadriceps muscle. These constructs were placed in an extramuscular position; in effect we
are converting the quadriceps muscle into a “quintriceps” muscle. After 8 weeks, the engineered
muscle was densely packed with fully differentiated myotubes that were distributed into stacked
and linear parallel arrays that mimicked native tissue (Figure 3.6). This developing muscle tissue
displayed well-formed myofibrillar elements. However, a range of cytoskeletal structural
patterns was observed. For example, some areas of the tissue displayed loosely packed arrays of
myofibrils (Figures 3.6(d) and 3.6(e)); other domains differentially took up the stains used to
enhance contrast for light (Figure 3.6(g)) and transmission electron microscopy (Figure 3.6(h)).
We suspect this differential staining is a reflection of protein density or protein identity with
respect to the myofibrillar subunits. Collagen bundles were evident along the borders of the
implanted tissue.
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Figure 3.6: Muscle Fabrication: 8 Weeks. (a) Low magnification survey image depicting the
terminal portions of muscle tissue engineered in situ. Images depicted in panels (b) and (c) were
taken from the cross-sectional area denoted as “B” and “C”, respectively in panel (a). The tissue
distal to the attachment sites exhibited stacked arrays of myotubes ((b), asterisks). Tissue
alignment is disrupted to some degree at the distal attachment sites as a consequence of the
sutures used to place the tissue ((c), arrows indicate functional blood vessels). Myofibril density
is observed to vary within cells that are in close proximity to one another ((d), arrowheads and
asterisk; also the myofibrillar density in (d) and (e) to (g) and (h)) and some subdomains of the
tissue stain differentially at both the light (g) and EM levels (h) with stains designed to enhanced
contrast. The tissue is highly biosynthetic as evidence by the accumulation of proteins in the
vicinity of the nuclei and golgi (g, asterisk). A subset of engineered tissue exhibits sarcomeres (f)
with unusual cytoarchitectural patterns at the Z bands (arrows) and H zones (arrowheads)
characterized by accessory electron dense structures. At the ultrastructural level, the implants are
surrounded by collagen fibrils ((i) asterisks). Scale bar in (a) = 50 µm, (b) & (c) = 20 µm, (d) &
(g) = 10 µm, (e) & (h) = 2.5 µm, (f) = 250 nm, (i) = 5 µm.
47

Analysis of Collagen Alpha Chain Structure and Function

Protein Analysis
We next conducted experiments to characterize how various processing conditions
impact acid-soluble collagen and how these manipulations might regulate the evolution of the
functional properties of an electrospun fiber. We first examined the effects of thermal
denaturation on Type I collagen. These experiments were conducted to provide us with a
benchmark for the evaluation of collagen structure and its α chain content in response to various
steps in the electrospinning process. Collagen was isolated from calfskin corium using classical
acid extraction methods, a procedure routinely used to prepare collagen as a biomaterial and for
use in the electrospinning process

[4, 19]

. Figure 3.7 illustrates an SDS gel depicting the α chain

content of the acid soluble parent extract with respect to fractions that have been subjected to
varying degrees of thermal denaturation.
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Figure 3.7: Analysis of Type I collagen α chain content. (a) Representative SDS gel depicting
the effect of various degrees of heat denaturation on soluble collagen. Lane 1 = MW standards,
2 = control sample maintained and stored at 4 ˚C, 3 = sample heated to 50 ˚C for 1 hr, 4 = 60 ˚C,
5 = 70 ˚C, 6 = 80 ˚C, and 7 = 90 ˚C. (b) Densitometric analysis of α chain content from
denaturation experiments. (c) Densitometric analysis (c) ratio of α 1(III) to α 1(I), (d) ratio
of α 1(III) to α 2(I), (e) ratio of α 1(I) to α 2(I) as a function of thermal insult. Dotted lines in
(c)–(e) depicts the actual ratio of α chains present in collagen recovered immediately after
electrospinning (no thermal insult).
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Protein fractions were held at 4 ˚C or heated to 50, 60, 70, 80, or 90 ˚C for 1 hr.
Detectable changes in the protein banding patterns present on the SDS gels were visible in all
samples subjected to heating. Densitometric analysis of the separated protein fractions revealed
that 50% of the collagen α chains were lost within 1 hr when soluble collagen was exposed to
70 ˚C (Figure 3.7). Exposure to higher temperatures accelerated the loss of the collagen α chains
from the soluble fractions and resulted in progressively more α chain fragmentation and
smearing in the gel lanes typical of a sample that has been broken down into a heterogeneous
mixture of peptides. At temperatures of 80 ˚C and greater, the protein bands corresponding to the
individual α chains were completely lost after the 1 hr incubation interval. Commercially
procured gelatin (collagen that has been heated and denatured during isolation) samples
exhibited little or no protein banding associated with intact α chains on the SDS gels; these
samples ran nearly exclusively as a continuous smear of proteins (not shown, see [19]).
To examine how the electrospinning process (solvents, electric field, and the flashlyophilization of proteins that occurs during fiber formation) might alter collagen α chain
content, we next prepared scaffolds composed of electrospun Type I collagen or commercially
sourced gelatin (conditions optimized to produce average fiber diameters = 1 μm). As judged by
scanning electron microscopy, these scaffolds were superficially identical. However,
transmission electrospun microscopy reveals that scaffolds of electrospun collagen exhibit the
67 nm banding pattern typical of the native fibril (Figures 3.8(a)–3.8(d)). In contrast, fibers of the
electrospun gelatin lack this distinctive structure and are nearly homogenous in appearance.
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(b)

(a)

(c)

(d)

(e)
(f)
Figure 3.8: Ultrastructural and functional characteristics of collagen.

51

Figure 3.8: Ultrastructural and functional characteristics of collagen. Representative
scanning electron and transmission electron micrographs of electrospun collagen ((a), (b)) and
gelatin ((c), (d)). (e) Cell adhesion to various forms of collagen; maximal adhesion was observed
in samples heated to 70 ˚C. (F) RGD competition binding assay. Cyclic RGD peptides inhibited
adhesion to denatured collagens in a concentration-dependent manner and had minor effects on
control acid-soluble starting material and no effect on collagen recovered from electrospun
scaffolds. Scale bars in (a) and (c) = 10 µm. Scale bar in (d) for (b) and (d) = 100 nm.
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For protein characterization of the electrospun scaffolds, we re-dissolved the collagen and
gelatin-based scaffolds and separated the resulting extracts by SDS gel electrophoresis. The
protein banding patterns on the gels and the specific compliment of α chains in the electrospun
collagen and the control starting material (Acid soluble Type I Collagen: Figure 3.7) were
similar, but not identical. Samples of electrospun collagen exhibited subtle derangements
in α chain content and, as judged by densitometric analysis, it was enriched in the α2 (I) content
(see Figure 3.7) with respect to the other α chains. Protein separation analysis of the electrospun
gelatin revealed, as expected, nearly complete α chain fragmentation (these samples displayed
complete fragmentation even prior to the electrospinning process) and was comparable to the
calfskin collagen samples heated to 90 ºC for 1 hr (Figure 3.7).

Alpha Chain Functional Properties
Next we examined how thermal manipulation impacted the adhesion properties of acidsoluble collagen and its electrospun variants. In these experiments, we coated electrospun fibers
of charged nylon with equal amounts of the various protein fractions described in Figure 3.7.
This strategy made it possible to separate the fiber-forming capacity of each fraction from the
biological activity that it displayed while presenting each fraction in a “matrix” that exhibited
identical architectural patterns (fiber size, pore properties, and material properties). Equal
numbers of dermal fibroblasts were then plated onto protein-coated electrospun nylon fibers.
Rates of adhesion to the parent collagen fraction were approximately 50% greater than rates of
adhesion to BSA-coated surfaces (Figure 3.8(e)). With one exception, thermal manipulation of
the acid-soluble collagen fractions did not dramatically impact functional performance in these
assays. Samples heated to 70 ˚C supported substantially higher rates of adhesion than the
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BSA-coated surfaces and all of the other collagen fractions (p < 0.002), the gelatin samples
(p < 0.001), and the samples recovered from electrospun scaffolds (p < 0.001). Rates of adhesion
to Type I collagen recovered after electrospinning were not statistically different from the parent
controls and were qualitatively much higher than gelatin and the electrospun gelatin samples.
The denaturation of collagen α chains uncovers RGD binding sites

[29, 30]

. To test for the

presence of these sites in the different samples, we challenged cells in the adhesion assays with
increasing amounts of cyclic RGD peptide. The RGD peptide reduced adhesion in the control
samples by about 20% and nearly 60% in collagen samples that been heated to 70 °C prior to
their use in the assay. No inhibition was detected in the collagen recovered after electrospinning
(Figure 3.8(f)). It is clear from the RGD-based competition assays that collagen recovered after
electrospinning behaves very differently than denatured collagens or material recovered from a
scaffold of electrospun gelatin. This observation is relevant when considering the functional
properties of an electrospun collagen fiber that appears to lack the 67 nm repeat banding pattern.
As long as the α chains are intact, even if they are not arrayed into a polymeric form that exhibits
the 67 nm repeat banding pattern, these fibers can be expected to exhibit unique and potent
biological properties. Together, our SDS gel assays and adhesion results indicate that
electrospinning does not directly denature collagen α chains.
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DISCUSSION

In this study, through our functional assays, we explored the biological properties of
electrospun collagen and electrospun gelatin. These two materials (collagen and gelatin)
consistently exhibited very different functional profiles in all our assays. We note that
endothelial cells began to penetrate into the fiber arrays of both electrospun collagen and
electrospun gelatin once a critical fiber/pore threshold was reached. However, subjectively cell
growth appeared to be much more rapid on the collagen-based scaffolds. We conclude from
these in vitro experiments, in the absence of an inflammatory cascade or other antigenic
complications, that endothelial cell infiltration is not limited by scaffold composition. Rather,
gross structural properties are more important in this type of setting. The composition of the
scaffolds appeared to dictate more subtle functional characteristics that regulated cell growth.
Cell culture experiments conducted with osteoblasts indicate that fibrils of electrospun
collagen appear to be sufficient to induce differentiation and promote the accumulation of
hydroxyapatite crystals in vitro. We believe this rather unexpected result may be a reflection of
an intrinsic structural motif that is uniquely present in electrospun collagen. We did not observe
this same result when we plated cells onto a collagen gel, a form of collagen that normally selfassembles into fibrils that contain a repeating banding pattern that also mimics native collagen
[31]

. Since both electrospun collagen and the fibers present in a collagen gel can exhibit a banding

pattern, it is unclear what drives these results. It is clear that these two types of fibers have subtle
structural differences; fibers of electrospun collagen are not stable in an aqueous environment,
unless they are cross-linked. In contrast, the fibers of a collagen gel are fully stable under these
conditions and do not require such treatment. Fiber stability in a collagen gel is linked to the
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exothermic reaction that occurs during fiber polymerization; this leads to the partial denaturation
of the constituent α chains and results in a more stable fiber structure. In the electrospinning
process, collagen alpha chains essentially undergo flash lyophilization. These inherent
differences in the fiber formation process likely result in the production of fibers exhibiting very
different fine structure.
In dermal applications, wounds treated with electrospun collagen and electrospun gelatin
underwent resolution over a similar time course. The nature of the tissue that resulted at the
conclusion of wound closure was very different and varied as a function of fiber composition and
the extent of cross-linking that was introduced in the scaffolds. Injuries treated with lightly crosslinked electrospun collagen and all samples of electrospun gelatin underwent varying degrees of
wound contraction. Introducing additional cross-linking into the collagen-based materials likely
stiffens the constructs and makes them less susceptible to wound contraction. All of the collagenbased scaffolds were infiltrated by fibroblasts and exhibited numerous functional blood vessels.
In contrast, injuries treated with electrospun gelatin were consistently less densely populated and
showed an accumulation of foreign body giant cells at the borders of the wound. This adverse
response in the gelatin-based materials is undoubtedly related to the pro-inflammatory peptides
present in highly denatured collagens [32].
The essential capacity of electrospun collagen to support rapid cell infiltration was
readily apparent from the experiments in which we fabricated skeletal muscle in situ. The
interconnected nature of the pores present in a scaffold of electrospun collagen appears to
provide more than enough passive nutrient exchange to support the donor cell population. A
nascent vascular supply developed in tandem with muscle differentiation to support the increased
metabolic demand associated with this process. Consistent with this conclusion, we observed
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functional blood vessels traversing the external walls of the implanted tissue and penetrating into
the internal aspects of the constructs. In contrast, once again, tissue fabricated with electrospun
gelatin induced a marked inflammatory response, and by 3 weeks the tissue was largely necrotic.
To develop an understanding of the basis of biological properties of electrospun collagen,
we compared and contrasted the structure and function of collagen α chains in samples subjected
to varying degrees of thermal denaturation and electrospinning. Not surprisingly, α chain content
is dramatically altered in response to heating. At 70 ˚C for 1 hour, 50% of the α chains are lost;
at 80 ˚C there is essentially complete α chain fragmentation and specific bands corresponding
to α1(III), α1(II), and α2(I) are no longer detectable. The α chain content of collagen subjected to
electrospinning is subtlety altered from the pattern observed in the starting materials (acidsoluble collagen). Based on our analysis, we have concluded that electrospun samples become
enriched in α2(I) content. This conclusion is based on the observation that the ratio
of α1(III): α1(I) is normal in the electrospun samples, α1(III): α2(I) is reduced and α1(I): α2(I) is
reduced. Since the ratio of α1(III): α1(I) is unchanged we must assume that no change in α1(III)
content has occurred as a consequence of the electrospinning process. Given this assumption and
the observation that both α1(III): α2(I) and α1(I): α2(I) are depressed; the common factor is a
change in α2(I) content; an increase in α2(I) is the simplest explanation for the observed results.
As the denominator in both ratios, any increase in α2(I) content results in a decrease in these
ratios. It is unclear how this enrichment may occur; it is possible that differences in alpha chain
solubility (or stability) in the electrospinning solutions may exist, leading to a preferential
enrichment of the α2(I) chain. This result awaits further investigation.
Our baseline adhesion experiments failed to definitively identify a specific binding
profile that might be used to evaluate the functional profile of the collagen α chains. A number of
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integrins (α1β1, α2β1, α3β1) bind to Type I collagen in an RGD-independent manner and
the αvβ3 integrin binds with high affinity to denatured collagen in an RGD-dependent
manner

[30]

. In competition binding assays, RGD challenge had little or no effect in control

samples of collagen or collagen that had been recovered after electrospinning, suggesting that
electrospinning in and of itself does not induce damage in a fashion that specifically uncovers
cryptic RGD binding sites. We saw a dramatic decrease in adhesion when these same
experiments were conducted with collagen fractions that had been heated to 70 ˚C, these samples
exhibited clear evidence of denaturation in our SDS gel studies.
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CONCLUSIONS

Biophysical and structural evaluations demonstrate that electrospinning does not truly
reconstitute the native structure of the collagen fibril

[22]

. Additionally, our data suggests that

fibers of electrospun collagen become enriched in α2(I) content. However, our functional assays
demonstrate that electrospun collagen has unique biological activity in a wide variety of tissue
engineering applications. These data argue that it is not necessary to fully recapitulate the
structure of the native fibril to generate a biologically relevant tissue engineering scaffold.
We believe that there are likely three critical variables that ultimately interact to
determine the structural and functional properties of the electrospun collagen fibril. These
include the quality of the starting material, the specific electrospinning conditions and, finally,
the post-processing manipulations that are used to prepare the material for use in a tissue
engineering application. The first consideration is paramount; the starting material must not be
denatured during any of the processes used to isolate and prepare the collagen for electrospinning
(acid extraction, centrifugation steps, lyophilization and storage). The use of partially denatured
collagen will obviously compromise the functional profile of the final product. Gelatin, a
material that is composed of highly fragmented peptides readily spins into fibers but, it is highly
pro-inflammatory in many settings.
Second, the role of fiber size in the formation of the ultra-structural organization of
electrospun collagen has not been explored to any extent. The 67 nm banding pattern observed in
electrospun samples appears to be most prominent in constructs composed of small diameter
fibers. Some laboratories report that this banding pattern is confined to relatively small domains
in an electrospun scaffold or that it is absent altogether
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[22]

. We would argue that the 67 nm

repeat does not have to be present to impart potent functional properties onto the electrospun
collagen fiber. Our cell adhesion experiments demonstrated that native and denatured
collagen α chains have very distinctive biological properties, even when they are not assembled
into fibrils. Given the dramatic differences in performance that distinguish electrospun collagen
from electrospun gelatin in a broad spectrum of tissue engineering applications, it seems
premature to discount the functional significance of this material [22].
Finally, during electrospinning collagen α chains are subjected to a very high strength
electric field. This electric field must place these peptides in a high energy state as they traverse
the charged electrospinning field; these protein subunits are then frozen and trapped in this high
energy state by the flash lyophilization process that makes fiber formation possible. This residual
energy may have direct role in determining the fine structure (banding) of the resulting fibers.
Electrospun fibers of collagen that have been modestly cross-linked will undergo coiling when
placed into an aqueous solution; this coiling is dramatically reduced as a function of increasing
degrees of cross-linking

[21]

. At very high levels of cross-linking, fibers of electrospun collagen

retain a nearly linear conformation when hydrated.
Modest cross-linking conditions appear to stabilize gross fiber structure (sufficient to
keep the fibers from dissolving in an aqueous buffer); however, a modest degree of cross-linking
does not appear to be sufficient to completely suppress α chain reorganization as these subunits
return to a basal energy state. Upon hydration, the shedding of this excess energy appears to
drive coiling. At high levels of cross-linking, fibril coiling is suppressed, suggesting the α chains
are trapped in a very different tertiary configuration as compared to the fibers of more modestly
cross-linked structures that can undergo molecular reorganization. The potential contribution of
these variables in the formation of structure, and functional considerations in the electrospun
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collagen fibril, awaits further investigation. Given the potent biological activity of electrospun
collagen, in a broad spectrum of applications, we can anticipate the development of unique tissue
engineering scaffolds and the introduction of a new generation of tissue engineering products in
the clinical market place.
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Chapter 4. Two pole air gap electrospinning: Fabrication of highly aligned,
three-dimensional scaffolds for nerve reconstruction

Preface: The following manuscript appeared in Acta Biomaterialia, Volume 7, Issue 1, January
2011

[2]

. While this is a published manuscript, the section detailing the 2D FFT method for

measuring fiber alignment has been augmented beyond the original text of the paper. The
concept of fabricating scaffolds with aligned fibers was introduced in Chapter 2 and there are a
variety of tissue engineering applications that require scaffolds composed of aligned fiber arrays
(e.g. muscle engineering, tendon etc.). However, conventional electrospinning systems deposit
fibers into flat sheets, a structure that is difficult to translate into applications like nerve guides
that are best met by a more three-dimensional structure.
In the conventional electrospinning setup, the degree of fiber alignment, within limits, is
directly proportional to the rotational speed of the mandrel [10]. These systems are composed of a
single power supply and a grounded rotating mandrel. While effective at inducing alignment in
fibers, alignment does deteriorate in these systems at smaller fiber diameters (< 1 µm). This is
likely caused by multiple factors. For example, the chaotic nature of fiber whipping that takes
place with the formation of a smaller diameter fiber limits the extent to which the orientation of
the charged jet can be controlled. Conversely, conditions that favor the formation of larger
diameter fibers allow the charged jet to carry more momentum and, as a result, it undergoes less
whipping in the electric field. In this model of fiber alignment less whipping during fiber
formation is associated with a “stiffer” charged jet that exhibits a straighter trajectory, a
characteristic feature that increases the fraction of the material that can be collected, and reeled
onto the rotating mandrel as linear segments.
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Undoubtedly, the moving mandrel also induces the formation of a very complex electric
field which greatly exacerbates the complexity of fiber whipping that intrinsically occurs with the
bending instabilities that are present during fiber formation. The Coulomb repulsion charges
that are present within the electrospinning jet drive these bending instabilities; these charges
interact with this external electrospinning field in a highly complex fashion

[7]

. Air currents

induced by mandrel rotation (which for a square mandrel that is 10 mm on each side might
require a rate of rotation that approaches 8,000 RPM to induce alignment) also disrupt the
trajectory of small diameter fibers as they approach the spinning mandrel. These air currents
can be expected to have a much larger effect on a smaller diameter fiber (< 800 nm) than a
larger diameter fiber (> 800-1,000 nm) [5] (spinning under a vacuum to reduce this effect has not
been explored to any great extent and is technically difficult). Upon visual inspection, and most
likely owing to a more elastic nature, smaller diameter fibers will display a more tortuous
topography than lager diameter fibers – this intrinsic property further degrades the ability to
induce alignment with nano-scale diameter fibers with a rotating mandrel system. These
properties limit the extent to which the fibers of constructs that are composed of smaller
diameter fibers can be aligned.
Fiber alignment is a difficult parameter to define and several different metrics have been
used to transition subjective statements of alignment into a meaningful and objective
measurement that can be quantified. Each method has its own advantages and disadvantages. A
visual inspection of a scaffold can reveal that it has some degree of alignment, but the more
critical question is how much alignment is there? A direct measurement of anisotropy can be
made using destructive materials testing techniques

[11]

. To test for anisotropy a series of

candidate scaffolds are tested to failure along the presumptive axis of fiber orientation and at a
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90 degree angle to this orientation. If a scaffold is composed of aligned elements it will exhibit a
higher degree of stress and undergo less strain along the axis of fiber alignment with respect to
any testing conducted off this axis

[11]

. This is because the material properties in the aligned

direction will be governed by the physical properties of the polymer. Off-axis material properties
are more closely associated with the physical properties that are dictated by scaffold
architecture and any interactions between adjacent fibers. In the case of an aligned material the
material properties would be largely determined by the electrostatic interactions of the adjacent
fiber arrays and not the polymer itself

[21]

. Materials testing is an extremely effective method to

measure the extent of fiber alignment that is present in a scaffold, unfortunately, by definition
materials testing is a destructive test and the scaffold under consideration is lost to further use.
Our laboratory has developed and refined optical methods for measuring fiber alignment
based on the 2D FFT function

[14]

. This approach is entirely non-destructive in nature and as

such its principle advantage is this metric makes it possible to evaluate the alignment of a
scaffold and then use that same scaffold in a tissue engineering application. The software to
conduct this analysis is readily available as shareware (Image J). In this technique a digital-data
image of the scaffold is captured, this image may be a light, scanning electron microscope or a
fluorescence image. The 2D FFT function then examines the image to determine the extent to
which edges (transitions in contrast) occur along different orientations in the data image. We
have externally calibrated and verified the efficacy of the 2D FFT method by measuring fiber
alignment in a scaffold using this technique and then using destructive materials testing on that
same sample to verify its material properties and therefore its alignment [11]. Those experiments
revealed that incremental changes in fiber alignment induce incremental changes in the stress
observed at failure for the electrospun scaffolds.
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This Chapter will discuss the use and characterization of a novel electrospinning
technique to fabricate scaffolds with aligned fibers and its use to promote nerve regeneration.
Macroscopically, the nerve guides produced by this novel processing strategy are cylindrical in
nature. These guides are composed of dense fiber arrays that are oriented in parallel with the
long axis of the construct. Unlike conventional synthetic hollow nerve guides, these guides
exhibit a unique 3D architecture; they lack a central lumen. The intrafiber spaces of these
constructs literally provide thousands of individual channels to direct axon growth. These
channels are designed to limit axon growth cone deviations and drive the elongation of axons to
occur predominately in one axis, thereby accelerating the regeneration process. In turn, this can
be expected to decrease de-innervation atrophy and the associated complications of delayed
peripheral nerve regeneration.
Critical to the performance of these are the aligned fiber arrays that comprise the
structure. These fiber arrays must provide guidance cues to direct preferential axon outgrowth
and exhibit sufficient material strength to bear the mechanical forces encountered during
manual manipulation and the movements that occur in situ once it is in place. To this effect, our
laboratory has devised the technique of two pole air gap electrospinning that is discussed in
detail in this Chapter. The basic set-up used in the fabrication technique is illustrated in figure
4.1. It uses a dual collecting target to induce the formation of a cylindrical construct composed
of aligned fiber arrays. Our assays demonstrate that this system can induce, unlike conventional
electrospinning systems, an unprecedented degree of fiber alignment, independent of fiber size.
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Figure 4.1: Schematic representation of the mechanism of two pole air gap electrospinning.
The two metallic poles are separated by the air-gap. The length of the air-gap can be modulated,
and is dependent on the characteristics of the electrospun polymer solution. As opposed to
conventional electrospinning, where the entire fiber is deposited onto the target (usually a
metallic disk), in two pole air gap electrospinning only the ends of the fiber loops closest to the
poles adhere. The remaining fiber lengths are suspended between the poles producing an
electrospun construct with highly aligned fibers along its longitudinal axis.
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As detailed in Chapter 2, the electrospinning process consists of a syringe containing a
positively charged electrospinning solution (or in some cases negatively charged) and a ground
target (or an oppositely charged target). The charged jet from the Taylor cone undergoes coiling
as it travels away from the needle and forms loops in the air (Figure 2.2A,B). In conventional
electrospinning utilizing a collector plate as the target, the charged loops completely deposit on
the target. In contrast, two pole air gap electrospinning utilizes two small, charged poles,
approximating point-charges, as the target. The gap between the two poles of the target array
constitutes the air gap. In this system, as positively charged loops of the fiber jet oscillate
between the targets, they form alternating point-adhesions to the poles. The rest of the fiber (not
depositing on the negatively charged poles) is suspended across the air-gap, creating an
anisotropic 3D structure comprising of highly aligned fibers oriented nearly uniformly along the
longitudinal axis of the construct (the direction in which in the regenerating axons need to be
guided).
This electrospinning technique, like the conventional electrospinning process, has many
variables which can be modulated to fabricate the construct comprising of the desired
characteristics of fiber size, scaffold’s porosity, scaffold’s material strength and so on. This
study describes the regulation of critical electrospinning variables present in a two pole system
and the fabrication of constructs designed for use as nerve guides. The structural features,
material properties and degree of fiber alignment present in the resulting constructs are
evaluated. Finally, a series of tissue culture experiments are conducted to evaluate the extent to
which axons can penetrate the fiber arrays, and we present the results of a pilot study done in
the rodent designed to test the efficacy of using this design to treat in nerve injury.
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ABSTRACT

We

describe

the

structural

and

functional

properties

of

three-dimensional

(3D) nerve guides fabricated from poly-ε-caprolactone (PCL) using the air gap electrospinning
process. This process makes it possible to deposit nano-to-micron diameter fibers into linear
bundles that are aligned in parallel with the long axis of a cylindrical construct. By varying
starting electrospinning conditions it is possible to modulate scaffold material properties and
void space volume. The architecture of these constructs provides thousands of potential channels
to direct axon growth. In cell culture functional assays, scaffolds composed of individual PCL
fiber diameter ranging from 400 to 1500 nm supported the penetration and growth of axons
from rat dorsal root ganglion. To test the efficacy of our guide design we reconstructed 10 mm
lesions in the rodent sciatic nerve with scaffolds that had fibers 1 μm in average diameter and
void volumes > 90%. Seven weeks post implantation, microscopic examination of the
regenerating tissue revealed dense, parallel arrays of myelinated and non-myelinated axons.
Functional blood vessels were scattered throughout the implant. We speculate that end organ
targeting might be improved in nerve injuries if axons can be directed to regenerate along
specific tissue planes by a guide composed of 3D fiber arrays.
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INTRODUCTION

After an injury, peripheral nerves can undergo an astounding degree of regeneration.
When a nerve is severed, all signals distal to the injury site are immediately lost. Over time,
downstream axons undergo Wallerian degeneration [33]. The surviving nerves of the proximal
segment subsequently begin to undergo regeneration in response to soluble factors, many of
which are produced by Schwann cells [34, 35]. If the precipitating injury cleanly severs the nerve,
treatment may be confined to a surgery that is designed to re-establish the continuity between the
truncated stumps of the damaged nerve. In this surgery the proximal and the distal aspects of the
perineural sheath are sutured together to form an end-to-end anastomosis. In more extreme
injuries where a long segment of the nerve is crushed or completely lost, treatment is greatly
complicated. Under these conditions a conduit, or nerve guide, is used to bridge the gap and
direct the regenerating axons to grow towards the distal stump.
Nerve guides have a relatively long clinical history; these tubular constructs are designed
to direct the natural processes that lead to regeneration [36,

37]

. A variety of natural and

bioengineered materials have been used in this type of application, with mixed success [38]. Early
synthetic guides consisted of a simple, hollow tube that provided little more than a protected
environment [39]. Next generation nerve guides have been fabricated to contain signal
molecules [40] and/or structural features [41] that are intended to provide guidance cues to the
regenerating axons. Functional recovery with these constructs can be quite extensive, as long as
the nerve guide is used to bridge a gap of less than about 10 mm in length. Once the injury gap
exceeds this threshold (> 10 mm), the regeneration process will be compromised to varying
degrees. Typically, in these injuries only a limited number of axons will actually traverse
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the wound bed and the efficiency of targeting to the distal tissues is poor, resulting in limited
functional recovery. Further exacerbating these complications, a series of irreversible
degenerative changes begins to evolve in the distal tissues. As these degenerative changes
become entrenched, the prospects of meaningful functional recovery are greatly diminished,
even if a large number of axons are efficiently targeted to these sites.
Several published studies have demonstrated that aligned arrays of electrospun fibers can
provide the guidance cues necessary to induce axons and glial cells to express a highly polarized
phenotype [42-45]. Despite these preliminary and encouraging results, it is difficult to fabricate a
clinically relevant nerve guide using the conventional electrospinning process, which uses a
rapidly rotating target mandrel to produce aligned fibers. Conventional electrospinning systems
are very effective at producing flat, two-dimensional (2D) sheets with highly anisotropic
fibers [46-48]. These constructs are easily amenable to experimentation in vitro; however, a 2D
sheet is less acceptable, or adaptable, for use in vivo. Despite these limitations, the efficacy of
using the conventional electrospinning process to fabricate hollow, cylindrical nerve guides has
been explored to some extent. In these experiments the electrospun fibers have been deposited
onto a round, rotating mandrel. While the fibers of this type of construct can be induced to
exhibit a considerable degree of alignment when produced under these conditions, the fibers,
unfortunately, are deposited onto the target mandrel in a circumferential orientation (i.e. the axis
of alignment is ~90° off with respect to the long axis of the hollow tube). For obvious reasons
this architectural pattern does not lend itself well to providing guidance cues to regenerating
axons. However, the nano-to-micron diameter fibers that form the wall of this type of construct
do represent an effective barrier that reduces the risk of inflammatory cells penetrating into the
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lumen of the guide. Blocking the infiltration of these cells into the lumen of a nerve guide is
critical to the regeneration process [49, 50].
In our view, a more ideal nerve guide configuration closely mimics the structure of the
autologous nerve graft. This idealized guide would display a cylindrical shape and be composed
of dense three-dimensional (3D) arrays of highly aligned electrospun fibers that were oriented in
parallel with the long axis of the construct. The gaps and elongated spaces that will exist between
the stacked fiber arrays would literally provide thousands of channels for directed axonal growth.
This type of configuration can be approximated by rolling a 2D sheet of aligned fibers into a
cylinder. Although not tested, this design will result in a seam in the construct that could provide
an avenue for the infiltration and penetration of inflammatory and interstitial cells into the
construct. The seam could also represent a nexus for mechanical failure. Air gap electrospinning
makes it possible to circumvent these limitations and produce cylindrical, seamless, and truly 3D
constructs composed of aligned arrays of electrospun fibers that are oriented in parallel with the
long axis of the cylindrical construct.
In this study, we characterize the air gap electrospinning process and examine how this
fabrication technique can be exploited to produce nerve guides that facilitate the regeneration
of peripheral nerve fibers. We chose poly-ε-caprolactone (PCL) as the polymer for the
manufacture of the nerve guide owing to its slow rate of degradation [51]; thus it can act as a
guide for the new axons throughout the nerve regeneration process. PCL was electrospun at
varying concentrations for in vitro testing to determine the most appropriate air gap
electrospinning variables for the manufacture of constructs suitable for directing the axons
in peripheral nerve injuries.
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METHODS

Electrospinning
PCL (Sigma-Aldrich: PCL 65,000 MW) was dissolved in trifluoroethanol (TFE) at
various concentrations, including 50, 75, 100, 125, 150, 175, 200, 225, 250 and 275 mg mL−1.
Solutions were loaded into a 10 mL syringe that was capped with an 18 gauge blunt-tipped
needle. Conductive, circular washers of varying diameters were placed over the blunt-tipped
needle; several different electrospinning configurations were tested at each concentration of
PCL. The air gap electrospinning system used in this study consists of two vertical piers
grounded to a common voltage, typically set to −4.0 to −16.0 kV (Fig. 4.2, point A). From each
vertical pier an additional set of horizontal piers project inwards at 90° with respect to the upright
piers (Fig. 4.2, point B). A gap (which can be adjusted from about 1 to 6 inches) separates the
terminal ends of these projecting piers. Electrospinning solutions were charged to +22 kV and
directed into the gap separating the grounded horizontal piers. Polymer solutions were metered
into the air gap system using a syringe driver with rates of delivery varying from 2 to
20 mL h−1 (see Table 4.1 for specific conditions). The distance between the solution reservoir
and ground target array was varied from 10 cm to 30 cm. Once the charged electrospinning jet
forms in this type of spinning, the polymer stream reaches the target and is laid out in a series of
loops that pass back and forth between the terminal portions of the grounded piers, resulting in
the formation of a bundle of parallel fiber arrays (Fig. 4.2, point C). Conditions for
electrospinning at each PCL concentration were optimized to maximize fiber formation and
collection onto the mandrel. We note that the electrospinning conditions disclosed in Table
4.1 are optimized to our specific laboratory environment (e.g., 68 °F with ~40% humidity) and
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electrospinning cabinet. Adjustments may be necessary to account for varying ambient
conditions and different polymers.
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B

B
C

A
A

Figure 4.2: Schematic of the ground target used in a two pole air gap electrospinning
system. (A) Vertical, hollow piers transmit ground wires to horizontal piers (B) that project
inward towards one another. (C) Fibers accumulate across the gap that separates the two
horizontal piers. The positions of the syringe and electrospinning source are relatively arbitrary
and largely dependent upon the cabinet used for electroprocessing. For this study we positioned
the electrospinning source parallel to the base of the ground device and at a height that
corresponded to the height of the grounded horizontal piers (B).
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Table 4.1: Summary of specific electrospinning conditions for PCL in the two pole
electrospinning system. With increasing PCL concentration the target voltages, the
electrospinning distance between the syringe reservoir and target as well as the distance between
the poles of the air gap system must be reduced in order to induce fiber deposition across the
poles.
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Scanning Electron Microscopy (SEM)
Electrospun constructs were removed from the target and cut into three sections of equal
length. All the three segments, without any further processing, were mounted onto a scanning
electron microscope studs and sputter-coated with gold for 2 minutes. A Zeiss EVO XVP
scanning electron microscope equipped with digital acquisition was used for image capture.
Average fiber diameter was determined from N = 3–5 SEM images captured at magnifications
ranging from 450 to 5000× from each of the three sections using the NIH ImageTool
software [49].

Fiber Alignment Analysis
Using the digital SEM images captured for fiber diameter analysis, the relative degree of
fiber alignment was measured in each guide segment using the ImageJ 2D Fast Fourier transform
(2D FFT) function [14, 46]. By using the 2D FFT approach an alignment plot can be generated. The
height of the resulting peaks, read from the Y-axis, reports the degree of orientation in the data
image. The position of the peaks on the X-axis reports the principal angle of fiber
orientation [14, 46]. The FFT alignment data was normalized to the lateral edges of the cylindrical
constructs which were arbitrarily assigned a value of 90° on the unit circle. The relative degree
of fiber alignment and the principal angle of fiber orientation were determined for each of the
construct formulations using the 2D FFT method.
2D FFT processing takes spatial information present in a data image and converts it into a
“frequency” map. That frequency map essentially records the frequency at which pixels that are
adjacent to one another change in contrast (the threshold of this change can be user selected). In
essence it is a method of detecting edges. This property of the FFT “output” image makes it
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possible to use this mathematical transformation to evaluate the alignment of objects that are
present in the data image by determining how uniformly oriented the edges are in that image.
The FFT image itself is composed of pixels that map the frequency at which contrast changes
occur, in turn this information is a reflection of the degree of alignment that is present in a data
image.
When a data image of electrospun fibers that are present in a random pattern is processed
using the FFT, the resulting output image will be composed of pixels distributed in a
symmetrical, circular shape centered in the middle of the FFT image (Image J FFT
transformation, some FFT functions invert this relationship). The outlying areas of the FFT
image will be black; the central area will contain white pixels (much like a map of an electron
density map). The FFT “maps” low frequency pixels, data associated with the background of the
image and other domains that contain pixels with a similar value, into the center of the image.
This pattern is generated because changes in the intensity of adjacent pixels in a random image
are theoretically similar in any direction. A 2D FFT function of an image containing aligned
fibers (or other aligned elements) produces a frequency image that contains pixels distributed in
a non-random, elliptical distribution that is centered in the middle of the image. This pattern
develops because changes in pixel intensities in the data image are present in specific
orientations. The high frequency pixels mapped on the FFT output corresponds to edges present
in the data image; in an image of aligned structures the edges demark rapid changes in pixel
intensity and they are preferentially oriented along a defined axis. Pixels along the fibers that are
aligned do not change as there is no “edge”; those pixels are “oriented” along the fiber and
define its shape. The elongated portions of the elliptical aspects of the FFT image are oriented at
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90° with respect to the primary axis of orientation present in the data image. The extent to which
the elongated aspects are distorted is proportional to the extent of alignment that is present.
The next step of the process is to quantify the extent of elliptical distortion that is present
in the FFT image. This achieved by placing a circular projection on the FFT output image and
then conducting a summation of the pixel intensities for each degree along a radial line running
between 0° and 360° in 1° increments around the circular projection (e.g. summing the pixel
value along each radius from 1 to 360°). For a random structure this process should produce a
pixel summation that is essentially identical along any radius of the circle. Summing the radial
projections for the aligned structures in the FFT image, which contain pixels mapped into the
elliptical distortions, will produce different summations along each radius. The summed value
will be higher along the orientation of the elliptical distortion (more pixels) and lower in the
smaller and more circular aspects of the image.
In practice the summed radial values are then plotted as a scatter plot for each degree
between 0° and 360°. Plotting data from a random image produces a graph containing four very
low, broad peaks which correspond to the “edges” of the data image (these “spurious” peaks can
be largely filtered out but for most applications this is not necessary). Data from images
containing aligned structures have two much higher and narrowly defined peaks, and two
corresponding to the off axis orientation-much smaller peaks-in this type of graphical depiction.
In practice, the FFT data set is rotated 90° to allow the principal axis of orientation to be directly
determined from the position of the peaks in the intensity plot. The amount of alignment is
reflected by the height and overall shape of the peak present in this plot. For a complete
discussion of the FFT method see the published and comprehensive review published by our
laboratory in reference [14].
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Materials Testing & Physical Properties
Materials strength was measured by uniaxially testing the constructs to failure at an
extension rate of 10 mm min−1 using a Bionix 200 Mechanical Testing Systems instrument (MTS
Systems Corp., Eden Prairie, MN). Cylindrical electrospun samples were prepared from variable
concentrations of PCL (100, 150, 200 and 250 mg mL−1; N = 4–6). Testing the material
properties of an electrospun sample is typically done with a flat sheet of material, whereas our
constructs are cylindrical in nature. To address this limitation, we elected to flatten the scaffolds
and then cut out “dog-bone” shapes using a die punch (2.67 mm wide, gauge length of
0.295 mm). This approach, at least, allows us to use a configuration that controls for grip and
geometry effects to evaluate how fiber diameter in each of our scaffolds contributes to their
material properties. Specimen thickness was estimated using a Mitutoyo IP54 digital micrometer
(Mitutoyo American Corp., Aurora, IL). In this study, we report stress at failure for these
scaffolds [47]. Data sets were screened by One-Way Analysis of Variance (ANOVA; p < 0.01).
We quantified the physical properties of the scaffolds in terms of their overall void space.
Cylindrical electrospun samples prepared from variable concentrations of PCL (100, 150, 200
and 250 mg mL−1; N = 4–6) were tested using the liquid intrusion method of Pham et al.

[52]

.

Scaffolds were electrospun, put under vacuum for 10 min and weighed (W1). Then, they were
soaked in 90% ethanol for 10 min for initial hydration, and subsequently in distilled water for
30 min. Hydrated scaffolds were weighed (W2). The void space was calculated by dividing the
volume of intruded water (as determined by the change in mass due to intrusion of water having
density of 1 g mL−1) by the total volume after intrusion:

Data sets were screened by Student–Newman–Keuls multiple pairwise comparison; p < 0.05.
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Cell Culture
Dorsal root ganglion (DRG) explants were prepared from embryonic day 15 rats as
described previously [53,

54]

. PCL scaffolds for cell culture experiments were prepared from

representative starting concentrations (125, 200, and 250 mg mL−1). Scaffolds were soaked in
100% ethanol overnight, then rinsed in 70% ethanol, and then rinsed three times
in sterile phosphate buffered saline (PBS). A 25-gauge needle was used to prepare an opening
into the dorsal surface of each scaffold, and a single DRG was inserted into the resulting
cavity. DRG explants

were

maintained

for

7–10 days

in

media

supplemented

with

0.1 μg mL−1 NGF. Media was changed every other day.

Immunofluorescence Microscopy: DRG Explants
DRG explants were rinsed in PBS and fixed in 4% paraformaldehyde prepared in PBS.
Samples were extracted in 0.1% Triton x-100 and immunostained with the neuron specific
marker TuJ1 (Tubulin J1: MMS-435P, Covance, 1:500). Antibodies were diluted in PBS
supplemented with 1% BSA and incubated with all samples overnight at 4 °C. Scaffolds were
rinsed and counterstained with Goat anti-mouse antibodies conjugated with Texas Red (1:200).
All samples were stained with 2% DAPI to reveal nuclei. A Nikon TE300 microscope equipped
with a 10× objective and a DXM 1200 digital camera was used to capture images at a pixel
resolution of 3840 × 3072. Individual images of the DRG explants were assembled into
montages using Adobe Photoshop software.
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Electrospinning for in vivo Experimentation
For implant studies, nerve guides were electrospun from a starting concentration of
200 mg mL−1 PCL

using

optimized

conditions

(Table

4.1).

To

reduce inflammatory

cell infiltration into the fiber arrays of the guide, an exterior coating of PGA:PLA (50:50)
copolymer was electrosprayed (100 mg mL−1 in TFE) onto the outside of the completed
constructs. This was achieved by placing a circular, 120 mm diameter steel plate directly behind
the completed nerve guide. To process the PGA/PLA copolymer an alligator clip was attached to
the electrospinning source syringe (no washer was used) and charged to +22 kV; the steel plate
was charged to −2 kV for collection. By placing the completed nerve guide between the
electrospinning source solution and the grounded steel plate, the fibers of PGA/PLA copolymer
deposit on the surface of the nerve guide construct, forming a barrier that is designed to limit the
penetration of interstitial cells into the reconstructed nerve in vivo [49].

Surgery
All surgical and postoperative care procedures were performed in accordance with the
Virginia Commonwealth University Institutional Animal Care and Use Committee. Nerve guides
were prepared from starting concentrations of 200 mg mL−1 for preliminary implant studies.
Adult (70–90 day) Long Evans Hooded rats (Harlan laboratories) (N = 3) were intubated and
brought to a surgical plane with 2.5% isoflurane. Body temperature was kept normothermic
using a homeothermic blanket. Hair was removed from the hindquarters, and skin was swabbed
with

betadine.

Using sterile techniques, skin and muscle overlaying

the sciatic

nerve were

mobilized, and a 10 mm segment of the nerve was excised. This interval represents a critical
threshold in short term regeneration experiments that can be used to characterize the efficacy of a
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candidate guide in the rodent model. Electrospun nerve guides were sutured to the distal and
proximal stumps of the injured tissue using 10-0 nylon sutures (Ethicon Inc., USA). At the
conclusion of surgery, skin incisions were stapled and the animals were allowed to recover on a
warming pad. After surgery all animals were given free access to food and water and housed two
per cage. Analgesic medication (Tylenol oral suspension, 2 mg mL−1) was mixed into the
drinking water and administered for the first 3 days post-surgery.

Immunofluorescence Microscopy: Implanted Nerve Guides
Tissue was immersed for 2 hr in 4% paraformaldehyde prepared in PBS at room
temperature and then incubated overnight in 30% sucrose prepared in PBS at 4 °C. The samples
were frozen and cut into 30 μm thick sections for staining. Primary antibodies, including S100
(Schwann cell marker, Dako, Denmark, 1:500), MBP (Myelin basic protein, SMI-99, Covance,
1:1000), and NF-68 (Neurofilament 68, Sigma-Aldrich, 1:1500) were incubated on the sections
overnight at 4 °C. Samples were rinsed in 0.5% Triton x-100, and counterstained with Goat antimouse or Goat anti-rabbit secondary antibodies (Alexis) (1:200) for 60 min at room
temperature. 2% DAPI was used to image the nuclei.

Tissue Processing
After 7 weeks, animals were sacrificed with a lethal dose of pentobarbital (Sigma–
Aldrich, St. Louis, MO), and the nerve implants were harvested for microscopic analysis. Tissue
was recovered and immersed in 2% glutaraldehyde plus 2% paraformaldehyde for 12 h at 4 °C
and post fixed in 1.0% osmium plus 2.5% potassium ferricyanide. Samples were subjected to a
graded series of dehydration in alcohol (starting with 50% ethanol for 15 min, then 70% ethanol
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for 15 min, next 95% ethanol for 15 min, then 100% ethanol 2× for 15 min). Samples were next
embedded in Poly/Bed (Polysciences). We note that it is difficult to get good plastic infiltration
into the dense matrix of an electrospun scaffold that has been densely populated by cells; air
bubbles are often trapped and interfere with subsequent processing. To overcome this limitation,
we place our samples under a vacuum during the final infiltration step. Vacuum was applied to
the samples until air bubbles visibly evolved from the samples. Then the samples were kept at
this vacuum level for 1 hr.
A Leica EM UC 6 ultramicrotome was used to make semi-thin sections of 0.5 µm for
morphometric studies and to make ultrathin sections of about 60-70 nm for TEM imaging.

Morphometric Analysis
We sampled the proximal domains that were 1 mm into the reconstructed tissue and the
distal domains 1 mm proximal to the distal border of the lesions. Semi-thin sections were
prepared and stained with a solution of 0.1% Toluidine Blue, 0.1% Methylene Blue, 0.1% Azure
II in 1% sodium borate. To determine the total number of axons passing through the implants, a
montage of the complete cross-sectional area of the graft was prepared from images captured
with 10× bright-field objective lens and a Nikon TE300 microscope. The images were imported
into the ImageTool (UTHSCSA version 3.0) to measure the area encompassed by the fibrotic
capsule (induced by the PGA/PLA coating). Total axon number was determined for a series of
images captured at systematic intervals of approximately every 500 µm throughout the nerve
cross-section using a 100× oil immersion lens. The number of myelinated axons present in each
data image was determined by non-biased sampling methods. Each individual raw data image
covered an area of 125 μm × 125 μm and was subdivided into a series of twenty five
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25 μm × 25 μm squares using a 5 × 5 grid. Of these twenty five squares in each raw image,
alternate squares were used for morphometrics, i.e. of the total twenty five squares in each raw
image, either twelve or thirteen squares were used for myelinated axons counts depending on
whether the first square was included for the analysis or not. The raw data images from each
cross-section sample were divided into two groups. In images of the first group, the first square
was included in the analysis, resulting in thirteen squares for axon counts from those images; in
the second group the not the first, but the second square was included in the analysis resulting
twelve squares for axon counts from those images. Additionally, the myelinated axons touching
the top and the left border of each square were excluded from the counts and the myelinated
axons touching the bottom and the right border of each square were included in the count. To
extrapolate the total number of axons present in the cross-sectional area, the density of
myelinated axons in the sampled images was multiplied by the total cross-sectional area of the
grafts. All measurements were calibrated with a stage micrometer.

Electron Microscopy
Ultrathin sections were obtained after tissue processing as detailed above and all
ultrastructural analyses were conducted with Jeol-1230 electron microscope equipped with a
Gatan UltraScan 4000SP 4K x 4K CCD camera.
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RESULTS

Electrospinning Characteristics and Fiber Properties
The discussion concerning fiber properties is subdivided into three sections based on
starting conditions and electrospinning characteristics. Overall, the average fiber diameter of the
scaffolds produced varied as a function of the starting conditions ([Fig. 4.3] and [Fig. 4.4]).
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Figure 4.3: Representative scanning electron micrographs (SEM). (A) SEM of scaffolds
produced from 50 mg mL–1 starting concentrations using air gap electrospinning. Note that even
heavily beaded scaffolds exhibit aligned fibers. (B) Scaffolds produced from 75 mg mL–1, (C)
100 mg mL–1, (D) 125 mg mL–1, (E) 150 mg mL–1, (F) 175 mg mL–1, (G) 200 mg mL–1, (H)
225 mg mL–1, (I) 250 mg mL–1, (J) 275 mg mL–1. All images captured at 1000× magnification.
Scale in (J) for (A)–(J) = 20 μm.
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Figure 4.4: Average fiber diameter. (A) Average cross-sectional fiber diameter varied as a
function of starting conditions. Of note in the graphical representation the range of fiber
diameters also increased with increasing polymer concentration. (B) Average fiber diameter as a
function of starting PCL concentration. From 50 to 200 mg mL–1 PCL average fiber diameter
increased in a nearly linear fashion (linear regression analysis over this specific range of
concentrations: R2 = 0.918); however, at concentrations above 200 mg mL–1 this relationship
markedly deteriorated. Overall, for the entire range of starting concentrations that we
investigated a quadratic equation best described the relationship between starting concentration
and average fiber diameter, although even in that analysis the data represented a poor fit, at best
(R2 = 0.666). (C) Summary of pairwise comparisons across all treatment groups. The broad range
of fiber diameters present in the scaffolds produced from 275 mg mL–1 solutions exhibited
substantial overlap with a variety of other scaffolds. Scaffolds produced from this starting
concentration had fibers that were not statistically different than scaffolds produced from the
125, 150, 175, 200, 225 and 250 mg mL–1.
90

Starting

Solutions

50-100

mg/mL.

At

concentrations

ranging

from

50

to

100 mg mL−1 PCL, there was nominal to poor fiber formation and fiber collection. Fibers
appeared to coalesce out of an amorphous cloud of material that collected in the vicinity of the
target grounds. These scaffolds exhibited extensive beading; these beads were interconnected
with an array of small diameter fibers that were oriented in parallel with the long axis of the
cylindrical scaffolds (Fig. 4.3A–C). Macroscopically, these cylindrical constructs were
predominately composed of aligned elements (Fig. 4.5).
Beaded structures can form in an electrospinning field as a consequence of Rayleigh
instabilities that develop in the charged jet as a result of: (a) inadequate flow rates of the
electrospinning solution; (b) electric field effects; (c) inadequate polymer chain entanglements in
the solvated spinning solution and; (d) too low a starting polymer concentration [55]. Increasing
the flow rate of the polymer solution into the electric field did not suppress bead formation in
these scaffolds. Instead, increased flow rates resulted in the accumulation of a dense cloud of
solvent in the vicinity of the target which prevented fibers from forming altogether. Nor was the
formation of the beaded structures visibly altered by directly altering the potential of the electric
field, manipulating the distance between the syringe reservoir and ground targets, or by changing
the diameter of the washer used to direct the charged electrospinning jet at the bi-polar target
(key elements of specific electrospinning conditions are summarized in Table 4.1). Given these
results it is clear that a 50 mg mL−1 starting solution represents the near absolute minimal
threshold concentration for fiber formation to take place in this particular air gap electrospinning
system.
Starting Solutions 125-200 mg/mL. Over this range of starting concentrations average
fiber diameter increased and was more heterogeneous with respect to the fibers electrospun from
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the 50–100 mg mL−1 solutions (Fig. 4.4). As the starting PCL concentration was increased
beyond 125 mg mL−1 the beaded structures present in scaffolds produced from the lower starting
concentrations became increasingly less apparent (Fig. 4.3). Average fiber diameter in scaffolds
produced from the 125 mg mL−1 solutions was 382 nm; these fibers ranged from 90 nm to
1.3 μm in cross-sectional diameter. Scaffolds produced from the 200 mg mL−1 solutions had an
average fiber diameter of 906 nm with a range of 60 nm to more than 5.1 μm in average crosssectional diameter.
The visible components of the electrospinning field changed dramatically over this range
of starting concentrations. At 125 mg mL−1, the charged electrospinning jet was distinct and
composed of a continuous jet of material that emanated from the syringe tip; this jet was several
centimeters in length. As the charged jet approached the targets it became unstable and fibers
appeared to form out of an amorphous cloud of material. As the starting concentration was
increased to 150–200 mg mL−1 the charged jet appeared as a distinct series of spiraling loops that
originated from a prominent Taylor cone. The appearance of this stable jet coincided with a
marked reduction in bead formation, a physical property indicating that sufficient polymer chain
entanglements are present in the solvated spinning solution to suppress the Rayleigh instabilities
observed at lower polymer concentrations. The spiraling jet of material was directed towards the
gap between the two poles of the air gap system. Fibers formed in the immediate vicinity of the
grounded piers and were visibly collected across the gap separating the two grounded targets. As
additional fibers collected across the targets, the pre-existing fibers collapsed into a much more
compact cylindrical structure. With the formation of the spiraling jet of charged material it was
necessary to reduce the distance between the electrospinning source reservoir (syringe) and the
grounded targets (Table 4.1). Fiber deposition was optimized when the apparent diameter of the
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spiraling jet coincided with the distance between the piers of the bi-polar ground. Under these
conditions fibers were observed to rapidly accrue on the ground targets.
Starting Solutions 225-275 mg/mL. The relationships between the starting solution
properties and final fiber properties were less well defined in scaffolds produced from starting
concentrations greater than 200 mg mL−1 (Fig. 4.4B). Scaffolds spun from the 225, 250, and
275 mg mL−1 solutions exhibited marked heterogeneity in fiber size (Figs. 4.3H–J and 4.4). For
example, scaffolds produced from the 225 mg mL−1 solutions had an average fiber diameter
of ~816 nm with a range from 120 nm to ~3.5 μm (Fig. 4.4). At 250 mg mL−1 average fiber
diameter increased to 1.7 μm and the scaffolds exhibited fibers ranging from 240 nm to 6.2 μm
(Fig. 4.4). Average diameter in scaffolds prepared from the 275 mg mL−1 solutions decreased to
750 nm, substantially less than the average fiber diameter observed in scaffolds prepared from
starting solutions ranging from 125 to 250 mg mL−1 (Fig. 4.4).
In order to fabricate scaffolds from the 225 and 250 mg mL−1 solutions it was necessary
to increase the diameter of the washer used to direct the electrospinning jet towards the grounded
target. We suspect that the mass and momentum of the electrospinning jet at these higher starting
concentrations restrict its lateral deviations as the jet passes from the syringe to the air gap
targets. As we increased the diameter of the washer placed over the syringe, the lateral deviations
in the spiral jet increased and fibers collected across the grounded piers, forming a cylindrical
construct. In parallel with this change, it was also necessary to (a) move the grounded targets
closer to the electrospinning reservoir, and (b) reduce the distance between the piers of the bipolar ground (Table 4.1). These modifications appear to bring the targets within a domain of the
electrospinning field that corresponded to the diameter of the spiraling jet of charged polymer.
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Fiber Alignment
2D FFT analysis was used to quantify the electrospun scaffold’s fiber alignment. This
analysis does not provide an absolute value to determine the degree of alignment, but the values
generated are relative to each other, thereby indicating the relative orientation of the fibers in
comparison to the other fibers in that assay. The FFT analysis of the different scaffolds produced
in this study demonstrates that fiber alignment is similar, regardless of fiber diameter, when
scaffolds are produced using a bi-polar grounded target (in contrast to scaffolds produced in a
conventional electrospinning system where fiber diameter and rates of mandrel rotation interact
to determine the extent of alignment). In contrast to conventional systems, varying the PCL
concentration and/or increasing the average fiber diameter had little effect on fiber alignment in
scaffolds produced by the air gap system (Fig. 4.5D and E). Not surprisingly, the principal angle
of fiber alignment in all of these scaffolds was in parallel with the long axis of the cylindrical
constructs (Fig. 4.5). However, there were some subtle differences across the samples that we
examined. Scaffolds produced from the 50–100 mg mL−1 solutions contained structural elements
that

partially

degraded

alignment

values.

These

scaffolds

each

exhibited

a

characteristic shoulder in the 2D FFT alignment plot (occurring at about 180°). The beaded
structures and the off axis fiber that are present in this family of scaffolds undoubtedly contribute
to these results (Fig. 4.3). Even so, these scaffolds still exhibit considerable fiber alignment, and
for this family of constructs the 2D FFT analysis generated alignment values ranging from 0.14
to 0.16 units (Fig. 4.5A). The 2D FFT analysis reported that constructs produced from starting
concentrations of 125–200 mg mL−1 lacked the distinct shoulder detected in scaffolds produced
from lower starting concentrations of PCL. Overall, these scaffolds were incrementally more
aligned than scaffolds produced from the 50–100 mg mL−1 solutions (Fig. 4.5B). A similar trend
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was observed in scaffolds prepared from the starting solutions of 225–275 mg mL−1 and these
samples displayed the highest degree of fiber alignment (Fig. 4.5C).

95

Figure 4.5: Analysis of fiber alignment by 2D FFT. (A) Average fiber alignment over the
entire length of constructs produced from 50-125 mg mL-1 solutions; (B) 150-200 mg mL-1
solutions; and (C) 225-275 mg mL–1 solutions. Average fiber alignment is similar in each
construct, although there is a trend towards an increase in the peak FFT value as a function of
increasing average fiber diameter. Scaffolds produced from the 50 and 75 mg mL–1 starting
concentrations exhibit a broader distribution of alignment values and shoulders on the FFT plots
(illustrated at 180° on the alignment plot) typical of structures that degrade alignment values
(beads and fibers off axis). (D) Fiber alignment as a function of initial starting PCL
concentration. (E) Fiber alignment as a function of average fiber diameter. These data indicate
that increasing fiber diameter has a relatively nominal effect on increasing alignment in the
electrospun constructs as the FFT values are similar and not distinguishable from one another.
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Materials Testing and Physical Properties
To verify the structural properties of scaffolds produced in the air gap process we
conducted materials testing experiments (stress at failure increases as a function of fiber
alignment in electrospun materials, see reference [47]). 2D FFT analysis indicates that fiber
alignment incrementally increased as a function of starting PCL concentration (and increasing
fiber diameter). A similar trend was noted in the bulk material properties of the scaffolds (Fig.
4.6). For example, peak stress in scaffolds produced from the 100 mg mL−1 solutions
was ~2.00 MPa. This value increased to 3.25 MPa in scaffolds produced from the
150 mg mL−1 solutions, and to 4.25 MPa in scaffolds produced from 200 mg mL−1 solutions.
Peak stress was 3.5 MPa in scaffolds produced from the 250 mg mL−1 solutions. Statistical
analysis of these data indicates that scaffolds produced from 150, 200 and 250 mg mL−1 PCL
exhibited similar material properties at failure. Peak stress in each of these constructs was greater
than what was observed in scaffolds produced from 100 mg mL−1 PCL (p < 0.007). These
values, with the exception of scaffolds produced from the 100 mg mL−1 solutions, compare
favorably to the material properties of native rodent sciatic nerve [56].
While each scaffold is composed of highly aligned fibers, considering the variable fiber
diameters, the spaces between each of the individual fibers can be expected to be very different,
which would influence the penetration of regenerating axons. Our analysis, as determined by
liquid intrusion measurements, revealed significant differences in scaffold void space
(“porosity”) develop as a function of starting conditions (p < 0.05; Fig. 4.6B). Average void
space for scaffolds produced from 100 mg mL−1 solutions was ~58% and ranged to greater than
95% for scaffolds produced from the 250 mg mL−1 starting solutions.
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Figure 4.6: Materials testing. (A) Peak stress of electrospun constructs produced from varying
concentration of PCL (100, 150, 200, and 250 mg mL–1). The peak stress of the scaffolds
increases with the increasing concentration of PCL from 100 to 200 mg mL–1. At 250 mg mL–1,
the strength of the construct is qualitatively reduced, but not statistically different, with respect to
scaffolds electrospun from PCL at a concentration of 200 mg mL–1. (B) Void space in
electrospun constructs produced from varying PCL concentrations (100, 150, 200, and
250 mg mL–1) measured using the liquid intrusion method. The percentage of void space
increased with increasing concentration of PCL (p < 0.05).
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Cell Culture Experiments.
While each of the scaffolds produced in this study did exhibit similar degrees of fiber
alignment, there are additional considerations that must be accounted for in the selection of a
candidate construct that is to be used in nerve reconstruction. For example, scaffolds produced
from 50–100 mg mL−1 PCL exhibit extensive beading and tensile properties that are below that
of the rat sciatic nerve [56]. The beaded structures could represent obstacles to regenerating axons
and or disrupt guidance cues present in the aligned fibers. At the other extreme, scaffolds
produced from the 275 mg mL−1 solutions have highly aligned arrays of fibers and material bulk
material properties that exceed the sciatic nerve of the rodent. However, the electrospinning
configuration that is necessary to process these solutions into a scaffold results in very short
constructs, limiting their utility in a clinical application.
An additional consideration regarding the physical properties of the constructs concerns
how the functional porosity of scaffolds affects axonal regeneration. In these cell culture assays
we tested how effective different scaffold configurations were at supporting the penetration of
axons into the fiber arrays using explanted DRGs as a model system. We elected to test scaffolds
produced from the 125 (average fiber diameter = 383 nm ± 228 nm SD), 200 (906 nm ± 923 nm)
and 250 (1667 nm ± 1165 nm) mg mL−1 PCL starting concentrations in these assays.
DRGs were implanted directly into the cylindrical scaffolds (scaffolds were prepared
with a length of 10–15 mm and 5–7 mm in diameter) and cultured for 7 days in the presence of
NGF. At the conclusion of this experimental interval all the scaffolds exhibited axons that
projected into and parallel with the surrounding fiber arrays (Fig. 4.7D–F). These experiments
suggest that constructs composed of smaller diameter fibers foster the penetration of numerous
individual axons along individual PCL fiber tracks (or perhaps more accurately within the pore
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spaces). This pattern was particularly evident in DRGs cultured in the scaffolds prepared from
the 125 mg mL−1 starting solutions. At the other extreme, DRGs plated into scaffolds prepared
from the 250 mg mL−1 solutions exhibited pronounced fasciculation (Fig. 4.7F). In these cultures
the axons appeared to interact with one another, form bundles and then pass along far fewer fiber
tracks. A nuclear stain of the explanted cultures revealed that cells associated (Schwann cells and
interstitial fibroblasts) with the DRGs heavily infiltrated the scaffolds and tracked in association
with the DRG axons (Fig. 4.7G).
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Figure 4.7: Cell culture experimentation.
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Figure 4.7: Cell culture experimentation. (A) SEM tangential sections of scaffolds produced
from 125 mg mL–1, (B) 200 mg mL–1 and (C) 250 mg mL–1. While there is evidence of fiber
damage and some compression in the cut zones note the high porosity of the constructs that is
present in parallel with the axis of fiber alignment. Scaffolds produced from the
125 mg mL–1 solutions have the beaded structures typical of these constructs ((a), asterisks, see
also Fig. 4.3). Scale bar in (C) = 10 μm for (A)–(C). (D) Fluorescence images of DRG in
scaffold produced from the 125 mg mL–1 solution. (E) 200 mg mL–1 solution and
(F) 250 mg mL–1 solutions. Note the increasing trend towards fasciculation with increasing PCL
fiber diameter. This effect is particularly evident in the samples cultured in the scaffolds
produced from the 250 mg mL–1 solutions. The axons that are projecting perpendicular to the
primary axis of the construct are within the channel used to implant the DRGs into the scaffold
(arrows in (F) and (G)). (G) corresponds to (F) stained to reveal nuclei. Note the extensive
overall cellularity of the cultures and the association of nuclei with the axons bundles. The
asterisks in (F) and (G) represent the initial implant site for the DRG. Inset in (G) represents an
illustration regarding the method and site of DRG injection into the scaffolds. Bar in (G)
represents 100 μm in (D)–(G).
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Preliminary Peripheral Nerve Reconstruction Experiments.
For in vivo testing, we prepared nerve guides from the 200 mg mL−1 starting
concentrations of PCL. This construct formulation exhibited highly aligned fibers, excellent
material properties and extensive void spaces to support the penetration of axons along
individual. In these experiments, a 10 mm section of the right sciatic nerve was removed and
replaced with an electrospun nerve guide.
During the 1–2 weeks after surgery, the lesioned animals walked on three limbs and
carried the injured limb. Motion at the knee and distal joints was substantially absent. After
3–4 weeks the animals carried weight on the injured leg, but gait in this limb was characterized
by a pronounced abduction at the hip. By 6 weeks, gait improved and the exaggerated abduction
at the hip was replaced with motion in more normal planes as mobility increased at
the knee and ankle joints. At this time point, the animals also responded to a sensory stimulation
in the guise of a withdrawal reflex in response to a foot pinch. Given these results, we elected to
recover our implants 7 weeks after the initial surgical reconstruction.
At recovery the implanted nerve guides were visibly well integrated with the stumps of
the transected nerves (See Fig. 4.8A). The guides lifted easily out of the surrounding tissue, and
there was very little evidence of fibrosis on, or in the vicinity of, the implant sites. Frozen
sections taken from the mid-point of the regenerating tissue had a pronounced anisotropic
structure and were densely populated with cells (Fig. 4.8B, C). Staining for NF-68 revealed a
dense population of axons in the regenerating tissue. These axons were aligned in parallel with
the long axis of the cylindrical nerve guides (Fig. 4.8D). Myelin basic protein was present in a
dense fibrillar pattern (Fig. 4.8E). Staining for S100 revealed elongated Schwann cells that were
aligned in parallel with the long axis of the regenerating tissue (Fig. 4.8F). Together, the staining
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patterns for S100 and MBP suggest that a subset of the axons present in these central domains
(of the implants) is actively undergoing myelination.
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Figure 4.8: Nerve reconstruction – frozen sections. (A) is a representative implant recovered
after 7 weeks in vivo. Arrow indicates the proximal attachment site of the implant. The guides
were well integrated into the tissue of the damaged nerve. Bar in (A) = 10 mm. (B) Nomarski
image of frozen sections taken mid-point in guide. Note the anisotropic nature of the tissue.
(C) DAPI staining, (D) neural filament 68 (NF-68), (E) myelin basic protein (MBP), and (F)
S100 Schwann cell marker. (B)–(F) captured with 40× objective. Bar in (F) = 100 μm for (B)–
(F).
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To verify the architectural organization of the reconstructed nerves, we embedded
representative samples for light and transmission electron microscopy, and cut them in crosssection. Semi-thin sections imaged by light microscopy revealed that the proximal segments of
the nerve guides that were densely packed with myelinated axons. These axons were more
variable in size than axons present in a normal sciatic nerve (see Fig. 4.9A and B). Nonmyelinated axons were interspersed with the myelinated axons (Figs. 4.9C, arrows and 4.10A).
The PGA/PLA coating that we used on the implants induced the formation of an epineurium-like
capsule (Fig. 4.9D). Samples taken from the mid-point of the grafts exhibited numerous bundles
of axons that were surrounded by a delimiting band of tissue that was reminiscent of
the perineurium (Fig. 4.9E). Cells with an elongated, spindle-like morphology were present in
association with the periphery of these fascicule-like structures (Fig. 4.10C, arrow).
Functional blood vessels, as indicated by the presence of red blood cells (Fig. 4.9C, asterisk
and Fig. 4.10B), were observed at scattered intervals within the reconstructed tissue.
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Figure 4.9: Nerve reconstruction – semi-thin sections.
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Figure 4.9: Nerve reconstruction – semi-thin sections. (A and B) Control sciatic
nerve samples. Sections are densely populated by myelinated nerves. Scattered blood vessels are
present ((a), arrow). The epineurium is well defined ((B), arrow). (C and D) Samples taken
within 1 mm of the proximal nerve stump. Myelinated and non-myelinated axons of varying
caliber are present ((C), arrows). (*) in (C) denotes a blood vessel, arrow in (D) denotes external
capsule of implant. (E) Sample taken within 5 mm of the proximal nerve stump. This domain
was characterized by bundles of axons surrounded by a delimiting band of tissue that resembles
the perineurium of native nerve ((E), arrow). (F) Samples taken 8–10 mm distal to the
proximal nerve stump. Axon caliber and density is reduced with respect to the proximal domains
depicted in (C)–(E). Arrowhead denotes the perineurial-like structure (precursors to the
structures present in (E)). Note the nearly uniform alignment of the axons in all of the crosssections. All images captured with a 100× oil immersion lens. Bar in (F) for (A)–(F) = 10 μm.
(G) Frequency of the regenerating axon 2D cross-sectional area at proximal and distal sites of the
implanted scaffold. The frequency at which the smaller caliber axons are encountered in
the distal domains is greater than the proximal aspects of the tissue, typical of the early stages
of nerve regeneration.
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Figure 4.10: Transmission electron microscopy. (A and B) Proximal domains, (C and
D) distal domains of regenerating tissue. In these cross-sections, the proximal and distal domains
exhibit well differentiated myelinated axons (mAX) interspersed with unmyelinated axons (*).
Functional blood vessels in the regenerating tissue range from capillaries to small arterioles ((B),
BV) with smooth muscle cells ((B), Sm). Distal domains (C and D) contain the profiles of
numerous Schwann cells (Sc) in association with small caliber axons. The box in (C) denotes one
of these profiles, in (D) a high magnification detail of a Schwann cell surrounding a small caliber
axon and adjacent to a fibroblast (F) is illustrated. Note the relatively high degree of maturation
in the myelin sheaths. Cytoskeletal elements are clearly evident in the axons. Interstitial spaces
are filled with parallel arrays of collagen fibrils ((B), inset shows a tangential section
of collagen fibers, also see Col in (B and D)). Inset (D) illustrates a PCL fiber, note the lack
of myelination on these structures. Scale bar in (C) for (A-C) = 2 µm, scale bar in (D) = 0.5 µm.
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Overall, we note that the extent of myelination present on individual axons is surprisingly
mature within the regenerating tissue. The myelin sheath surrounding the axons was
considerably thicker than we anticipated, given the relatively short period of time that we
allowed for regeneration (Fig. 4.10). Also surprisingly, the regenerating tissue was packed with
highly aligned fibrils of collagen that were predominately oriented in parallel with the long axis
of the developing tissue (Fig. 4.10B, inset). At this time the role of these fibers in directing axon
growth remains an open question. Conversely, these fibers do not appear to have adversely
affected the regeneration process; guides composed of collagen have exhibited efficacy
in nerve reconstruction [57].
Using quantitative morphometrics we calculated that the proximal section of the grafts
contained 8400 myelinated axons, a figure that is comparable to the estimates given in the
intact sciatic nerve [58]. At the distal end, and again based on our light microscopy survey, we
calculated that there were about 1900 myelinated axons present in the regenerating tissue.
Consistent with the early stages of regeneration that we have examined in this study, we
observed that the average 2D myelinated axon cross-sectional area decreases as a function of
increasing distance from the proximal nerve stump, and that majority of axons present in
the distal domains were, on average, smaller in caliber and more uniform in size distribution as
compared to the proximal domain (Fig. 4.9G).
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DISCUSSION

In this study we have used two pole electrospinning to fabricate “semi-solid”, 3Dcylindrical constructs composed of fibers that have been deposited into highly aligned arrays that
are oriented parallel to the long axis of the constructs. In contrast to conventional electrospinning
systems, the extent of fiber alignment in air gap spinning is clearly much less dependent upon the
size of the fibers. In our air gap system, we have been able to electrospin scaffolds composed of
aligned PCL fibers ranging from less than 200 nm to ~1.5–1.8 μm in average cross-sectional
diameter. The uncoupling of fiber alignment from its normal dependence on fiber diameter has
allowed us to develop and test a family of scaffolds with distinct material properties and
intrafiber spacing (void volume) to select the best configuration for a nerve conduit.
Several studies already have demonstrated that 2D sheets composed of anisotropic
electrospun fibers can effectively induce the alignment of neuronal cells [42-44] as well as the
directed and accelerated migration of a variety of cell types [45, 59, 60]. This type of 2D surface is
particularly well suited for in vitro applications; cells plated onto a flat sheet are readily
accessible for analysis by a variety of microscopy techniques [5]. These 2D constructs are less
well suited for use in the actual reconstruction of a damaged nerve.
Sheets of electrospun materials have been described as 3D in the literature; however,
arguably, the 3D aspect of this depiction may be overstated and is largely confined to a
description of the surface topography of the scaffold. Air gap electrospinning makes it possible
to produce a truly 3D cylindrical construct composed of linear arrays of fibers oriented along a
common axis. We have produced cylindrical scaffolds 15–20 mm in cross-sectional diameter
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using this system and we have observed virtually no degradation in fiber alignment in the large
scale constructs.
As noted, the fabrication of nerve guides using conventional electrospinning processes
has been explored to some degree. Electrospun PCL-based devices have been fabricated as
hollow, cylindrical tubes that are designed to confine regenerating nerves to the lumen of the
device while restricting the penetration of inflammatory cells into the injury site [50]. These
hollow devices appeared to initiate only a nominal inflammatory response when used in sciatic
nerve reconstruction. Additionally, PCL breaks down slowly, and as a result, has displayed good
biocompatibility in a variety of other bioengineering applications. Our experiments yielded
similar results and we did not observe evidence of inflammatory cells or scarring within our
guides. Morphometric analysis would suggest that hollow nerve guides produced by
conventional electrospinning processes using PCL can direct perhaps 25% of the axons (based
on volume of tissue, not the actual number of axons) present in the proximal stump to regenerate
down the length of 10 mm tube over a 14 week interval [50]. While the metrics between this study
and our study vary to some degree, our estimates suggest that we achieved a similar degree
of axon regeneration (approximately 25% of the axons present in the proximal section reached
the distal end of the guides as determined by morphometric analysis) in our 3D guides over a
7 week interval (we believe the regeneration process has not reached its penultimate extent by
any means in our experiments, given the very brief time interval of these preliminary
experiments.
The extent of functional recovery that can be achieved after nerve injury is limited by the
nature of the precipitating injury and by processes that exist downstream to the
actual wound bed. For example, in peripheral nerve injuries, functional recovery may essentially
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be complete if the continuity of the endoneurium is spared during precipitating event
(neuropraxia). In this type of injury the myelin sheath that is distal to the wound bed represents a
“full-length” guidance conduit. The regenerating axons are confined to returning to the end
organs associated with the surviving endoneurium. These observations suggest that guidance
cues incorporated into a synthetic nerve guide can play a critical role in directing the
regeneration process [41]. The extent, and fidelity, of nerve regeneration and subsequent
functional recovery are greatly reduced once the endoneurium has been compromised
(axonotmesis and neurotmesis).
While electrospun, hollow devices afford a measure of improvement over
existing nerve guide designs that have been fabricated by more conventional processes (excellent
porosity for nutrient exchange and good structural integrity), we would argue that hollow
electrospun tubes represent a relatively early evolutionary stage in nerve guide design. The
autologous nerve guide remains the gold standard treatment for nerve injuries that require
reconstruction. We have modeled our unique 3D design on the architecture of these “natural
guides”. The use of autologous implants is not without its limitations. For example, the action of
harvesting the autologous tissue obviously results in morbidity at the donor site. The axonal
debris that is present within the harvested tissue also must largely degrade before regenerating
axons can penetrate the tissue, a time delay that can exacerbate the onset of degenerative changes
in the distal tissues (e.g. loss of motor end plates in muscle, muscle disuse atrophy). While
regenerative processes in the peripheral nervous system can restore a considerable degree of
function to end organ tissues, the recovery of fine motor skills, unfortunately, is limited. We
believe that functional recovery can be improved by (a) accelerating axon growth across the
injury bed and simultaneously (b) confining these regenerating axons to a spatial domain (tissue
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plane) that mimics their original position within the nerve. Our synthetic guides are designed to
provide the guidance cues that are inherently present in autologous grafts without the time delay
needed to degrade the axonal fragments present in the harvested tissues. In addition, we believe
that our 3D guides can be used to confine regenerating axons to the tissue plane where they
existed prior to the precipitating event that damaged the nerve. This can be expected to increase
the probability that the axons passing down the guide structure will emerge closer to their
original position, a circumstance that should improve targeting and thereby increase functional
recovery.
In summary, air gap electrospinning makes it possible to directly incorporate guidance
cues into the structure of a truly 3D construct. The pore spaces present between the aligned fibers
in these nerve guides readily supported axonal growth. Somewhat surprisingly, even scaffolds
composed of the smallest diameter fibers supported the penetration of axons and Schwann
cells in our in vitro studies. It remains to be determined how the architecture of a 3D guide might
be exploited to further modulate axonal targeting, sprouting and fasciculation. At present we are
attempting to quantitatively determine how the number and density of electrospun fibers might
impact these processes. We can only speculate how the incorporation of cells or gradients
containing specific binding moieties and/or biochemical signals designed to enhance tissue
regeneration might be used to further enhance the functional properties of our construct. Physical
and biochemical cues that accelerate axonal regeneration can be expected to improve functional
recovery

in distal tissues

by

limiting

end-organ

complications

associated

with

de-innervation (i.e. atrophy). Notably, the use of such combinatorial strategies may hold great
promise in the development of treatment strategies and tissue engineering scaffolds that are
designed to promote regeneration in the central nervous system [60, 61].
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CONCLUSION

In peripheral nerve injuries, the extent of recovery depends upon the appropriate targeting
and the time taken by the regenerating axons to reach and re-innervate the target tissues. In
contrast to conventional hollow nerve conduits, our novel 3D nerve guide with dense arrays of
anisotropic fibers are very effective at directing axon elongation along a defined axis, thereby
providing the spatial cues for proper targeting. The use of our 3D nerve guide in place of an
autologous graft eliminates the complications associated with donor site morbidity and
theoretically accelerates the regeneration process by eliminating the need to degrade the axonal
fragments that typify material sourced from autologous tissues. These factors can be expected to
accelerate regeneration across the injury site, and thereby reduce the associated complications,
and thus improve functional recovery.
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CHAPTER 5
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Chapter 5. Designing of a drug delivery platform for sustained release of
gradients of growth factors at precise locations

Preface: In this chapter we describe the preliminary investigation and proof of concept
experimentation for the use of alginate as a solid phase platform designed to release growth
factors and other therapeutic reagents over a prolonged period of time to enhance the
regenerative environment of an injured tissue.
Tissue regeneration in the adult takes place under unique conditions. For example, in the
adult, when fully differentiated tissues are damaged they undergo a wound healing process that
superficially approximates developmental events. However, it is critical to remember that this
wounded tissue in the adult regenerates in an adult biochemical (and signaling) environment
that is likely to have mechanical damage and will more than likely have an ongoing
inflammatory response. Compounding these circumstances, wound healing in general, becomes
far less efficient with age and with a deteriorated physiological state. Injuries may compromise a
single tissue, like peripheral nerve, and leave associated tissues relatively unharmed. Fetal
tissues undergo de novo differentiation, development and growth and do so in concert with other
tissues. This makes for a very different environment than that of an adult. Wound healing in the
skin is a very well documented example of how healing in the adult and fetal environment differ.
For example, in adult dermal injuries, skin can undergo a certain degree of true regeneration
but the process almost always is impaired to some extent by the development of scar tissue

[62]

.

This scar tissue is non-functional and limits the extent to which the wound healing process can
restore normal structure and function in the skin. In contrast, wound healing in a surgically
induced injury in the fetus can undergo complete and scar-less healing. This has been largely
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attributed to the signaling environment that exists during these early stages of development.
TGFβ3-based signaling predominates in the fetus; in contrast TGFβ1 and TGFβ2 based
predominate in adult tissues. When wound healing in the fetus is experimentally manipulated to
take place with lower ratios of TGFβ3 versus TGFβ1 and TGFβ2, scarring can be induced even
in the privileged environment of the fetus. Conversely, blocking TGFβ1and TGFβ2 in the adult
and driving the healing with TGFβ3 reduces scarring in a skin injury

[63]

. These results

underscore the role that local environmental events can play on the wound healing process.
Our novel 3D nerve guide fostered tissue regeneration in an experimental model of
rodent sciatic nerve injury. These injuries are relatively short in length and there are concerns
that longer defect injuries may not undergo as complete healing as described in our pilot study.
To modulate the regenerative environment of the tissue injuries, we have developed a drug
delivery platform designed to provide the sustained release of growth factors in precise locations
and / or the establishment of growth factor gradients. This platform was then used in our 3D
nerve guides to modulate the regenerative environment in a rodent model of long defect nerve
injury to the sciatic nerve. These experiments are discussed in Chapter 6.
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ABSTRACT

This study investigates the use of alginate as a platform for the controlled release of
growth factors into a regenerative environment. Alginates are well characterized biopolymers
used extensively in this type of application. One specific advantage to alginate gels concerns the
observation that they can be fabricated into a variety of physical shapes and forms using very
simple conditions. We used electrospray to produce microbeads (5-10 m in diameter in a
hydrated state), controlled volume droplets to produce macrobeads (2-3 mm in diameter in a
hydrated state) and small segments of PVC tubing to produce linear threads (4-5 mm in diameter
in a hydrated state) of alginate. The thread form of alginate was found to have the best capture
efficiency of NGF. NGF release from the alginate threads was persistent and well sustained over
a prolonged period of time. When alginate threads were incorporated into an electrospun 3D
nerve guide, NGF was released and became concentrated in the vicinity of the thread. Imagining
studies indicate that a fraction of the growth factor becomes adherent to the surrounding
electrospun fibers. The fabrication methods to produce alginate threads are simple and can be
used to deliver gradients of the same and or multiple growth factors at specific locations in an
electrospun nerve guide.
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INTRODUCTION

In long defect peripheral nerve injuries (in humans this represents a loss of approximately
3 cm of tissue), where a segment of nerve tissue is completely crushed or severed, a nerve guide
is needed to restore the continuity of the damaged nerve. Functionally, these devices are
designed to physically link the severed ends of a transected nerve and constrain the regenerating
axons to grow in a directed fashion from the proximal stump of the nerve back into the
perineural remnants of the distal nerve stump. These devices have a long history and are
designed to direct the natural processes that lead to peripheral nerve regeneration

[36, 37]

. We

have developed a nerve guide with unique 3D architectural features that is composed of aligned
arrays of nano-to-micron scale diameter fibers. These constructs are produced by two pole air
gap electrospinning

[2]

and are composed of the bio-compatible polymer, polycaprolactone

(PCL). The guides are cylindrical in nature and contain literally thousands of individual channels
that are orientated in parallel with long axis of the guide. The air gap process makes it possible to
tailor the size (diameter) of these constructs to match the diameter of the nerve to be
reconstructed
In a pilot study, we demonstrated that our electrospun 3D nerve guides support nerve
regeneration across a 10 mm gap in the rodent sciatic nerve

[2]

. This injury gap represents a

defect that is just below the threshold (threshold is > 10 mm) of what is considered to be a long
defect nerve injury in the rodent. To address longer defect injuries, we suspect that it may be
necessary to provide additional exogenous trophic factors to the regenerative environment to
drive axon growth.
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In this chapter, we examine the use of the carbohydrate polymer, alginate, as a platform
designed to introduce NGF to precise locations and or in the form of gradients in the local
microenvironment. NGF and other neurotrophic factors have short half-lives [64] and regeneration
across a long defect nerve gap can take days to weeks depending on the nature of the injury,
making it critically important to develop strategies designed to provide therapeutic agents over
more prolonged intervals.
Alginate exhibits good biocompatibility and has been used as a delivery platform in a
variety of different applications in the past

[65-69]

. Alginic acid (also called algin or alginates) are

naturally occurring polysaccharide polymers isolated from brown seaweed (Phaeophyceae).
They contain blocks of D-mannuronic acid and L-guluronic acid (Figure 5.1). Commercially
available alginate is in the form of sodium alginate salt. These salts form a gel when a solution of
the sodium alginate is extruded into a divalent cross-linking solution containing Ca2+, Ba2+, or
Sr2+. The process of gelation occurs when sodium ions associated with the guluronic acids
exchange with the divalent cations, this exchange causes the sugar moieties to stack and form a
characteristic egg-box-like structure (Figure 5.1 and 5.2)

[66, 70]

. Each polymer chain of alginate

can dimerize and form junctions with many other chains and results in the formation of a crosslinked alginate gel. This gelation process can be used to trap growth factors and other therapeutic
reagents into the resulting alginate gel

[66, 67, 71]

. After the gelation process alginate is typically

collected and cured and or / dried by any number of different methods. Once the dry alginate is
placed back into an aqueous environment it undergoes hydration and gradually dissolves as the
diavant cations begin to dissociate from the sugars, releasing reagents that are trapped in the
carbohydrate based matrix. In this study, we exploit the characteristics of alginate and explore
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the use of this material as a delivery system designed to incorporate growth factors in precise
locations and / or to produce gradients of growth factors within a nerve guide.
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Figure 5.1: Structure of alginic acid residues. Alginic acid is a linear polymer with
homopolymeric blocks of M = mannuronic acid and, G = guluronic acid residues covalently
linked together (From Tonnesen and Karlsen, 2002 [66].

Figure 5.2: Schematic of the characteristic egg-box structure. The poly-L-guluronate
sequences are cross-linked by the calcium ions resulting in alginate gelation process. Upper part
of the figure represents random coils of the mannuronic acid and guluronic acid residues
converting to ribbon-like structures containing arrays of calcium ions. The lower part of the
figure represents the proposed binding between the calcium ions and the guluronic acid residues.
(From Gombotz and Wee, 1998 [70]).
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In an effort to enhance peripheral nerve regeneration by providing biochemical cues to
the regenerating axons, we used Nerve Growth Factor (NGF) as a model protein. One specific
advantage of this particular growth factor is that its functionality can be easily evaluated in tissue
culture experiments. The growth and survival of explanted dorsal root ganglions (DRGs) is
depended upon this reagent in vitro

[2, 72, 73]

. In this study we tested various permutations of

alginate and gel structures to develop a delivery platform designed to provide the sustained
release of NGF at precise locations in between the electrospun fibrils of the 3D nerve guide.
Each form that we examined exhibited its own relative merits and limitations in this
particular application. Many reagents, when added directly to the organic solvents used in
electrospinning can be damaged [74]; to address this processing limitation, we developed alginate
microbeads as a means to trap and sequester therapeutic reagents in a compartment that can be
directly added to the organic solvents used in the electrospinning process and co-spun into the
fibers of an electrospun scaffold. Unfortunately, the capture efficiency of trapping reagents into
these beads is very low. We next designed threads of alginate as a means to develop gradients of
therapeutic reagents. ELISA results show that this platform demonstrated much better capture
efficiency and favorable release kinetics. When implanted into a scaffold there threads release
NGF, which then adheres to the surrounding fibers of the electrospun matrix, producing a
functional gradient.
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METHODS

Alginate Microbeads Preparation.
Unless otherwise noted, all alginate solutions were prepared by dissolving the sodium salt
of alginic acid from brown algae (Sigma-Aldrich) in deionized water at 12.5 mg mL-1. All
solutions in controlled release studies were supplemented with Bovine Serum Albumin (BSA) at
a concentration of 10 mg mL-1 (Alginate–BSA solution). Nerve Growth Factor (NGF) was added
in various concentrations to the alginate solution, Alginate–BSA–NGF solution was loaded into
a 10 mL syringe which was capped with an 18 gauge blunt-tipped needle. The syringe was
attached to a vertically oriented syringe driver set at a delivery rate of 2 mL hr-1 (Figure 5.3). A
250 mL Pyrex beaker containing 100 mL of 2% calcium chloride solution prepared in deionized
water was placed underneath the vertical syringe such that the distance between the needle tip
and the base of the beaker was approximately 6.5 cm. The alginate solution was charged to +22
kV with a positive electrode connected to the needle; a metallic plate charged to -22 kV was
placed beneath the glass beaker containing the calcium bath. The potential difference between
the alginate solution and the metallic plate under the beaker results in the ejection of a fine
aerosol mist of the Alginate–BSA–NGF from the needle tip. The resultant alginate aerosol is
deposited into the calcium bath, causing alginate solution to undergo polymerization / gelation
and formation of alginate microbeads (5-10 m in diameter). Beads were incubated for 10 min in
the calcium bath; the calcium bath was then transferred into 50 mL centrifuge tubes and
subjected to gentle centrifugation (400× g) for 10 minutes. Beads were collected, rinsed in fresh
calcium bath solution supplemented with 10% propanol and re-suspended in this same buffer.
The calcium propanol solution was then supplemented, by volume, with 25% HFP (Sigma-
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Aldrich). This results in the formation of a bi-layer solution with the beads collecting at the
interface. Beads were recovered and dried under a vacuum.
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Syringe Driver

Syringe with
alginate solution

Calcium bath

Figure 5.3: Schematic of the electrospraying apparatus for preparing alginate microbeads.
The alginate-BSA solution with / without the NGF was loaded into the syringe with its needle
connected to the positive electrode of a high voltage power supply. The negative electrode was
connected to a metallic plate placed under a 250 mL beaker containing 100 mL of 2% calcium
chloride. The rate of delivery for the syringe driver was set at 2 mL hr-1. The potential difference
of the charges resulted in electrospraying of the alginate beads from the needle tip; the spray is
directed inside the beaker and into the calcium bath where the droplets of alginate are induced to
undergo gelation.
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Alginate Macrobeads Preparation.
Macrobeads were used for comparison and as controls in selected experiments. Alginate–
BSA–NGF solution was applied in 25 µL aliquots using piston-driven air displacement pipettes
into a 250 mL beaker containing 100 mL of 2% calcium chloride solution prepared in deionized
water. Macrobeads were incubated for 10 minutes in the calcium bath and processed through the
propanol and HFP washes as described for the microbeads.

Alginate Threads Preparation.
To produce linear threads of alginate we pipetted Alginate–BSA–NGF solutions into
segments of PVC tubing with an inner diameter of 2 mm. To produce “micro” gradients of NGF
along the length of these threads, alginate solutions were supplemented with varying amounts of
NGF. An aliquot was injected into the tubing and then frozen at -70 ºC for 15 minutes. Once
frozen, additional aliquots of NGF supplemented alginate prepared with varying concentrations
of growth factor were sequentially added to the already frozen material. This process is easy and
can be done quickly enough such that only the interface of the frozen material undergoes any
melting when the next solution is added to the “casting tube”. This slight amount of melting
“connects” the aliquots together (see (Figure 5.4). Once an additional aliquot has been added to
the tube it is returned to the freezer once again. By repeating this process a thread can be
produced. Once the thread has been fabricated a thin plunger is used to extrude the frozen
alginate into a 250 mL beaker containing 100 mL of 2% calcium chloride solution prepared in
deionized water. The threads were incubated for 10 minutes in this solution then recovered
washed and dried as described.
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= concentration 1
= concentration 2
= concentration 3

Freezing

Freezing

Cycle

Cycle

Extruded into a calcium
bath in a frozen state,
alginate
induced
to
undergo polymerization
forming a fiber with a
specific growth factor
gradient

Figure 5.4: Fabrication of alginate thread with concentration gradients. A desired amount of
alginate solution with one concentration of a reagent is pipetted into a segment of PVC tubing
and this sample is frozen. Then a second aliquot of alginate solution containing a second
concentration of reagent is pipetted into the same PVC tube directly on top of the first aliquot of
the now frozen alginate solution. The vessel is then frozen again. This cycle is repeated until a
frozen thread of alginate containing a reagent gradient is completed. Finally, the complete
column inside the tubing is extruded into a calcium bath for polymerization. The minor amount
of melting that occurs as each subsequent aliquot of alginate solution is added to the frozen
material is enough to ensure that the thread remains intact as a continuous linear structure when
the column is extruded as we well as when it undergoes polymerization.

130

Routine Scanning Electron Microscopy (SEM).
Dried alginate microbeads, macrobeads, and threads without any further processing were
mounted onto a scanning electron microscope stud and sputter-coated with gold for 2 minutes. A
Zeiss EVO XVP scanning electron microscope equipped with digital acquisition was used for
image capture.

Enzyme Linked Immunoprecipitation Assays.
For NGF release assays, alginate structures were incubated in serum-free Minimum
essential media (MEM) (GIBCO), media was collected and changed out daily. Samples were
stored at -70 ºC until needed. On the last day of experimentation, the remaining fragments of
alginate were processed in dissolving buffer (10 mM 3-(N-Morpholino), Propane-Sulfonic acid
(MOPS), 100 mM sodium citrate, and 27 mM sodium chloride; all Fisher Scientific) for 30 min
at 37 ºC

[65]

. This procedure was done to measure the amount of NGF left in the alginate on the

last day of the release assays. For NGF capture assays, the efficiency of NGF capture in the
different forms of alginate was determined by directly incubating the alginate constructs in
dissolving buffer for 30 min at 37 ºC. After collection of the samples, NGF ELISA was
conducted on NGF Emsx ImmunoAssay System (Promega) following the manufacturer’s detailed
protocols.

Statistical Analysis.
To compare the growth factor capture and release profiles in the different forms of
alginate, One-Way ANOVA was used to screen the data sets, and Holm-Sidak method was used
for multiple pairwise comparison in the post hoc analysis (p values as reported).
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Imaging of NGF.
NGF was labeled with NHS-Rhodamine (EZ-label Rhodamine Protein Labeling Kit,
Pierce Biotechnology) using the manufacturer’s protocol. Three aliquots of alginate (10 µL each)
were supplemented with the Rhodamine-labeled NGF at concentrations of 200, 400, and 1000 ng
NGF mL-1 respectively and used to prepare a gradient thread. The thread was hydrated and
imaged by fluorescence microscopy then dried, embedded in Tissue-Tek (Sakura, Inc) and
frozen. Threads were cut in 20 µm thick sections in parallel with the longitudinal axis of the
constructs using Shandon cryostat.
In limited experimentation alginate threads were supplemented with 25 ng of
Rhodamine-labeled NGF. Alginate threads (+ or – NGF), were placed near the two ends of a 3D
nerve guide and within the fiber arrays. This was accomplished by spinning a small amount of
PCL onto a target array in a two pole air gap electrospinning system. Once the PCL had collected
across the target array the threads were placed onto the fibers. The electrospinning process was
re-started and completed. This results in a 3D nerve guide with an alginate thread enveloped and
completely trapped within the fiber arrays. The electrospun scaffolds, with the two spatially
separate alginate threads were incubated in serum-free MEM (GIBCO) for 4 days with media
being changed daily. On day 5, the scaffold was recovered and embedded in Tissue-Tek, frozen
and cut into 60 µm thick longitudinal sections using the Shandon cryostat. All samples using the
rhodamine-labeled NGF were imaged with a Nikon TE300 microscope equipped with a 10×
objective and a DXM 1200 digital camera. Images were captured at a pixel resolution of 3840 ×
3072. Individual images of the alginate threads and scaffolds were assembled into montage
images using Adobe Photoshop software.
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Cell Culture.
3D nerve guides with alginate threads were prepared for cell culture experiments.
Alginate threads were prepared using 15 ng NGF/thread in the starting conditions. From our
preliminary experiments we assume a capture efficiency of approximately 50% for the NGF used
in these assays. Given this assumption, starting with 15 ng of NGF in the capture aspect of thread
fabrication will result in the capture of 7.5 ng of NGF in each thread. Scaffolds were prepared
using two pole air gap electrospinning using a starting concentration of 200 mg mL−1 PCL as
described in reference 2 (and Chapter 4 of this thesis). Dry alginate threads were placed at one
end of these scaffolds and within the fiber arrays. Scaffolds were incubated overnight in MEM
(GIBCO) supplemented with 10% FBS, 2.0% antibiotics, and 0.3% glucose. Media was changed
and a 25 gauge needle was used to prepare an opening into the dorsal surface of the scaffold.
Dorsal root ganglion (DRG) explants were prepared as described previously [53, 54]. Intact
ganglia were removed from the spinal cords of embryonic day 15 (E-15) rats, tissue was pooled.
A single explanted and intact DRG was inserted into the cavity prepared in the electrospun
scaffolds. DRG explants were maintained for 3 days, media exchanged every other day.

Immunofluorescence Microscopy: DRG Explants.
DRG explants were rinsed in PBS and fixed in 4% paraformaldehyde prepared in PBS.
Samples were extracted in 0.1% Triton x-100 prepared in PBS and immunostained for
the neuron specific marker TuJ1 (Tubulin J1: MMS-435P, Covance, 1:500). Antibodies were
diluted in PBS supplemented with 1% BSA and applied to cultures overnight at 4 °C. Scaffolds
were rinsed and counterstained with Goat anti-mouse antibodies conjugated with Texas Red
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(1:200). A Nikon TE300 microscope equipped with a 10× objective and a DXM 1200 digital
camera was used to capture images at a pixel resolution of 3840 × 3072. Individual images of
the DRG explants were assembled into montages using the Adobe Photoshop software.
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RESULTS

Alginate Microbeads vs. Macrobeads vs. Threads.
The microbeads, macrobeads and alginate-based threads showed varied morphology
macroscopically (Figure 5.5). Dry microbeads exhibit a saucer-like appearance (Figure 5.5A);
the macrobeads (Figure 5.5B) and threads (Figure 5.5C) both displayed complex surfaces with
many convolutions.
To characterize the relative efficiency of NGF capture in the different alginate constructs,
samples were prepared and then directly dissolved in the alginate dissolving buffer. The amount
of growth factor present in each sample was then assayed (Figure 5.6). This capture efficiency is
a critical variable to define for future in vivo experimentation. This information is necessary in
order to insure that constructs are formulated with effective doses of material. ELISA assays
indicated (N=3) that the capture efficiency of NGF in the alginate macrobeads was superior to
that of microbeads (p < 0.001). Alginate threads were more efficient than microbeads (p < 0.001)
and the macrobeads (p = 0.003) at trapping the NGF.
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Figure 5.5: SEM images of (A) alginate microbeads, (B) macrobeads, (C) threads. Scale bar
in (A,B) = 100 µm, Scale bar in (C) = 50 µm.

Figure 5.6: NGF capture efficiency of different forms of alginate delivery platforms. ELISA
assays (N=3 separate experiments) indicated that NGF capture efficiency in alginate threads (p =
0.003) > macrobeads (p < 0.001) > microbeads.

136

Effect of Alginate Concentration on NGF Capture and Release.
Given the poor capture efficiencies of the microbeads and the poor dimensional
characteristics of the macrobeads (too large to electrospin, too large to incorporate into a nerve
guide directly), we concentrated our efforts on characterizing the threads prepared by extrusion.
Our ELISA assays indicated that threads were highly efficient at capturing the NGF. We next
examined how varying the concentration of alginate impacted the capture and release efficiency
of this growth factor. Alginate threads were fabricated from alginate at starting concentrations of
2.5 mg mL-1, 7.5 mg mL-1, and 12.5 mg mL-1, each was supplemented with 10 ng NGF. The
alginate threads prepared using 12.5 mg mL-1 alginate acid were more efficient at capturing the
NGF protein as compared to the alginate threads prepared using 2.5 mg mL-1 (P = 0.022) (Figure
5.7A). The capture efficiency of the alginate thread prepared using alginate at 7.5 mg mL-1 was
not statistically different from the thread made from 12.5 mg mL-1 alginate acid. Thus, capture
efficiency is modulated to some extent by the concentration of alginate used to prepare a
construct; however we note that increased viscosity of the higher concentrations of alginate make
the material more difficult to process.
In release studies the total cumulative amount of NGF that was released from alginate
threads prepared from 2.5 mg mL-1, 7.5 mg mL-1, and 12.5 mg mL-1 alginate was not statistically
different after 7 days (Figure 5.7A). However, an examination of the amount of NGF that is
released on a daily basis reveals that release is slower from structures prepared from higher
concentrations of alginate. Additionally, at the conclusion of the experimental interval, there was
more NGF remaining in the constructs prepared with the higher concentrations of alginate. Thus,
as alginate concentration is increased, capture efficiency is improved and the captured material is
available for a longer period of time with a slower, more sustained release pattern.
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Figure 5.7A. NGF capture efficiency of alginate threads and total NGF release in 7 days
from different concentration alginate threads (2.5 mg mL-1, 7.5 mg mL-1, and
12.5 mg mL-1). Increased capture efficiency is noted in alginate threads prepared from 12.5 mg
mL-1 concentration vs. 2.5 mg mL-1 concentration (p = 0.022). However, no statistical difference
is noted in the NGF release from these threads over a 7 days period.

Figure 5.7B: NGF release profile from varying concentration alginate threads. Constructs
were each prepared with 10 ng of NGF. Release from alginate threads prepared using
12.5 mg mL-1 alginate is comparatively slower as compared to the alginate threads prepared
using lower concentrations of alginate.
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Saturation Value of Alginate Thread for NGF Loading.
We were not able to ever come close to capturing 100% of the NGF added to our alginate
solutions. One explanation for this result is that we might have already reached the saturation
levels of capture for this particular growth factor in our experiments. To test this hypothesis, we
next loaded varying amounts of NGF (5-100 ng) into a fixed volume of alginate solution (25 µL
at 12.5 mg mL-1) and prepared alginate threads. The constructs were then directly processed in
dissolving buffer; the recovered material was assayed by ELISA for NGF content. The fractional
amount of NGF that was captured in these experiments did not vary with the starting
concentration of growth factor. For example, the capture efficiency for 5 ng of NGF was
approximately 55%; the capture efficiency for 100 ng of NGF was nearly identical (Figure 5.8).
These data indicate that the amount of NGF added to our alginate solutions during thread
fabrication does not represent the rate limiting step in the capture efficiency. During thread
fabrication the frozen alginate appears to thaw as it undergoes polymerization (these processes
appear to take place nearly simultaneously) and we suspect that it is during this step that a
fraction of NGF is lost before it can be trapped in the forming gel. Also, NGF may be present on
the surface of the construct and this material simply diffuses away when the alginate is immersed
in the calcium bath. Consistent with these conclusions, an examination of the soluble phase of
our polymerization buffer (calcium bath) indicates that most of the lost NGF is present in this
fraction (Figure 5.9).
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Figure 5.8 (A,B). NGF capture efficiency of alginate threads loaded with varying
concentration of NGF. The threads were prepared from 25 µl alginate at a concentration of
12.5 mg mL-1 and loaded with 5, 10, 15, 20, 25, 50, and 100 ng of NGF. Capture efficiency was
approximately 50-60% for all conditions assayed. All data plus / minus the standard deviation.

Figure 5.9: % NGF present and lost to the calcium chloride bath during the process of
alginate thread polymerization. ELISA assays revealed that regardless of the amount of NGF
added to the system that approximately 50% of the growth factor is lost during polymerization.
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NGF Release Profile.
To determine how the starting concentration of NGF impacts the kinetics of growth
factor release, we conducted additional controlled release studies. Alginate threads (alginate
volume 25 µL at 12.5 mg mL-1) were prepared and supplemented 5 ng, 15 ng, or 25 ng of NGF.
In these experiments there was a burst of release from each of the samples on day 1. This was
followed by a sustained release of NGF from all the samples from day 2 continuing until day 8
(Figure 5.10).
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Figure 5.10: NGF release profile from alginate threads. (A) NGF release profile of the
alginate threads prepared from 25 µl volume of 12.5 mg mL-1 alginic acid sodium salt. We tested
3 different concentrations of NGF were examined: threads were loaded with 5ng (green), 15 ng
(red), or 25 ng (blue) of NGF. (B) NGF release profile with expanded scale on the Y-axis of the
plot between 0.001 ng and 1.0 ng to reflect the variable release kinetics, from day 2 to day 8, of
the 3 groups of alginate threads loaded with varying amounts of NGF. All data plus / minus the
standard deviation.
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Characterization of NGF within a 3D Electrospun Nerve Guide Scaffold.
We prepared 3D nerve guide scaffolds and incorporated alginate threads containing
varying amounts of NGF into these constructs. In controlled release experiments, and with
respect to threads in media (i.e. threads in media alone and not incorporated into scaffolds), only
about 15-25% of the NGF (values varied with the starting amount of NGF) that was expected to
be released appeared in the media at day 1 in samples that had been incorporated into scaffolds.
By day 3, the released valued declined to 11-18% of that observed in the control threads (threads
not incorporated into scaffolds). Given the large surface area present in the fibers of a 3D nerve
graft, the logical conclusion to these experiments is that a substantial proportion of the NGF
becomes trapped within the fiber arrays of the scaffolds and is not released into the surrounding
media. This conclusion was supported by imaging experiments.
To characterize how the NGF interacted with the electrospun fibers, we loaded alginate
threads with or without rhodamine-labeled NGF and incorporated these constructs into 3D
electrospun scaffolds. After 4 days of incubation under conditions identical to those used in the
controlled release experiments, the labeled NGF release was found to be concentrated in the
vicinity of where the alginate threads were originally embedded (Figure 5.11B). The electrospun
PCL fibers in these domains were coated with the labeled NGF. When control threads were
imaged no signal could be detected.
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Figure 5.11: NGF release and capture from alginate thread inside electrospun 3D nerve
guide. (A) Montage brightfield image of electrospun 3D scaffold. Alginate thread with 25 ng
NGF was placed in between the fiber arrays (left side of image). A control alginate thread with
no NGF was placed inside the scaffold on the right. (B) Immunofluorescence of rhodaminelabeled NGF demonstrating the local release and concentration of growth factor in a relatively
localized domain.
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Functional Assay
DRG cultures were used to confirm the bioactivity of the NGF released from alginate
threads. DRG explants require NGF for survival and in order to extend neurites in tissue culture.
DRGs were cultured for 3 days in scaffolds plus or minus alginate threads prepared with NGF.
At the conclusion of the experimental interval DRGs cultured in 3D nerve guides supplemented
with NGF produced elaborate arrays of neurites that grew in parallel with the surrounding fibers
(Figure 5.12). These results indicate NGF was released in physiologically relevant levels within
the nerve guides. No outgrowth was observed in the absence of NGF.
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Figure 5.12: DRG culture in scaffold with NGF in alginate delivery platform. The
elongating axons stained with TuJ1 anti-body growing inside the 3D nerve guide confirms the
bioactivity and availability of the NGF released from the alginate threads inside the 3D nerve
guide. Scale bar = 100 µm.

146

Alginate Thread with NGF Gradient.
Finally we investigated the extent to which we could fabricate a growth factor gradient
over a very short interval. Gradients of growth factors have different effects on regenerative
environments as compared to the effects of that same factor distributed in a homogenous
fashion

[75]

. For example, a gradient of NGF elicits an enhanced response in regenerating axons

as compared to uniformly distributed NGF

[64]

. Using the repeated freeze cycles as described

above in the methods section, gradients of NGF (or other factors or blends of factors) can be
incorporated into a single segment of an alginate thread for the sustained release of materials
within a 3D nerve guide. In this series of experiments we used three concentrations of
Rhodamine-labeled NGF (200, 400 and 1000 ng NGF mL-1 respectively) to prepare the
gradient-thread by the process of sequential freezing. The results of these experiments are
illustrated in Figure 5.13.
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Figure 5.13: NGF gradient in the alginate thread. (A) Brightfield image of an alginate thread,
focal plane at the surface of the construct; (B) fluorescence image of the same thread
demonstrating the distribution of rhodamine-labeled NFG gradient. The gradient runs from
lowest to highest from left to right in the depicted sample. (C) Frozen longitudinal section of the
same thread confirming the gradient distribution of NGF within the thread. (A)-(C) captured with
10× objective and assembled into a montage image. Bar in (A) = 1 mm for (A - C).
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DISCUSSION

The unique properties of the alginate make it possible to use this material as a platform to
trap and deliver a variety of proteins and other therapeutic reagents. For example, for this
material: (i) the gelation process occurs at room temperature, (ii) the gels are porous allowing for
the outward diffusion of molecules not directly embedded in the gel, (iii) the gelation process is
flexible and can be induced using a variety of methods (extrusion, drops, sprays, and so on), (iv)
biodegradation of the alginate occurs under normal physiological conditions thereby releasing
materials that have been incorporated into the gel structure, (v) and, it exhibits good
biocompatibility.
We compared the efficacy of three different forms of polymerized alginate gels –
microbeads, macrobeads, and threads. Capture and controlled release studies indicate that
alginate threads have far better efficiency in capturing NGF as compared to the alginate microand macro-beads. Loss may occur in microbead formation in any number of different sites in the
fabrication process. The NGF is mixed directly with the alginate and electrosprayed into a
calcium bath. Overspray and poor targeting must account for some loss. Beads are also likely
lost during recovery as they have a small volume. Directly fabricating macrobeads by simply
dropping a constant volume of alginate into a calcium bath improves capture efficiency, but the
physical dimensions of this form of alginate gel limits its use in our tissue engineering
applications. Moreover, even with improved NGF capture efficiency, as compared to the
microbeads, there still was a substantial loss of growth factor during the fabrication steps. As
determined from our assays (e.g. Fig 5.9) most of this loss occurred during the alginate
polymerization stage in the calcium bath.
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Alginate threads exhibited the highest capture efficiency among all the alginate forms
tested. This increased efficacy can largely be attributed to how the polymerization process was
initiated; the frozen alginate structure was directly extruded into the polymerization buffer.
Directly applying the frozen (and solid form of) alginate into the calcium bath for polymerization
likely reduces the inherent loss of NGF from the construct that we observed when we processed
the (wet) microbeads and macrobeads for gelation. Our experiments with the alginate
macrobeads clearly indicate that a considerable amount of growth factor is lost to diffusion into
the calcium during the gelation step (Figure 5.6).
Our goal in the fabrication of alginate in the form of microbeads was to produce a
platform that would protect incorporated reagents from the electrospinning solvents typically
used to produce tissue engineering scaffolds. We had initially planned on placing these beads
directly into the electrospinning solutions with the PCL polymer and electrospinning them into
the scaffold at the time of fabrication. The small dimensions of the microbeads (in a dry state less
than 5 microns in diameter) make them suitable for this type of use. However, given the poor
capture efficiency that we observed, a far more reliable strategy would appear to be the use of
alginate threads. It may be possible to produce the supplemented threads and then simply grind
them into a powder using mortar and pestle prior to adding the material to the electrospinning
solutions.
In addition to the capture efficiency, the release kinetics represents another important
characteristic of any delivery platform. The alginate threads prepared from higher concentrations
of alginate exhibited prolonged and sustained release of the growth factor with respect to
constructs produced with lower concentrations of alginate. The early stages of release from all
formulations were marked by a burst of release on day 1 (all alginate forms, using varied alginate
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and / or NGF concentrations). This would suggest that a fraction of the NGF adheres to the
surface or near the surface of the alginate structures and that it can diffuse freely from this
compartment upon hydration. As necessary this fractional loss during the early stages of release
might be reduced through the use of additional coatings of alginate and other polymers.
However, this burst of release may be desirable, when an alginate thread is placed into an
electrospun scaffold a fraction of the released material does appear to become trapped on the
surrounding electrospun fibers. In effect, this burst of release and subsequent adhesion or
trapping on the electrospun fibers may produce yet another functional compartment for the
release of materials. As reflected in the ELISA assays, reagent release is more uniform after day
2 of incubation (Figure 5.10), suggesting this release originates from a different kinetic
compartment. This secondary compartment may originate with the breakdown of the alginate
and or the diffusion of NGF out from the internal pores that we observed in our SEM study.
We have shown integration of an NGF-loaded alginate thread into and between the
fibrillar arrays of a 3D nerve guide results in the localized release of growth factor inside the
construct. Controlled release studies with alginate threads placed into an electrospun scaffold
composed of PCL suggest that about 30% of any NGF that is expected to be released from the
alginate compartment becomes trapped on the fibers and fails to diffuse out of the constructs.
Cell culture experiments conducted with explanted DRGs confirm the functionality of NGF
released from the alginate threads.
We expect that an even higher concentration of NGF will be trapped in the “fibrillar”
compartment of a 3D nerve graft that has been fabricated with the external coating of PGA/PLA
copolymer that we use when the devices are to be used in vivo to reconstruct a damaged nerve.
We elected to conduct our in vitro release assays without this coating to allow us to examine the
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intrinsic interactions of the released NGF and the fibrillar arrays. We note that regardless of how
these release studies are conducted, there are nearly insurmountable technical limitations. As
noted, our 3D nerve guides are typically over-coated with a PGA/PLA to reduce interstitial cell
penetration into the fiber arrays in an implant study. The distal ends of these constructs are
sutured to the nerve stumps. Together, these circumstances effectively seal the internal aspects of
the constructs from the surrounding tissues. To produce and evaluate the release of factors from a
nerve guide in that mimics these conditions using in vitro experiments will result in the
fabrication of a construct in which virtually no NGF can escape. Without the ability to recover
the released NGF, kinetic measurements cannot easily be made. Conversely, using a guide
without the overcoating allows us to measure release, but this type of construct does not really
very accurately reflect the conditions observed in a construct placed in vivo.
One possible method to address some of these issues may be to conduct in vitro assays
with a fully fabricated nerve guide (3D graft plus the overcoating) using radioactively tagged
NGF. By fabricating a series of replicate scaffolds it may be possible to trace the diffusion of the
tagged NGF along the longitudinal axis of the constructs. Replicate scaffolds could be isolated at
intervals, cut into cross-sectional segments and assayed for the labeled material. This approach
has limitations in the evaluation of NGF distribution in the radial axis. It would be difficult to
discern how the labeled material is compartmentalized in domains where alginate is still intact.
Determining if any particular fraction of the labeled material is associated with the fibers or still
retained within alginate would remain a relatively complex task. Still, this approach has merits
and it should provide good kinetic data overall to complement the experiments described in this
chapter. In the end the most critical assay that can be conducted is one that is conducted under
actual regenerative conditions as undertaken in the next chapter of this thesis.
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CONCLUSION

We characterized a delivery platform using alginate that can be incorporated into
electrospun scaffolds. This construct was designed to deliver therapeutic reagents over a
prolonged period of time and at precise locations in a regenerative environment. The fabrication
processes used to produce alginate threads are very simple and straightforward, and provide an
avenue to produce signaling gradients over relatively short distances. The simplicity of this
approach makes it possible to load the threads with different concentrations and/or different
growth factors and deliver those materials in a spatially and temporally to the regenerative
environment.
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Chapter 6. Electrospun 3D nerve guides: A comparative study

Preface: Our objective is to develop a next generation nerve guide that can supplant the
autologous graft which is considered as the gold standard treatment for peripheral nerve
injuries; our pilot data presented in Chapter 3 of this document clearly shows that our design
has great promise. Those studies confirmed that our device can support axon growth in tissue
culture experiments and nerve regeneration in vivo. However, to truly replace the autologous
nerve graft, we must directly compare and contrast the performance of our designs with this
standard of care. This chapter describes a study in which we directly compare and contrast the
performance of our 3D design with an autologous graft, and conventional hollow core graft in a
rodent model of a long defect injury to the sciatic nerve. In addition to making this basic
comparison, we also examine how 3D graft enhanced with an NGF gradient prepared after the
methods described in Chapter 4 impacts the regenerative process. We use a variety of structural
and functional metrics to characterize our grafts and evaluate the results of this expanded study.
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ABSTRACT

Robust axon regeneration can occur after peripheral nerve injuries, provided that a proper
regenerative environment is present to support the process. This study is designed to test the
performance of a unique 3D nerve guide fabricated from PCL using two pole air gap
electrospinning. These 3D guides were fabricated with / without an exogenous source of NGF
and compared against autologous nerve grafts and hollow core nerve guides in a rodent model of
a long defect nerve injury in the sciatic nerve (15 mm lesions). Functional and structural metrics
were used to evaluate the different treatments. The animals treated with 3D nerve grafts
displayed more rapid and increased functional recovery with respect to animals treated with
autologous nerve grafts and hollow core nerve guides.
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INTRODUCTION

Peripheral nerve undergoes an astounding degree of regeneration; however, the surgeon,
office worker, or hobbyist that has experienced a long defect injury is unlikely to regain the
strength and or fine motor control that is necessary to truly re-engage in pre-injury pursuits [76, 77].
Insidious “time-to-regeneration” barriers imposed by autologous nerve graft material and
conventional nerve guides play a central role in limiting the extent of functional recovery that
can be achieved after a nerve injury.
In humans, long defect peripheral nerve injuries (>3 cm) must be treated by surgical
reconstruction using an autologous graft or an engineered nerve guide; direct anastomotic repair
places too much tension across the tissue and results in a poor regenerative response [78]. Despite
extensive research, the autologous nerve graft remains the gold standard treatment for these
devastating injuries. However, this approach has well recognized inherent limitations. There is
paucity of donor nerves for autologous grafts; mismatch of the donor nerve size and / or length
with the recipient nerve site is very common limiting completely successful regeneration; the
secondary surgery for extracting the autologous graft increases intraoperative time, exacerbates
the risk of infections, and results in donor site morbidity. Additional complications that may
develop at the donor site include the evolution of neuromas and or hyperesthesia [50, 79]. Far more
importantly, autologous material retains axonal debris that must first degenerate before
regenerating axons can pass through the graft. Regeneration across this type of graft is further
slowed by proteoglycans that accumulate in the tissue and the adjacent nerve stumps, in response
to injury [80].
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Interventions that reduce the regeneration delays associated with the time it takes axonal
fragments in an autologous graft to degenerate represents a crucial avenue for improving
functional outcomes, and patient quality of life

[81]

. Achieving this goal is, in part, is one reason

why so many different nerve guide designs have been developed and promulgated as next
generation treatments designed to replace autologous material. Reducing the regeneration delay
is critically important because denervation leads to the onset of atrophic changes in the
downstream tissues. Within hours of denervation, motor endplates undergo re-organization
and the terminal Schwann cells spread into the synaptic cleft

[83]

[82]

. Over time the motor endplates

disperse, and the fine structure of the neuromuscular junctions is lost [84]. Disuse atrophy evolves
in the underlying muscle tissues [85-88]. Once these degenerative changes become entrenched, the
neuromuscular junctions will fail to fully reform even when axons are restored to the muscle [89];
not surprisingly, the prospects of significant functional recovery are very limited under these
circumstances.
A broad variety of nerve guides have been developed and explored, with mixed and
limited success, as indicated by the continued use of autologous material

[90, 91]

. To address the

limitations imposed by autologous material and the time-to-regeneration barriers that ultimately
limit functional recovery, we have developed a 3D “semi-solid” nerve guide that mimics the
anisotropic structure of native tissue

[2]

. These constructs are fabricated from the biocompatible

polymer, poly-ɛ-caprolactone (PCL) using two pole air gap electrospinning. This modification of
the electrospinning process produces seamless, cylindrical constructs that are composed of
dense, highly aligned arrays of PCL fibers that are oriented in parallel with the long axis of the
guides. Unlike conventional hollow cylindrical guides, and electrospun variants of this simple
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tubular design [50], our 3D guides lack the central lumen (hence “semi-solid”); axons grow along
the aligned fibers within the longitudinally arrayed intra-fiber spaces.
Our pilot study concentrated on describing our fabrication techniques and clearly
demonstrated the efficacy of the 3D design in the repair of a 10 mm lesion in the rodent sciatic
nerve. In this study, we use a battery of functional and structural metrics to compare and contrast
the performance of the 3D design with respect to the autologous graft and a conventional hollow
core cylindrical graft using a long defect injury in the rodent sciatic nerve. We also describe our
strategies to incorporate therapeutic reagents directly into our constructs to enhance graft
performance. The basic 3D nerve guide design (A) improved Sciatic Functional Index (SFI)
scores (B) and accelerated recovery of the withdrawal reflex to pain within 30 days with respect
to autologous grafts and conventional hollow grafts. In conjunction with these functional metrics
animals treated with the 3D grafts also exhibited evidence of dramatically improved nerve-tomuscle signal amplitudes and increased gastrocnemius muscle mass. These preliminary results
are unprecedented and superior to results reported in the literature for a variety of existing graft
designs [92-97].
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METHODS

Electrospinning
All reagents were purchased from Sigma-Aldrich unless noted. Polycaprolactone (PCL
65,000 M.W.) was dissolved in 1,1,1-trifluoroethanol (TFE) overnight at a concentration of
200 mg mL-1. 3D nerve guides were fabricated after the methods of Jha et al., 2011

[2]

as

described in Chapter 4 using two pole air gap electrospinning. The hollow tube nerve guides
were prepared by spinning PCL (200 mg mL-1 TFE) onto a rotating (100 rpm) stainless steel
1 mm diameter grounded mandrel. Electrospinning conditions were optimized such that the
nominal average PCL fiber diameter was 1 µm for all electrospun constructs. The 3D and hollow
tube nerve guides were over-coated with a layer of 50:50 PGA/PLA co-polymer (100 mg mL-1 in
TFE). This layer induces the formation of a fibrotic capsule on the surface of the electrospun
guides and serves to reduce interstitial cell infiltration into the fiber arrays

[19]

. All electrospun

constructs were calibrated to match the cross sectional diameter of the intact sciatic nerve.

Alginate Thread with NGF
A stock solution of sodium salt of alginic acid from brown algae (Sigma-Aldrich) was
prepared in deionized water at a concentration of 12.5 mg mL-1 and supplemented with
10 mg mL-1 Bovine Serum Albumin (BSA). A 25 µL volume of this solution was supplemented
with 15 ng NGF and placed into a segment of PVC tubing with inner diameter of 2 mm
(Nalgene). The aliquot was frozen at -70 ˚C for 15 minutes. Using a thin plunger, the frozen
alginate-BSA-NGF solution was extruded into 100 mL of 2% calcium chloride prepared in
deionized water and allowed to incubate for 10 minutes. The resulting “alginate thread” was
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rinsed in 2% calcium chloride supplemented with 10% propanol and dried under vacuum for
4 hours. This fabrication strategy for capturing NGF into the alginate is approximately 50%
efficient. Alginate threads containing NGF were placed directly into the forming fiber arrays
during the electrospinning process. This was achieved by initiating the formation of a 3D graft in
the two pole electrospinning system and stopping the process after the graft was 25-50%
complete. A single alginate thread was placed onto the electrospun fibers suspended between the
two target poles. After the placement of the alginate thread, the process of electrospinning was
resumed to completion. We assume based on empirical experimentation that the final NGF
concentration present within the grafts is 7.5 ng/implant.

Surgical Manipulation
Adult Long Evans Hooded rats (Harlan laboratories) were brought to a surgical plane
with isoflurane, sciatic nerve exposed as described in Jha et al.

[2]

. Depth of anesthesia was

verified by the absence of a corneal reflex and maintained with isoflurane delivered via a nose
cone. A 15 mm lesion was introduced into the left sciatic nerve and reconstructed with a 15 mm
segment of a 3D electrospun nerve guide (plus or minus NGF), a hollow core electrospun
cylindrical nerve guide or an autologous graft (N=3 for each permutation). Autologous material
was prepared by removing a 15 mm gap from the sciatic nerve and flipping that tissue 180º prior
to surgical placement. All implants were anchored with two sutures (10-0 Ethicon). For the
electrospun grafts, the sutures were placed through the outer layer of PGA/PLA and the
epineurium of the native tissue at its proximal and distal ends, for the autologous implants the
sutures were placed through the epineurium of both the implant and the proximal and distal ends.
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Additional fiduciary sutures were placed in the epineurium of the adjacent native tissue to mark
the injury borders.

Functional Recovery Analysis: Sciatic Functional Index (SFI) for Motor Function
SFI was used to monitor motor functional recovery [92]. All animals were assessed at day
10, 20 and 30 after surgery. On days 40-60 after surgery animals evaluated every 5 days.
Animals were trained to walk along a track with a clear bottom; data for gait and footprint
analysis was captured using a video recorder positioned underneath the walking track. Single
images were captured from the videos using Sony Vegas Pro software. To ensure that footprint
analysis was conducted when the limb of interest was fully weight bearing, still images were
captured from the videos when the contralateral leg was flexed and retracted from the surface of
the track at the midpoint of the stride. SFI was calculated from the average of 5 “footprints” from
each hind paw based on the Bain’s formula [92], where:
Sciatic Functional Index = -38.3 (PLF) + 109.5 (TSF) + 13.3 (ITF) – 8.8
PLF (Print length function, distance between heel and longest toe) =

TSF (Toe function, distance between 1st and 5th toe) =

ITF (Intermedian toe function, distance between 2nd and 4th toe) =

All images were calibrated for measurements from a scale bar captured at the time of data
acquisition.
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Functional Recovery Analysis: Withdrawal Reflex for Sensory Function
Withdrawal reflex to noxious heat was used to monitor sensory recovery. Animals were
positioned so that one foot of the rear extremity was placed in contact with hot plate set at 56 ˚C.
The pain withdrawal reflex was defined as the interval of time between contact with the plate and
hind limb retraction (each hind-limb is tested 3× with a 2 minute inter-trial interval and a
maximum exposure time of 10 seconds). Data was collected on day 10, 20, 30, 40, 50 and 60 on
the evenings of SFI evaluation; individual trials were averaged.

Statistical Analysis
The SFI and withdrawal reflex studies consisted of 3 animals from each treatment group
for days 10-30, two animals from each treatment group for days 31-45 and one animal from each
treatment group for day 45-60. A two-way repeated measures ANOVA was used to screen the
data from the SFI and withdrawal reflex studies conducted on day 10, 20 and 30 after surgery,
where variable 1 = implant identity, and variable 2 = time interval after surgery. Output was SFI
score or time to withdrawal. The Holm-Sidak method was used for post hoc analysis in each
study for these data sets (p values as reported). No statistical treatment was used for the later
time points as there were insufficient samples for analysis after day 30 due to the nature of the
study design.

Electrophysiology
Selected animals were brought to a surgical plane with 2.5% isoflurane. Hair was
removed from the hindquarters, and skin was swabbed with betadine. Skin and muscle overlying
the sciatic nerve was mobilized and the sciatic nerves in both the hind limbs were exposed. The
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Compound Action Potential amplitude (signal amplitude) of the sciatic nerves was recorded
across the test distance. This amplitude is an indirect measure of the total axonal innervation
across the distance between the electrodes. For nerve-to-nerve amplitude testing across the
reconstructed tissue, electrodes were placed on native tissue immediately rostral and immediately
caudal to the lesion site. When recording nerve-to-muscle amplitudes, stimulating electrode was
applied rostral to the implant site and a recording electrode was positioned in the gastrocnemius.
After placing the electrodes, the stimulus voltage was increased to obtain the maximum
amplitude of the compound action potential between the stimulation and the recording
electrodes. Beyond this maximal stimulus voltage, a further increase in stimulus voltage
produced no further increase in the compound action potential amplitude. Nicolet Viking Select
Electromyography machine was used for testing.

Tissue Processing
Tissues were isolated for analysis from each treatment group at day 30, 45 and 60 after
surgical reconstruction. Animals were injected with euthasol, flushed with 200 mL of sterile
PBS and perfusion fixed with 4% paraformaldehyde plus 0.5% glutaraldehyde using a
transcardial puncture. After 24 hr, sciatic nerve tissue was removed and immersion fixed for an
additional 24 hr at 4 ºC in 4% paraformaldehyde plus 2% glutaraldehyde prepared in 0.1 M
Cacodylate buffer. They were washed 3× in 0.1 M Cacodylate buffer and post-fixed in 1.0%
osmium plus or minus 2.5% potassium ferricyanide for 1 hr

[2, 19]

. All samples were subjected to

a graded series of alcohol dehydration (starting with 50% ethanol for 15 min, then 70% ethanol
for 15 min, next 95% ethanol for 15 min, then 100% ethanol 2× for 15 min). Samples were next
embedded in 1:1 Poly/Bed(Polysciences):Propylene oxide for 2 hr, followed by embedding in
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2:1 Poly/Bed:Propylene oxide overnight in dessicator. A Leica EM UC 6 ultramicrotome was
used to make semi-thin sections of 0.5 µm for morphometric studies and to make ultrathin
sections of about 60-70 nm for TEM imaging.
The lumbricals were recovered from the control and experimental limbs and immersion
fixed for an additional 24 hr in 4% paraformaldehyde plus 0.5% glutaraldehyde. Simultaneously,
gastrocnemius muscles from the control and reconstructed legs were recovered, minced,
lyophilized to obtain the dry weight mass. We expressed gastrocnemius muscle mass observed
on the experimental side as a percentage of muscle mass on the contralateral side to control for
any differences in overall rodent body mass.

Motor-End Plate Staining in the Lumbricals
Lumbricals were washed for 10 min in PBS at room temperature and then incubated in
0.1 M glycine plus 0.1% Triton x-100 and 1% BSA in PBS for 15 min. Tissue was placed onto
an orbital shaker for 1 hr at 4 ºC with Texas red-conjugated α-bungarotoxin (1:1000 dilution) in
PBS. The lumbricals were then compressed overnight between two microscope slides, recovered
and mounted on in Vectashield and imaged using a 63× objective on Leica TCS-SP2 AOBS
Confocal Laser Scanning microscope. The data images presented in this study represent stacked,
maximum data sets of the individual Z scans (ImageJ software).

Morphometry
We sampled the proximal domains that were 1 mm into the reconstructed tissue, at the
midpoint of the reconstructed tissue, 1 mm proximal to the distal border of the lesions and 1 mm
caudal to the distal attachment site of the implants (represents the number of axons that
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completely regenerated across the lesion). Semi-thin sections were prepared and stained with a
solution of 0.1% Toluidine Blue, 0.1% Methylene Blue, 0.1% Azure II in 1% sodium borate. To
calculate the total nerve cross-sectional area, montages from the implants were prepared using
size calibrated digital images captured using a Nikon TE 3000 microscope equipped with a 10×
brightfield objective. Individual images were assembled using the automated montage function
of Adobe Photoshop. The cross-sectional area of the different domains of the grafts were
calculated from the montage images using analysis tool of Adobe Photoshop software as defined
by the fibrotic capsule induced by the PGA/PLA layer or the epineurium of autologous material.
For morphometric analysis of myelinated axon content, a 100× oil immersion lens was used to
capture digital images at intervals of approximately every 500 µm throughout the nerve crosssection at a resolution of 3072 × 3072 covering an area of 125 µm × 125 µm. The number of
myelinated axons present in each data image was determined by non-biased sampling methods.
Each raw data image was subdivided into a series of twenty five 25 μm × 25 μm squares using a
5 × 5 grid. Of these twenty five squares in each raw image, alternate squares were used for the
morphometrics, i.e. of the total twenty five squares in each raw image, either twelve or thirteen
squares were used for myelinated axons counts depending on whether the first square was
included for the analysis or not. The raw data images from each cross-section sample were
divided into two groups. In images of the first group, the first square was included in the
analysis, resulting in thirteen squares for axon counts from those images; in the second group the
not the first, but the second square was included in the analysis resulting twelve squares for axon
counts from those images. Additionally, the myelinated axons touching the top and the left
border of each square were excluded from the counts and the myelinated axons touching the
bottom and the right border of each square were included in the count. To extrapolate the total
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number of axons present in the cross-sectional area, the density of myelinated axons in the
sampled images was multiplied by the total cross-sectional area of the grafts. Total myelinated
axon number was extrapolated from morphometric studies using the total cross sectional area of
the reconstructed tissue. All measurements were calibrated with a stage micrometer.

Electron Microscopy
Ultrathin sections were obtained after tissue processing as detailed above and all
ultrastructural analyses were conducted with Jeol-1230 electron microscope equipped with a
Gatan UltraScan 4000SP 4K x 4K CCD camera.

167

RESULTS

Functional Recovery Analysis – Sciatic Functional Index (SFI)
The loss of sciatic nerve function compromises ankle dorsiflexion in the rodent and
results in characteristic defects in the foot morphology resulting in gait deviations which
gradually resolve as the distal muscles are innervated by the regenerating axons of the sciatic
nerve. The SFI exploits these characteristics to generate a score that reflects the extent of sciatic
nerve function present at any given time after the surgical intervention. On this functional index
scale -100 represents complete impairment and 0 represents normal functioning.
Treatment groups consisted of 3 animals each in the SFI analysis through day 30, making
it possible to use two-way repeated measures ANOVA to evaluate the functional profile of the
different treatment groups over this interval. A graphical depiction of the time course of SFI
scores is presented in Figure 6.1 and a summary of the statistical results are presented in the
Table 6.1.
On post-operative day 10, the first day of evaluation after the surgery, the degree of
dysfunction was consistent across the different treatment groups with a mean SFI of
approximately -73.50 (Figure 6.1). Between days 10 and 20, the SFI for each treatment group
deteriorated with respect to day 10. This deterioration was most pronounced in the animals
treated with the autologous graft; this treatment group generated an average SFI of -94.99 at day
20 (p < 0.001 with respect to day 10). On day 20, animals treated with hollow grafts had an
average SFI decline to -87.21 (p < 0.001 with respect to day 10), animals treated with the 3D
grafts had their SFI decline to -81.79 on day 20 (p < 0.001 with respect to day 10), and animals
treated with 3D grafts + NGF had their SFI decline to -83.67 (p < 0.001 with respect to day 10).

168

At day 20, the SFI scores for animals treated with the 3D grafts + NGF (-83.67) vs. the hollow
grafts (-87.21) and 3D grafts (-81.79) vs. 3D grafts + NGF (-83.67) were not statistically
different from each other; however, the SFI for animals treated with the 3D grafts (-81.79; p <
0.001) were improved with respect to animals treated with autologous grafts (-94.99) and the
hollow grafts (-87.21) at this time point. Additionally, animals with autologous grafts (p < 0.001)
had lower SFI scores as compared to animals with hollow and 3D grafts + NGF. Overall the
decline in SFI scores at day 20 is most likely associated with the evolution of atrophy in the
distal muscle tissues.
On day 30, the different treatment groups remained stratified. The average SFI for the
animals treated with the autologous material improved to -81.93 (p < 0.001 with respect to day
20). Animals treated with the hollow grafts showed no measurable improvement on day 30 (-86
with respect to day 20 -87). Animals treated with the 3D grafts improved to -73.85 (p < 0.001
with respect to day 20) and the 3D + NGF group improved to -76.02 (p < 0.001). At day 30, the
SFI score for animals treated with the 3D grafts and 3D + NGF grafts was higher with respect to
animals treated with the autologous grafts (p < 0.001) and the hollow grafts (p < 0.001); and the
autologous treatment group was better than the hollow core grafts (p = 0.005). There was no
difference observed in the performance of animals treated with 3D grafts and 3D + NGF grafts.
These results indicate that motor functional recovery was faster in animals treated with the 3D
grafts = 3D + NGF grafts > autologous grafts > hollow grafts over the first 30 days of our study.
Only two animals remained in each treatment group over the interval of day 30 to 45.
With only 2 animals per treatment group in these later time points no statistical treatment was
applied to these results. However, the graphical depiction of the results depicts plus and minus
the standard error to illustrate the range of data collected from the two animals remaining in the
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functional studies at this time point. Animals treated with autologous material had an average
SFI score of -73.07, hollow graft animals had an average SFI of -79.36, 3D graft animals had an
average SFI score of -67.75, and 3D + NGF graft animals had a SFI of -62.73 by day 45.
From day 45 to day 60 there was only one animal in each treatment group. Over this
interval, the animals treated with the autologous and the hollow core implants displayed no
evidence of any additional motor recovery as judged by the SFI. These two animals in aggregate
achieved a SFI score of approximately -75 by this time point. In contrast, the animals treated
with the 3D graft or the 3D graft + NGF continued to display evidence of steady improvement
over this interval and each attained an SFI of about -52. The trajectory of changes observed in
gastrocnemius muscle mass over our study interval (Figure 6.3) provides additional evidence that
3D grafts support a rapid and robust recovery in the peripheral tissues.
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Figure 6.1: Sciatic Functional Index. Functional motor recovery of all the treatment groups.
Values near -100 represent impairment as compared to values closer to 0 represent normal motor
functioning.

Table 6.1: Statistical analysis for sciatic functional index (SFI) assay.
Statistical Summary I. Time after surgery
Day 10-20*
Autologous
Hollow
3D
3D + NGF

Day 20-30*

Day 10-30*

p < 0.001
p < 0.001
p < 0.001
p < 0.001

p < 0.001
No
p < 0.001
p < 0.001

p < 0.001
p < 0.001
No
No

Day 10

Day 20

Day 30*

No
p < 0.001
No
No
No
p < 0.001

p < 0.001
p = 0.002
No
p < 0.001
No
p < 0.001

p < 0.001
p < 0.001
No
p < 0.001
p < 0.001
p = 0.005

Statistical Summary II. Treatment

3D vs. Autologous
3D vs. Hollow
3D vs. 3D + NGF
3D + NGF vs. Autologous
3D + NGF vs. Hollow
Autologous vs. Hollow

* N=3 with 9 cases: two-way repeated measures ANOVA; Variable 1=Post-surgery time
and Variable 2=Treatment
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Gastrocnemius Muscle Mass Comparisons
The gastrocnemius muscle is distal to the site of our nerve lesion and it begins to atrophy
after de-innervation. As a result, the mass of this muscle after injury reflects the extent of sciatic
nerve re-innervation. On post-operative day 30, mass of the gastrocnemius muscle in the
impaired limb in the animal treated with the 3D graft was 34%, the 3D graft + NGF was 42% the
autologous graft was 39%, and the hollow core graft was 35% of the contralateral side (Figure
6.2). By day 45, the gastrocnemius muscle mass of the impaired limb in the animal treated with
the 3D graft was 48% of the contralateral side. In comparison, the impaired limb’s gastrocnemius
mass of the animal treated with the 3D graft + NGF was 40%, the autologous graft was 31% of
controls and the hollow core graft was 29% of controls. By day 60 the affected limb’s mass of
the gastrocnemius in animals treated with a 3D graft was 55%, 3D graft + NGF was 55% of
controls, autologous graft was 42%, and the hollow core graft was only 28% of controls. These
data are in support our SFI data indicating that animals treated with 3D grafts with / without
NGF undergo a more rapid and extensive degree of nerve regeneration than the other treatment
groups.
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Figure 6.2: Gastrocnemius muscle atrophy comparison. Higher percentage of contralateral
muscle mass represents limited muscle atrophy with good regeneration indicative of enhanced
peripheral nerve regeneration.
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Functional recovery analysis: Withdrawal Reflex.
To monitor recovery in the sensory tracks we used the withdrawal reflex to noxious heat.
The results of these experiments substantially parallel the results of our SFI studies, with the
exception of the animals implanted with the 3D nerve guide supplemented with NGF. These
animals exhibited a much slower rate of recovery for this reflex over the first 30 days of the
experiment than animals treated with the un-supplemented 3D grafts. A summary of the results
and the p values in the statistical tests are presented in the Table 6.2.
At day 10, the first day of testing, all animals exhibited a statistically identical response
to the noxious heat stimulus. The average time for withdrawal reflex in animals with autologous
grafts was 9.67 sec, in hollow graft animals was 9.47 sec, in animals with 3D grafts was 9.08 sec,
and in animals with 3D graft + NGF was 9.4 sec (Figure 6.3).
No measurable improvement occurred from day 10 to day 20 after surgery in the animals
treated with the autologous or hollow core grafts. However, on day 20 there was significant
improvement in the animals with 3D grafts (8.37 sec; p = 0.032) and in the animals with 3D +
NGF grafts (p = 0.010) with respect to day 10. Also, animals treated with the 3D grafts and with
3D + NGF grafts had faster response times than the autologous (p ≤ 0.044) and hollow core
grafts (p < 0.001) at day 20 after surgery. There was no difference in the response times for the
animals treated with the autologous graft and the hollow core grafts at day 20; similarly, there
was no difference between the 3D graft animals and 3D + NGF graft animals at this time point.
With the exception of the animals treated with the 3D + NGF grafts, all treatment groups
exhibited an improved withdrawal reflex by day 30 with respect to day 20 (p < 0.001). The
animals with 3D grafts responded markedly faster than animals treated with the hollow core
grafts (p < 0.001), the autologous grafts (p = 0.008), and the 3D + NGF grafts (p < 0.001) at this
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time point. The animals treated with the autologous grafts exhibited faster withdrawal reflexes
than the animals treated with the hollow core grafts (p = 0.001).
As with the SFI study, only two animals remained in the withdrawal reflex study from
days 30-45. No statistical treatment was applied to these results, however, the graphical depiction
of the results depicts plus and minus the standard error to illustrate the range of data collected
from the two animals remaining in the functional studies at this time point. The two animals
treated with 3D grafts were nearly at control levels by day 45 with an average response time of
4.13 sec and the animals treated with the 3D + NGF graft responded in an average time of 6.89
sec. Animals treated with the autologous grafts had an average withdrawal time of 5.48 sec and
the animals treated with the hollow core grafts had an average response time of 8.02 sec.
At day 60 one animal remained in each treatment group, the animal with the 3D graft
responded to the noxious stimuli within 1.62 sec (implying hypersensitivity), the animal treated
with the 3D + NGF graft responded within 3.35 sec, the animal with the autologous graft
responded within 3.63 sec and the hollow graft responded within 7.4 sec. These results indicate
enhanced sensory recovery in the un-enhanced 3D graft as compared to all other treatment
groups over the first 30 days after surgery.
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Figure 6.3: Sensory testing using the withdrawal reflex. Functional sensory recovery of all the
treatment groups. The animals responding faster or closer to the values of contra-lateral control
limb represent better response as compared to higher response time.
Table 6.2: Statistical analysis for withdrawal reflex assay.
Statistical Summary I. Time after surgery
Day 10-20*
Autologous
Hollow
3D
3D + NGF

No
No
p = 0.032
p = 0.010

Statistical Summary II. Treatment
Day 10
3D vs. Autologous
3D vs. Hollow
3D vs. 3D + NGF
3D + NGF vs. Autologous
3D + NGF vs. Hollow
Autologous vs. Hollow

No
No
No
No
No
No

Day 20-30*

Day 10-30*

p < 0.001
No
p < 0.001
No

p < 0.001
p = 0.010
p < 0.001
p < 0.001

Day 20

Day 30*

p = 0.030
p < 0.001
No
p = 0.044
p < 0.001
No

p = 0.008
p < 0.001
p < 0.001
No
No
p = 0.001

* N=3 with 9 cases: two-way repeated measures MANOVA; Variable 1=Post-surgery time
and Variable 2=Treatment
176

Motor End Plates
SFI, reflex withdrawal studies and changes in gastrocnemius muscle mass all indicate
that functional recovery is well entrenched by day 45 after surgical reconstruction in animals
treated with 3D grafts. We next examined the motor endplates of the lumbrical muscles of the
treated animals as an additional metric to evaluate the regenerative process. For these
experiments the motor endplates were stained with Texas red labeled -bungarotoxin to image
the post-synaptic acetylcholine receptors. In control tissues, the motor endplates exhibited classic
lobular structure.

At day 30 the endplates present were largely unrecognizable. The

-bungarotoxin positive structures present at this time point were indistinct and scattered on the
surface of the myotubes as small fluorescent foci, or clusters of foci (Figure 6.4).

By day 45,

this pattern had undergone a remarkable transformation. At this time point -bungarotoxin
positive features were clustered into structures consistent with that expected for functional rodent
motor endplates. At day 60 the motor endplate staining pattern was still evident, however, we
note that the staining in animal treated with a autologous graft and the hollow core graft was
less distinct than at day 45 and far more difficult to image. Motor endplates in animals treated
with the 3D and 3D + NGF grafts were similar to those observed at day 45.
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A

Figure 6.4: Lumbrical motor end plates.
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Figure 6.4: Lumbrical motor end plates. Motor end plates labeled with Texas red-conjugated
-bungarotoxin in the first lumbrical muscle of the rodent. (A) Diagrammatic representation of a
neuromuscular junction with acetylcholnine receptors shown in green along the crest of postsynaptic cleft. (B-C) Control motor end plates from contralateral normal foot. (D-F) motor end
plates of animals with autologous graft at post-operative day 30 (D), day 45 (E), and day 60 (F).
(G-I) motor end plates of animals with hollow graft at post-operative day 30 (G), day 45 (H), and
day 60 (I). (J-L) motor end plates of animals with 3D graft at post-operative day 30 (J), day 45
(K), and day 60 (L). (M-O) motor end plates of animals with 3D graft + NGF at post-operative
day 30 (M), day 45 (N), and day 60 (O). Scale bar in (O) for (B-O) = 20 µm.
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Electrophysiology
All of the metrics that we have used to measure functional recovery indicate that day 45
represents a watershed interval and clearly demonstrate that varying degrees of regeneration have
taken place in each of the treatment groups by this time point in the distal target tissues.
Electrophysiological studies were conducted at this time point to confirm these results.
Compound action potential amplitudes, an indirect measure of axon number, were taken across
the lesions – “nerve-to-nerve” (electrodes rostral and caudal of the injury gap), and “nerve-tomuscle” (one electrode rostral to the injury site and one electrode in the gastrocnemius muscle).
In the nerve-to-nerve study, the signal amplitude in the animal treated with the autologous graft
was 303 µV, the hollow graft was 5,729 µV and the 3D graft was 15,104 µV (Figure 6.5). The
signal amplitude for the nerve to nerve study in the contralateral normal sciatic nerves in our test
rodents ranged from 17,000 to 20,000 µV. Thus, the 3D nerve graft was approaching the normal
sciatic nerve’s electrophysiological functional properties at this time point. Nerve-to-muscle
signal amplitudes at the gastrocnemius muscle in the animal treated with the autologous graft
was 17 µV, the hollow core graft was 158 µV and 1,203 µV in the animal treated with the 3D
nerve graft (Figure 6.5).

180

(µV)
Figure 6.5: Signal amplitudes across the implants at post-operative day 45. Higher nerve-tonerve signal amplitudes were recorded across the 3D nerve grafts (green), as compared to the
hollow graft (red) and autologous graft (black). Nerve-to-muscle signal amplitudes across the
native nervous tissue proximal to the injury site and the gastrocnemius muscle were also higher
in 3D nerve graft as compared to the hollow and autologous grafts (gray bars).
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Morphometric Analysis
To characterize the underlying regeneration response supported by the different graft
designs, morphometric analysis was conducted to estimate the total number of axons that crossed
the lesion site in each of the different treatment groups. This preliminary survey was conducted
using a light micrographic survey of semi-thin cross sections taken from specific domains in the
implanted tissue at days 30, 45 and 60. Figure 6.6 illustrates the gross architectural appearance of
the autologous, hollow, and 3D grafts at their proximal and distal segments on post-surgical day
45. For each segment of tissue examined, a montage image taken with a 10× objective was
prepared from the semi-thin sections (like Figure 6.6A-F), these images were then used to
calculate the total cross-sectional area of the implant. A series of 100× images from these
sections (like Figure 6.6G-L) were then used to do morphometric analysis to give the myelinated
axon count at that segment. Data for myelinated axons was generated for samples taken 1mm
into the implanted tissue (denoted as proximal), at the mid-point of the implanted tissue (denoted
as middle), 1mm proximal to the caudal attachment site of the implanted tissue (denoted as distal
implant) and 1mm distal to the caudal attachment site of the implanted tissue (denoted as distal
native tissue).
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Figure 6.6: Tangential semi-thin sections 45 days post-surgery.
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Figure 6.6: Tangential semi-thin sections 45 days post-surgery. Montage images (using 10×
lens) of cross-section 3D graft, proximal segment (A-C) and distal segment (D-F): Autologous
graft (A, D), hollow graft (B, E), and 3D graft (C, F); all the grafts were well infiltrated with the
nervous tissue. Proximal (G-I) and distal (J-L) domains of the implant using 100× lens with the
5 × 5 grid mask used for morphometric analyses: Autologous graft (G, J), hollow graft (H, K),
and 3D graft (I, L). Scale bar in (A) for (A-C) = 100 µm, scale bar in (D) for (D-F) = 100 µm,
scale bar in (L) for (G-L) = 20 µm.
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Figure 6.7 graphically represents the results of the morphometric analysis of the different
treatment groups. It summarizes the myelinated axon count at different domains of the
reconstructed nerve (proximal, middle, and distal domain of the implant, and the segment of the
native tissue distal to the implant) at each of the time points assayed (30, 45, and 60 days).
A brief summary of this data indicates that on post-surgical day 30, autologous and
hollow implants exhibited higher counts of myelinated axons at the proximal segment as
compared to the 3D graft +/- NGF. We anticipated that our 3D grafts would support a much
more rapid penetration of axons than the autologous material. One clear possibility to account for
this result may be the compression and distortion of the terminal aspects of the fibers present in
an electrospun 3D guide which may occur during surgical placement (in a related study we have
observed that the distortion of the terminal aspects inhibits cellular penetration in the central
nervous system-data not shown). At day 30 for the proximal section total axon count for the
autologous > hollow > 3D > 3D + NGF. No myelinated axons were detected in the distal
segments of the hollow, 3D, or 3D + NGF; however, there were a considerable number of axons
present in the distal segments of the autologous graft. It is difficult to explain the apparent
efficiency at which this graft appears to have supported axon penetration (especially considering
the poor functional recovery displayed in this treatment group overall). Day 30 represents a very
early time point and while it seems unlikely we can not discount the possibility that these axons
in the distal segments of the autologous graft might represent axons which have not yet been
completely degraded. Countering this argument, however, are two relevant observations. First,
these axons appear to be completely normal at the light microscopic level. Second, axons are
completely absent in the native distal segment of the animal treated with the autologous graft,
indicating that sufficient time has passed to allow for axonal debris to develop and be removed.
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No axons were present in any of the implants in the distal native segment, consistent with our
observation that motor-endplates were degenerated at this time point in all of the animals.
On post-surgical day 45, the number of myelinated axons present in the proximal
segments of all the implanted grafts was similar. At this time point the total axon count in this
domain was highest in the 3D guide > autologous implant > 3D + NGF and the hollow core
graft. Total axon count remained highest in the middle segment in the autologous graft.
Myelinated axons were visible in the distal native segments at this time point in all of the
treatment groups. Total axon counts in this distal domain were highest in the 3D graft > 3D +
NGF > autologous > hollow core.

Superficially, these results would appear to generally

correlate with the electrophysiology data; however it is important to remember that myelinated
and non-myelinated axons, both contribute to the formation of the compound action potential
amplitudes we observed in the electrophysiological data.
By day 60, the number of myelinated axons present in the distal downstream segments of
the autologous and hollow core grafts increased with respect to day 30. This is not unexpected;
axons in any particular graft likely grow at varying rates. The distal implant and distal native
segments of these two graft designs were populated by more myelinated axons than they were at
day 30 after surgery. Surprisingly, and despite clear and unambiguous evidence of a robust
functional recovery in animals treated with the 3D and 3D + NGF implants, we failed to detect
more than a very small number of myelinated axons in the distal implant or distal native
segments in our assay. Of note at this time point is the myelinated axon count in the middle
segment of the hollow nerve guide. It is very high as compared to all the treatment groups and
also as compared to the axon count in the proximal and distal segment of the same implant. We
suspect that this high axon count represents an overestimation of the total number of axons
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present in this particular implant; in absence of guidance cues for individual axons in the hollow
guide the axons might may have elongated indiscriminately in non-specific directions resulting
in the same axon being counted more than once in a cross-sectional data image. The axon crosssections present in this domain exhibited a variety of profiles (true cross sections, more
tangential and partial longitudinal). Axon sprouting undoubtedly may also have contributed to
this “inflated” count. The 3D graft exhibited a small increase in axons in the middle segment
with respect to more proximal and distal segments, however the magnitude of this increased
count was modest compared to the hollow graft. The 3D + NGF graft exhibited a low number of
myelinated axons, but each domain in this graft exhibited a very consistent count.
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Figure 6.7: Morphometric analysis.
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Figure 6.7: Morphometric analysis. Myelinated axon counts at different positions of the
autologous graft (A-C), hollow graft (D-F), 3D graft (G-I), and 3D graft + NGF (J-L) on postsurgical day 30 (A, D, G, J), day 45 (B, E, H, K), and day 60 (C, F, I, L). The ticks on the X-axis
of the plots indicate the domain of the graft under analysis where 2 = proximal segment of the
graft, 3 = middle segment of the graft, 4 = distal segment of the graft, and 5 = segment of native
nerve distal to the graft implanted. . *Data points coded as n.a. indicate samples where the entire
cross-section of the nerve was not recovered, making a total axon count unavailable.
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Electron Microscopy
Ultrastructural analysis (Figure 6.7) indicates that the functional recovery observed in
animals treated with the 3D, and 3D + NGF grafts is mediated by multitude of small caliber
(ranging up to perhaps 500 nm in cross-sectional diameter), un-myelinated axons. In domains
caudal to the distal attachment site of the grafts (regenerated tissue in the remnants of the native
epineurium), these axons were frequently observed in small clusters and in association with the
basal laminae. While we did observe some axons clustered together that were surrounded by
Schwann cells, we rarely encountered myelinated axons, and when we did, these axons were
very small with a diameter of than 1000 nm.
In addition to the small caliber, unmyelinated axons that populated these grafts, we
observed clusters of cells with cuboidal nuclei arranged in a roughly circular pattern.
Examination of these clusters revealed that these cells express complex folds of what we
presume to be thin processes of cytoplasm. The nature of these cells and these presumptive
cytoplasmic folds remains to be defined. There is no clear evidence of a basal lamina
surrounding these, suggesting that they are not Schwann cells.
Implants isolated from animals treated with grafts supplemented with NGF exhibited
axons that expressed desmosomes and hemi-demsosomes like structures. These junctions have
been observed in regenerating peripheral nerve in rodents treated with acetylcholinesterase
inhibitors [98]. The significance of these junctions is not known currently.
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Figure 6.8: Electron microscopy. Electron micrographs from 3D nerve graft animal (A-F) and
3D + NGF nerve graft animal (G-I) on post-operative day 45. Section through the segment distal
to the implant (distal native sciatic nerve) (A-D, G-I); section through the implant (E-F). Clusters
of small diameter axons (arrows; A) growing within the basal laminae in 3D graft and 3D + NGF
graft (arrows; B, C, G, H). Evidence of active myelination by Schwann cells is present (arrow;
D). Peculiar to the 3D grafts & 3D + NGF grafts are domains that contain cells with elaborate
processes present throughout the implant (E & F); identity of these cells remains unclear. Axons
in 3D + NGF grafts expressed desmosomes and hemidesmosomes like structures (arrows; H &
I). Scale bar in (G) for (A & G) = 0.5 µm, scale bar in (B & H) = 200 nm for (B, D & H), scale
bar in (C & I) = 100 nm, scale bar in (E) = 2 µm, scale bar in (F) = 1 µm
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DISCUSSION

Peripheral nerve injuries represent one of the most common causes of sensorimotor
deficits and the evolution of subsequent functional limitations. Despite all the attempts
developing alternative strategies, the autologous graft remains the gold standard treatment for
this type of injury. Unfortunately, and regardless of the treatment strategy, functional recovery
after this type of injury is rarely complete [99]. For all too many patients the extent of functional
recovery is limited and in many respects nearly cosmetic in nature. For example, in median nerve
lesions wrist and finger flexion is compromised. A patient with a lesion to this nerve of the upper
extremity that has been surgically reconstructed with an autologous graft may appear normal
upon superficial examination. However, he or she may lack the strength necessary to grasp and
lift normal everyday objects.
Our goal is to develop a synthetic implant to supplant the autologous graft and develop
treatment strategies to improve functional outcomes after traumatic nerve injuries. In this study,
we have compared the efficacy of our unique 3D nerve grafts and 3D nerve grafts supplemented
with NGF against the autologous graft and the conventional hollow core graft in peripheral nerve
regeneration. We have incorporated a variety of structural and functional metrics into this study
to characterize the performance of 3D nerve guides in the reconstruction of long defect nerve
injuries.
The SFI assay for motor function indicated that our 3D guides (with / without NGF)
promoted faster functional recovery over the first 30 days of our study than the autologous and
hollow core implants. In addition, the SFI scores for animals treated with 3D guides +/- NGF
improved in parallel with one another along nearly identical trajectories, suggesting the
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exogenous NGF was not necessary to promote these early stages of recovery. The SFI uses
changes in foot morphology and toe position as metrics of nerve function. The absence of normal
staining patterns for the endplates of the first lumbrical at day 30 would suggest that regenerating
axons have not yet reached these distal muscles at this early time point. The -bungarotoxin
positive features at day 30 appeared as scattered bright foci (a staining pattern that is very
different than the staining pattern of motor endplates present in the control side). These critical
structures must be in contact with nerve tissue in order to express a normal structural profile (we
note that we attempted to double label the lumbricals with -bungarotoxin and a nerve specific
marker-unfortunately, this double labeling procedure produced inconsistent results. As the
differences between day 30 and day 45 in the motor endplate staining patterns was so
dramatically different we elected to not use this data). By day 30 gastrocnemius muscle mass
appeared to be greatly improved in animals treated with the 3D nerve grafts (+/-NGF) with
respect to the other treatment groups, suggesting this more proximal tissue had been reinnervated by day 30-at least to some extent. Given these results the improved functional
recovery that we observed at day 30 in the SFI was most likely mediated by events taking place
in the calf muscles (which are normally exclusively innervated by the sciatic nerve). The muscles
of this posterior compartment act on the foot and mediate plantar flexion and toe flexion. Any
recovery in these muscles can be expected to impact SFI scores.
Sensory recovery was also enhanced in animals treated with the 3D guides at day 30.
Together, these data demonstrate that 3D guides promote faster rates of functional recovery in
the motor and sensory neurons than the other treatment options. This functional recovery must be
largely driven by small caliber unmyelinated axons; morphometric analysis failed to detect any
myelinated axons in the native tissue distal of the implant site at this time point. Such an
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unmyelinated population of axons would fall below the limits of detection in a light microscopic
survey.
By day 45, the two animals treated with the 3D graft and the two animals treated with the
3D grafts supplemented with NGF continued to exhibit evidence of functional improvements in
the SFI and both had increased muscle mass with respect to the other treatment groups. Motor
endplate staining also underwent a dramatic change at this time point, each of the different
treatment groups exhibited endplates that were substantially identical in structure in the
experimental and contralateral control sides. This result would be expected to occur only after
some critical number of axons had physically and functionally re-innervated these distal tissues.
At day 45 nerve-to-nerve signal amplitudes were very robust in the animal treated with
the 3D guide and approached control values (17000 – 21000 µV), indicating the guides were
densely populated with functional axons. And, nerve-to-muscle signal amplitudes between the
proximal stump of the injured sciatic nerve and the gastrocnemius muscle were nearly ten-fold
higher in this animal than observed in animals treated with the autologous or the hollow core
grafts (technical limitations in instrumentation did not allow us to measure signal amplitudes till
the lumbricals). In turn, and consistent with these electrophysiological results, our morphometric
assays indicated that more myelinated axons were present in the native, regenerated tissue that
was distal to the implant site in animals treated with the 3D guides with respect to any other
treatment group.
While the 3D grafts did have increased signal amplitudes and an increased number of
axons in the morphometric assay it seems likely that the bulk of the functional recovery observed
at day 45 (as speculated for day 30) was mediated by small caliber unmyelinated axons. The 3D
grafts had more axons but, the magnitude of the difference between this treatment group and the
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other treatment groups does not appear to be enough to fully explain the functional recovery or
the electrophysiological results. This disparity is particularly distinct when comparing the nerveto-nerve signal amplitudes in the autologous grafts and our 3D grafts. The signal amplitudes in
the 3D grafts are fully 15 fold higher than that observed in the autologous grafts yet the number
of myelinated axons is only on the order of 2 fold different. An electron micrographic survey of
the distal domains at this time point appears to support this conclusion and revealed numerous
small unmyelinated axons in these domains, a more complete quantitative study will be
necessary to confirm this hypothesis. There is precedence for this conclusion, results from
Radtke and Vogt, 2009

[100]

suggest that regenerating axons exhibiting smaller diameters, a

thinner myelin sheath and shorter internodes can achieve rapid conduction.
There is no obvious explanation to account for the delayed onset of sensory recovery
observed in animals treated with the 3D + NGF grafts that is manifest by day 45. NGF is a
neurotrophic factor produced by the target organs of the sympathetic and sensory nerves. This
growth factor stimulates neurite outgrowth and promotes survival of sensory ganglia, including
those which give rise to spinal sensory nerves in the sciatic nerve
NGF enhances regeneration in motor nerve as well

[99]

[101]

. Some reports show that

. It seems clear that there must be an

optimal time course and concentration of NGF needed to promote regeneration across a long
defect nerve injury [102]. NGF has two receptors trkA and p75NGFR. The trkA subtype, is a highaffinity NGF receptor with a Kd of ~1 ng mL-1, is absent in the motor neurons

[103]

. This would

appear to explain why there was no significant improvement in motor recovery (SFI tests) in
animals treated with the 3D nerve grafts vs. the 3D + NGF grafts. Conversely, the p75NGFR is a
low-affinity NGF receptor with Kd of ~40 ng mL-1. At higher concentrations of NGF there is
marked decrease in chemotactic effects and a repulsion of growth cones, even at a local

195

concentration of as little as 1.0 ng mL-1

[104, 105]

. In a study by Gold, 1997

[106]

, the continuous

intrathecal infusion of NGF delayed the onset of peripheral nerve regeneration, without
compromising the rate of regeneration, possibly indicating that the initial loss of NGF following
injury might act as signal for the onset of nerve regeneration

[107]

. We appear to have observed a

similar result in our sensory function tests. We have been unable to precisely define the release
kinetics of our NGF in situ. In part, this is because the NGF is delivered into a very confined
space, which is sequestered by a PGA/PLA coating on the graft from the surrounding
interstitium. We know from in vitro experiments that perhaps as much as 70% of the NGF
released over the first several days in a 3D graft becomes associated with the fiber arrays. Based
on our sensory metrics, it would seem that a relatively high local concentration of the NGF was
present inside these grafts. It is also possible that the NGF present in the graft served as too
effective of a chemo-attractant, regenerating axons may reach the domains containing NGF and
essentially “stall” until the growth factor is dissipated.
We continued to observe evidence of functional recovery at day 60 in animals treated
with 3D guides +/- NGF. In contrast the other treatment groups failed to progress much beyond
the level of recovery observed at day 45, despite the observation that animals treated with the
autologous and hollow core grafts had far more myelinated axons in the tissue distal to the lesion
site. This result indirectly implies that the enhanced functional recovery observed in animals
treated with the 3D grafts continues to be driven by small caliber un-myelinated axons. In
addition to this consideration the 3D grafts may also be supporting enhanced targeting efficiency.
Either scenario or a combination of the two may ultimately underlie the improved functional
recovery observed in these animals. We speculate that the unique architecture of the 3D graft
could enhance targeting efficiency by confining regenerating axons to a tissue plane that
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approximates their position within the nerve prior to injury. The axons would then emerge from
the distal end of the graft near the vicinity they existed prior to injury. It would be theoretically
possible to test this hypothesis by conducting targeting assays.

.
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CONCLUSION

The architecture of our novel 3D grafts is designed to mimic the anisotropic structure of
the connective tissue present within the intact peripheral nerve. A synthetic graft with this type
of highly anisotropic architecture has been presented as a theoretical replacement for the
autologous graft as it should provide the guidance cues necessary to drive the regeneration [41]. In
tissue culture experiments two-dimensional surfaces of aligned electrospun fibers prove to be
very effective at directing axon elongation along a defined axis in a fashion analogous to the
autologous graft

[42]

. Our present study extends the results of these tissue culture experiments

and demonstrates clear evidence that similar results can be achieved in vivo using threedimensional arrays of aligned fibers as a template to drive regeneration.
We observed substantially increased potential for functional recovery when the rodent
sciatic nerve was reconstructed with our unique 3D nerve guide. It is curious that the robust
functional recovery that we obtained appears to be driven largely by small caliber, unmyelinated
axons that were not detectable in our light microscope-based morphometric analysis of the
regenerated tissue. An electron microscopic survey was necessary to detect this population of
axons. The results of this study are in contrast to our previous results in which we reported that
our 3D grafts supported the regeneration and myelination of axons in our rodent model of sciatic
nerve injury using a 10 mm lesion gap. It remains to be determined if this discrepancy represents
a model specific technical issue or a truly inherent limitation in the design of our device. This
issue awaits further investigation. However, we note that regardless of the underlying events that
mediated the regenerative response, the extent of functional recovery that we observed in the
four animals that remained in the study at 45 days (2 each +/-NGF), and the two (1 each +/-NGF)
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animals that remained at 60 days was more rapid and extensive than that observed in animals
treated with the gold-standard autologous implant. In addition, the progress of functional
recovery demonstrated by the SFI analyses in our study in the animals treated with the 3D graft
was unprecedented with respect to a variety of published results using autologous grafts and
various permutations of synthetic and hybrid implants [92-97].
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Chapter 7: Conclusions and Future Research

CONCLUSIONS

Regenerative medicine has continued to gain importance in the research enterprise and
holds great promise in the treatment of a variety of injuries and disease processes. The goal of
this strategy is to stimulate endogenous repair mechanisms and / or to replace damaged or
missing tissues and organs by reconstructing or augmenting the structure and function of those
damaged tissues. Tissue engineering is an evolving component of the regenerative medicine
initiative. This discipline applies the principles of engineering and life sciences to the
development of biological substitutes that restore, maintain, or improve tissue function or a
whole organ [108]. The tissue engineering technique of electrospinning has gained much
prominence due to its ability to produce nano– to micron–scale diameter fibers, a fiber size scale
that approaches the scales observed in native tissue. The process of electrospinning affords
considerable control over fiber dimensions and the architecture, pore dimensions, and material
properties of a tissue engineering scaffold, making it possible to mimic many structural and
functional aspects of the native ECM [109].
Electrospinning potentially has a wide variety of potential applications as discussed in
Chapters 2 and 3 of this dissertation. Most of the electrospinning applications mentioned in these
chapters utilize conventional electrospinning systems where a charged polymer solution source is
used to produce a jet of fibers that is directed towards an oppositely charged collecting plate (for
randomly oriented fibers) or a rotating mandrel (for aligned fibers). One limitation to these
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conventional electrospinning systems concerns the observations that the resulting electrospun
fibers are deposited as two-dimensional sheets of material.
There is clearly a place for scaffolds with a two-dimensional configuration in the tissue
engineering paradigm. For example, this type of construct clearly mimics the structure of the
dermis and the walls of hollow organs such as the esophagus, stomach and intestinal track and
the vessels of the cardiovascular system. Data presented in Chapter 3 illustrates how a twodimensional sheet of electrospun collagen can be effectively be used to reconstruct dermal
wounds and its efficacy in the construction of hollow cylindrical tubes for muscle fabrication.
While electrospun collagen has unique biological activity in a variety of applications, the
architecture of a two-dimensional sheet of material limits its utility. For example, electrospun
collagen appeared to induce the differentiation of osteoblasts; however, it is very difficult to
envision how the thin two-dimensional sheets of collagen used in these tissue culture
experiments might be translated into structures suitable for bone reconstruction. A more threedimensional architecture is needed for this type of tissue engineering application. Data presented
in Chapter 3 also illustrates how critical it is to consider not only the architecture of a scaffold
but also how its composition must also be considered in the design of a scaffold for any given
application.
It is possible to roll and / or compress a two-dimensional sheet of material into a threedimensional configuration. However, it can be difficult to reliably reproduce a given structure
with this approach and the resulting construct may exhibit poor structural qualities overall. Nor
does this approach make it possible to control the distribution and organization of a large
population of nano-scale fibers within the final construct. Fiber orientation and distribution play
a central role in directing cell migration and determining the mechanical properties of an
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electrospun construct [13, 25, 42, 45, 59, 60]. In order to deposit large numbers of nano-scale fibers into
the unique structural organization needed to mimic the three-dimensional space occupied by a
solid tissue, it would appear to be necessary to fabricate this type of construct at the level of fiber
spinning. This allows for subtle and a far higher level of control over the physical properties of a
tissue engineering device.
As a component element of this study, we explored the use of two pole electrospinning to
develop tissue engineering scaffolds that have been specifically designed to promote the
regeneration of peripheral nerves after injury. This tissue presents several distinctive challenges.
Peripheral nerve is uniquely structured; it is composed of acellular and cellular elements that are
organized into a hierarchical three-dimensional array. Individual axons are surrounded by the
[101]

.

[96, 99]

.

endoneurium, a delicate connective tissue layer composed of laminin and Type IV collagen
The investing Schwann cells participate in producing this connective tissue compartment

Bundles of axons are bound together by the perineurium, this layer is composed of Type I
collagen. A population of fibroblasts synthesizes and maintains this compartment [93]. Finally, the
entire nerve is surrounded by an epineurium, a very tough connective tissue sheath of Type I
collagen. Blood vessels lie on the surface of this structure and periodically penetrate into the
nerve to provide nourishment. A network of small arterials and capillaries are present within the
axonal arrays along the epineurium.
After injury, peripheral axons will readily regenerate. And, even when the process is
directed by a hollow tube construct that lacks any discernible guidance cues, a considerable
number of axons can be guided to traverse an injury gap

[50]

. An examination of the regenerated

tissue that is present within such a construct indicates that crucial aspects of nerve architecture
are recapitulated even in this type of simple device, indicating that the information necessary to
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restore the basic structure of nerve is present in the tissue adjacent to the injury. Cross talk
between the Schwann cells and axons undoubtedly drives this process [96, 99, 103, 110, 111]. However,
based on our comparative study of the nerve guides in Chapter 6, we can say that the rate of
regeneration is not very efficient in these devices resulting in limited functional recovery. This
limited recovery can be attributed to a number of factors including a poor regenerative response
in which only a subpopulation of axons grow across the lesion and / or the subsequent failure of
those axons to efficiently target to the appropriate peripheral tissues. A more insidious limitation
is the onset of degenerative changes that begin with the loss of nerve function in the peripheral
tissues; if nerve function is not restored within a poorly defined window of time (estimates vary
as to the length of this critical window, certainly 12 months is adequate for these changes to
become entrenched) these degenerative changes may become entrenched. These irreversible
changes have been documented in both the motor and sensory target organs

[112-114]

. Once these

degenerative changes are fully entrenched the prospects of functional recovery are essentially
non-existent. This observation indicates that it is important to develop strategies to accelerate the
return of axons to these distal target tissues and thereby improve the extent of functional
recovery that can be achieved after injury.
Two-dimensional sheets of aligned electrospun fibers are very effective at promoting
neurite outgrowth to occur along the principle axis of fiber orientation [42-44]. Key to developing a
nerve guide is the translation of this fundamental observation into a structure suitable for use in
vivo. From the onset, our goal was to produce a seamless nerve guide that exhibited a cylindrical
structure comprising of fibers that were as uniformly as possible oriented along the longitudinal
axis of the construct. Hollow nerve guides fabricated by electrospinning have aligned fibers

[50]

,

however, the alignment of the fibers that compose the walls of these constructs is 90º off the
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primary axis of axonal growth. As a result of this type of architecture, the hollow device
provides limited guidance cues to direct axons towards the distal stump of the injured nerve.
Additionally, these hollow devices may be susceptible to crush injury associated with normal
everyday activity.
In addition to the criteria that our next generation nerve guide should be composed of
nano-scale fibers aligned in parallel with the long axis of the construct, we next we elected to
produce a guide with a semi-solid design. This structural design feature is designed to mimic the
anisotropic structure of intact nerve. To achieve this goal, we developed and characterized a
innovative and novel form of electrospinning denoted as two pole air gap electrospinning. Our
studies with this electrospinning technique indicate that high degrees of fiber alignment can be
induced with this approach, substantially independently of fiber size (conventional systems that
produce 2D sheets of material work best with larger diameter fibers)

[2]

. We were able to

fabricate cylindrical guides composed of aligned fibers that ranged from less than 100 nm to
about 2500 nm using the process of two pole air gap electrospinning. Given our architectural
constraints, it was essential that our candidate construct exhibit adequate porosity to support
axonal penetration into the stacked fiber arrays. Our cell culture and liquid intrusion studies
clearly indicated, at least on a theoretical basis, that the 3D design can support axonal growth and
elongation into and between the fiber arrays. Those studies (Chapter 4) demonstrated that axonal
elongation was supported by scaffolds composed of three very different fiber diameters
(approximately 400-2,000nm). We also calculated that the 3D guides exhibited what appeared to
be very good overall void space volumes that range from 55% to 95%. In conjunction with these
basic structural and functional characteristics, we also wanted the final construct design to
exhibit mechanical properties that were sufficient to withstand the forces encountered during
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surgical placement (handling and suturing) and the post-implantation movements of the patient.
This final selection criteria, that broadly defined the material properties of the final device,
narrowed our choices to scaffolds produced to contain fiber diameters of approximately 1 µm.
Scaffolds with smaller fiber diameters had substantially less mechanical strength. The semi-solid
design was designed with the assumption that axonal growth could be accelerated by a multitiered array of individual fibers; essentially the fibers are intended to confine regenerating axons
from straying from a linear pathway. In turn this could be expected to increase the efficiency of
the outgrowth process and thereby accelerate the regeneration process.
From these selection criteria, we conducted preliminary implant studies in the rodent
sciatic nerve using an electrospun guide composed of 1 µm diameter fibers; this construct had
material properties that approximated native rodent sciatic nerve, void volumes of approximately
95% and supported directional axonal growth in tissue culture experiments. Using 3D nerve
guides with this design we were able to show evidence of sciatic nerve regeneration in rodents
subjected to a 10 mm sciatic nerve lesion. The animals in the study group exhibited a 100%
survival rate, showed no evidence of overt inflammation or the formation of fibrosis in
association with the implants, and developed near-normal gait patterns in the experimental limb
by 7 weeks post-surgery. At 7 weeks post-surgery, immunohistochemistry and TEM analysis
showed the presence of myelinated and unmyelinated axons, Schwann cells, associated
fibroblasts and blood vessels. Morphometric analysis indicated that about 25% of the myelinated
axons present at the proximal stump of the injury were directed by the 3D nerve guide to the
distal stump of the severed sciatic nerve in the 7 week interval. This study established the
efficacy of this 3D nerve guide design.
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This initial study, based upon the published sources

[39, 93, 115]

, used what may be

considered a sub-critical length lesion of 10 mm. A 15 mm lesion presents a more challenging
defect and is clearly considered a long defect nerve injury in the rodent sciatic nerve. The results
of the pilot study using the 10 mm lesion indicates that there were sufficient endogenous sources
of neurotrophic factors like NGF, BDNF, and / or CTNF throughout the 3D nerve guide,
originating from the proximal and distal nerve stumps, to support vasculogenesis, axonal
regeneration, axon growth and myelination. By nature, a short defect injury has a smaller
distance between the two ends of the severed axon; nutrients and ancillary supportive factors,
including Schwann cells, appeared to be able to provide a sufficiently robust regenerative
environment to support axon development and myelination.
Our second study (15 mm lesion) produced unexpected results given the outcome of our
initial experiments (10 mm lesion) using the 3D guide to reconstruct sciatic nerve lesions. The
second expanded study was designed to compare and contrast the performance of our 3D design
with the autologous implant, and conventional hollow core nerve guide designs. Based on
functional metrics, regeneration in the motor and sensory beds was faster and more extensive in
animals treated with the 3D guides with respect to the other designs in the first 30 days after
surgery. Consistent with this result, the animals treated with the 3D guides had more axons in the
distal nerve stump than the other treatment groups at day 45. As the study progressed, animals
treated with the 3D guides continued to display evidence of functional recovery; however, our
morphometric analysis indicated that the total number of myelinated axons present in the distal
native tissue actually declined with respect to the other treatment groups. TEM analysis of the
distal tissues suggested the continued recovery was mediated by a population small caliber,
unmyelinated axons. If the extent of functional recovery that we observed in animals treated
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with the 3D grafts was unprecedented, so too was the paucity of myelinated axons that we
detected in the regenerated tissues.
In the second study using a long defect injury, there are several factors to consider in the
analysis of our results. First, and obviously foremost, a longer defect requires the endogenous
elements to travel further to provide the signals necessary to drive regeneration. In an injury, the
most “effective” regenerative environment may be limited to the first few millimeters of an
implant and in the immediate vicinity of the native tissues. The middle section of the 3D guides
might be relatively devoid of endogenous nutrient support (i.e. diffusion barriers). Hybrid nerve
guides composed of conventional hollow silicon tubes interspersed with native autologous tissue
have been used to explore this potential limitation [95]. No specific benefits were ascribed to the
hybrid nerve guide described in that study. We considered this “distance” limitation in the design
of our long defect study described in Chapter 5 and developed a therapeutic reagent delivery
platform that could be incorporated into our nerve guides. Unfortunately, the incorporation of
NGF into our nerve guides did not appear to increase axonal outgrowth or myelination.
A second possible source of our results concerns the actual amount of “donor tissue” that
is present after we have removed a 15 mm section of tissue to prepare the lesion site. Removal of
this much tissue much certainly reduce the total number of endogenous Schwann cells that are
present and that can contribute to the supply of endogenous factors necessary to support the
development of a regenerative environment. This notion must be especially true in the distal
sciatic nerve stump. With the removal of a 15 mm segment of the this nerve starting just after it
has formed outside the vertebral column, the distal stump of the injured sciatic nerve left is very
small in diameter and therefore essentially contains a smaller number of Schwann cells and
endothelial cells to support regeneration. Shorter defect injuries have a distal stump with a much
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larger volume and therefore a larger pool of cells to draw on to repopulate the lesion site.
Curiously, if this was the sole factor in our reported results we would expect the hollow core
designs to be subject to similar “population limitations”. It may be that our 3D grafts have such a
large internal surface area for cell growth that proliferating Schwann cells cannot divide
sufficiently to populate this space. This argument basically states that Schwann cells continue to
divide until the available surface area is occupied and could be used to explain why hollow core
grafts do not seem to be subject to this population limitation.
One obvious way to address a regeneration limitation associated with a population barrier
of Schwann cells is to incorporate this unique cell type directly into the graft prior to
implantation. This approach has been used in the reconstruction of experimentally induced spinal
cord injuries in rodents with some degree of success

[60, 61]

. Similar experiments in peripheral

nerve injuries have generated conflicting results [96]. Our objective was to avoid the incorporation
of Schwann cells in our devices; from a treatment paradigm we want to develop an off-the-shelf
implant that does not require any further manipulation. We feel the incorporation exogenous
Schwann cells would ultimately lead to additional regulatory barriers as we move this device into
the clinical marketplace. It is also very difficult to precisely populate the 3D space of an
electrospun nerve guide with a known number of cells. Our solution to the possible shortage of
Schwann cells in a long defect nerve injury was to develop a method to trap therapeutic reagents,
like NGF “into a thread” of alginate as detailed in Chapter 5. This platform can be used to
deliver specific growth factors or mixtures of growth factors to our nerve guide environment.
In our expanded study described in Chapter 6, the functional outcomes for animals
treated with 3D nerve guides supplemented with / without exogenous NGF were very similar.
The trajectory of motor recovery was nearly identical over the entire time course of the study.
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There was some evidence that animals treated with the 3D + NGF grafts failed to recover
sensory function as quickly as the animals treated with the un-enhanced 3D nerve grafts. As
discussed in Chapter 6 we have ascribed this result to the potential inhibitory effects of a
relatively large and local dose of NGF during the early stages of nerve regeneration [106].
One technical aspect of the present study that distinguishes it from our initial pilot study
in which we used the 10 mm lesion gap concerns the nature of the injury. At the time we did not
fully appreciate the extent to which a 15 mm lesion might impinge on the overall blood supply of
the rodent sciatic nerve. This nerve is nourished by a series of penetrating branches of the
femoral artery. These branches reach the surface of the nerve at intervals along its length and
penetrate through the epineurium to reach the deeper structures. By removing a 15 mm gap of
nerve we have likely completely compromised this vascular network and believe the bulk of the
blood supply is provided to the regenerating axons by arterioles present within the nerve itself
that, in turn, originate from intact arterial branches still intact in sites above and below the lesion.
This same condition would hold true for the autologous and hollow core grafts and should also
limit regeneration in these constructs, suggesting that additional variables are impacting the
regenerative environment of the 3D graft. Still, the poor state of preservation that we observed in
some of our 3D nerve guides at recovery tends to support this hypothesis: perfusion fixation of
intact animals is highly dependent upon an intact vascular supply. If the vascular network was
marginal, the perfusion media will not adequately reach the tissue to cross link the tissue
adequately for microscopic observation. This condition might also be expected to limit Schwann
cell functionality and division [74] as well as the subsequent processes of axon growth and
myelination [102]. Autologous grafts will at least contain a potential population of endothelial
cells that can be recruited to establish a nascent vascular network and meet the metabolic
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demand present within the hollow core grafts may not be sufficient to lead to the myelination
defects we observed in the 3D grafts.
Finally, two other aspects of this study will require additional investigation to clarify our
present reported results. We assume, in the absence of other evidence, that the number of axons
present in the autologous and hollow core grafts that we have calculated by morphometric means
accurately reflects the number of functional axons present in the tissue. But, it is possible that we
have overestimated the number of axons present in these constructs. This could occur if the
regenerating axons present in these grafts have undergone branching and or grown chaotically in
such a way that we are counting the same axon more than once (axons have looped back and regrown down the graft). Either scenario will result in an over estimation of total axon number.
There are domains in the hollow core constructs where the axons are not in cross-section,
suggesting they have deviated from growing exclusively down the long axis of the construct. The
second issue that must be further considered concerns the overall efficiency of axon targeting to
the distal tissues. If a particular graft design supports the regeneration of larger number of axons
but they grow slowly or fail to properly target to the distal tissues, functional recovery will be
limited due to the onset of secondary degenerative changes in the motor and sensory beds.
In conclusion: (1) the 3D nerve guide is a suitable candidate platform for the
development of next generation nerve guide for the treatment of peripheral nerve injuries, (2) the
regenerative environment afforded by the 3D graft will likely have to be manipulated through the
addition of exogenous factors in order to drive the development of well myelinated axons.
Animals treated with the 3D grafts failed to express a large number of myelinated axons in the
tissues distal to the lesion site; however, they did display evidence of superior functional
recovery. This enhanced functional recovery was observed despite the absence of exogenous
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neurotrophic reagents or other biological cues (axon-adhesion proteins). Given that 3D grafts
with and without exogenous NGF supported similar degrees of functional recovery, we argue
that guidance cues provided by the unique architecture of these grafts represent the source of this
result. Axons grow along the aligned fibers, or perhaps more accurately within the intrafibrillar
spaces that are lined by the surrounding fibers, an architectural feature that must limit the lateral
deviations of growth cones and thereby accentuate growth done the length of the graft. This
would lead to more efficient axon elongation and ultimately faster growth across the lesion site.
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FUTURE RESEARCH DIRECTIONS

The peripheral nervous system has a remarkable capacity to undergo regeneration;
however this regenerative capacity is markedly challenged in long defect nerve injuries.
Continued research will be necessary to provide for an optimized regenerative environment in
this and other tissues. A more complete inventory of the various mechanisms underlying the
response of the PNS to injury can be expected to lead to innovative treatment strategies to
improve functional outcomes after these devastating injuries.
The 3D nerve guide developed and characterized in this study was designed to provide
regenerating axons with an anisotropic environment that mimics the native tissue. The aligned
fibers, and associated “aligned” intrafibrillar spaces, provide a substrate with guidance cues to
direct regenerating axons to grow efficiently across a lesion site. We hypothesized that constructs
designed to reduce the frequency and extent of lateral deviations that growth cones and
regenerating axons take as the regeneration process takes place would serve to accelerate
regeneration and improve functional outcomes. While we did observe evidence of improved
functional outcomes in our rodent model of a long defect nerve injury using the sciatic nerve,
this recovery appeared to be largely mediated by small caliber unmyelinated axons. This
surprising result indicates that something potentially crucial is missing from our engineered
regenerative environment (obliviously, additional longer term studies need to be carried out to
more fully understand this process-is it a failed regenerative response or a response that was
robust initially and then subsequently failed?).
Our overall objective is to develop a synthetic nerve guide that can supplant the use of the
autologous nerve guide. At least in this series of preliminary studies, we have generated data to
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suggest that this is possible using the strategies that we used to produce our graft. By replacing
the autologous nerve guide, in addition to the eliminating the complications associated with the
increased intra-operative time and donor site morbidity, we had hoped to limit the “time to
regeneration” delays associated with the interval of time needed for the axonal fragments that are
present in native tissue to undergo degradation. This debris must be removed before regenerating
axons can penetrate into these native implants. There have been efforts to accelerate this process
by physically or chemically removing this material from the donor tissue [90]; the efficacy of this
approach remains to be fully demonstrated. There are limits to this approach; if the donor tissue
is autologous you still cause functional deficits at the donor site. If it is sourced from cadavers
there will be concerns of disease propagation and or adverse immune responses. There is
consistently a shortage of donor tissues from cadavers (and living patients for that matter) nearly
regardless of the tissue under consideration. This circumstance leads to potential supply issues in
the marketplace. Together, these factors suggest that there is a viable market for a synthetic
replacement for the autologous materials and / or donor implants regardless of their source or
physical state.
Treatment regimes that accelerate axonal regeneration across the injury lesion represent
an important gateway to improved functional outcomes. This is because degenerative events
begin to take place within hours of nerve injury and the loss of innervation. These degenerative
changes become increasingly profound over time in both motor and sensory beds

[112-114]

. There

was clear physical evidence of this process in the lumbricals of the experimental limbs in our
study; motor end plates were essentially completely lost in these muscles by day 30 after surgery.
The observation that they returned to near normal appearance by day 45 indicates that all of the
treatment groups had some degree of nerve restoration in these most distal muscles. A
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consideration of the processes that surround regeneration in autologous tissues reveals several
potential sites in which we believe that relatively simple manipulations can be used to improve
the performance of our nerve guides
Myelinated and unmyelinated axons of the PNS are surrounded by Schwann cells which
in turn are surrounded by basal lamina that faces the endoneurium. The Schwann cells produce
and maintain the myelin sheath along the length of an axon, adjacent Schwann cells are separated
from one another along the nerve by an intermodal gap, the site of the Node of Ranvier. In
contrast, unmyelinated axons exhibit a continuous sheath of Schwann cells with no gaps between
the adjacent cells. Thus, both the myelinated and unmyelinated axons of PNS reside within a
continuous “tube” of basal lamina [101]. When the axon is severed from its cell body at injury, the
distal aspect of the axon gradually degenerates and eventually disappears by the process of
Wallerian degeneration. The Schwann cell, after losing contact with the underlying axon, starts
to degrade the myelin associated with the remnants of the distal segments of the injured axon,
leaving behind an empty tube of basal lamina. In an injury treated with an autologous graft, or at
sites distal to the actual lesion gap (within the remaining in aspects of the native tissue), the
regenerating axons grow into the (and in some cases onto the collapsed) hollow tubes of basal
laminae and extend outward to reach the distal target tissues. Schwann cells after degrading and
fragmenting the myelin, when macrophages infiltrate the tissue and begin to phagocytize the
partially degraded myelin, begin to undergo proliferation and form a cell “strand” that is
surrounded by the basal lamina tube, a structure called the Bands of Bungner [116]. The Bands of
Bunger are considered to be an essential substrate and pathway for regenerating axons [79, 101]. If
the axons fail to enter the compartment established by the Bands of Bungner or the original basal
lamina, elongation ceases after only a few millimeters and a failed regenerative response takes
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place. Autologous, acellular grafts take advantage of this observation and attempt to provide
“hollow remnants” of these structures to support and direct the regeneration of the axons [117].
The “empty tunnels” of basal lamina in these native, yet engineered native grafts serve to provide
guidance cues and a substrate for the adhesion and elongation of the regenerating axons and the
migration of the Schwann cells towards the distal target organs [101]. Multiple axons can grow
through these basal lamina tubes (an ultrastructural feature that we observed in tissues distal to
the implant site for our 3D grafts-see TEM images Chapter 6; Figure 6.8). Subsequently and / or
in parallel with the elongation of the axons they are surrounded by Schwann cells that ultimately
myelinate the individual axons. Finally, investing Schwann cells produce a nascent basal laminae
on the surface of the cell that faces away from the axon, and the old basal lamina is gradually
degraded [99].
Of note, in this sequence of events is the observation that that regenerating axons prefer
to grow through the remnants of the basal lamina and / or the Bands of Bungner formed by the
Schwann cells. The common denominator in both of these supportive regenerative environments
is that they both contain adhesion molecules which facilitate the formation of growth cones and
the elongation of the axon. Schwann cells, in an injured peripheral nerve, express high levels of
adhesion molecules from immunoglobulin superfamily (N-CAM and L1) and the cadherin
superfamily (N-cadherin). Axonal adhesion to basal lamina is mediated by laminin [75,

118, 119]

.

Neural cell adhesion molecule (N-CAM) and L1 have been both been found to promote Schwann
cell-mediated neurite outgrowth along the Bands of Bungner [99, 101, 110, 111, 116]. N-cadherin also
mediates axon-Schwann cell adhesion and is strongly expressed in these attachment sites,
indicating its role in the facilitation of axon outgrowth [101]. In many peripheral nerve injury cases
(mostly small crush injuries) regenerating axons have been found to sprout from the proximal
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stump of an injured nerve and grow into the distal basal lamina without being accompanied by
the Schwann cells during the initial phases of axonal regeneration. This indicates the critical role
of basal lamina in the support of axon growth. Basal lamina is rich in laminin, a glycoprotein
which is a potent adhesion molecule to the integrins expressed at the growth cone of the
regenerating axon [101, 120].
Considering these factors, the efficacy 3D nerve guide generated by two pole air gap
electrospinning might be greatly improved by making the polymer fibers functionally active.
Nerve guides fabricated from PCL at a concentration of 200 mg mL-1 having average fiber
diameter of 1µm have proven to be highly biocompatible, exhibit low toxicity, have very high
porosity (> 90% void spaces), and are biodegradable. This formulation has sufficient material
properties to sustain the structures during manual manipulation and surgical placement and
appear to be able to withstand crushing and or other mechanical damage once they are placed in
situ [2, 50, 51, 121]. The addition of the external layer of PGA/PLA we used further enhances the
mechanical properties of these constructs. However, PCL is a hydrophobic polymer [104]. This
property must reduce and / or at least impair the early stages of axon elongation by limiting
cell-fiber interactions (adhesion). The polymer itself, as a synthetic polymer, lacks physiological
cell-adhesion sites [104,

122]

. The absence of physiological binding sites, in addition to limiting

axon-scaffold interactions, can also be expected to restrict the migration of endothelial cells and
Schwann cells inside the nerve guide, events critical to stimulating and supporting axon
regeneration and subsequent myelination [39]. The fibrillar structure of the electrospun 3D nerve
guide mimics the macroscopic and anisotropic architecture of the native ECM present in
peripheral nerve. However, manipulations that reduce the hydrophilic properties of the PCL
polymer and serve to provide physiological binding sites can be used to further enhance
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axon–scaffold and / or Schwann cell–scaffold interactions, thereby facilitating infiltration of
regenerating axons and Schwann cells into the nerve graft.
Hybrid scaffolds can be fabricated by co-electrospinning two polymers to improve the
hydrophilic nature of the scaffold and / or by directly incorporating adhesion proteins like
laminin into the polymer solutions. For example, co-electrospinning natural polymers such as
collagen or gelatin with PCL during electrospinning has been shown to reduce the hydrophilic
nature of electrospun PCL and increase cell adhesion [104]. It is relevant to note that collagen has
been used in other physical forms to fabricate nerve guides [123, 124, 125]. We elected to use PCL in
the fabrication of our nerve guide, rather than electrospun collagen, to take advantage of the
increased biostability of the synthetic polymer. The co-spinning of PCL with laminin is an
attractive approach and should provide for a more physiologically relevant surface for Schwann
cell migration and axon regeneration. One specific advantage to the co-spinning process is that it
usually takes relative minute amounts (nano-gram quantities) of exogenous protein in the
electrospinning solvent to enhance the biological properties of a synthetic polymer. There is
excellent support in the literature for using laminin in our application; nerve regeneration in a
variety of nerve guides has been enhanced with addition of the specific protein [64]. Other
neurostimulatory proteins like LN-1, fibronectin and RGD domains also increase rates of axonal
regeneration [126]. Thus, improving the functional capacity of the electrospun fibers present in a
synthetic 3D nerve guide is a promising avenue for enhancing peripheral nerve regeneration.
Another limiting factor in the regeneration of long defect nerve injuries concerns the
signaling environment afforded by growth factors. Neurotrophic factors are synthesized in target
tissues and / or by the Schwann cells and these soluble factors are delivered to the nerve cell
body via retrograde axonal transport [107]. Following nerve injury, disruption of the retrograde
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transport of these neurotrophic factors can lead to neuronal cell death and limited regeneration.
Neurotrophic factors include neurotrophins (NGF, brain derived neurotrophic factor (BDNF),
NT-3, and NT-4/5), neurokines (ciliary neurotrophic factor (CNTF) and leukemia inhibitory
factor (LIF)), and the transforming growth factor (TGF)-β family (TGF-β1, 2, 3) and glial cell
line derived neurotrophic factor (GDNF). Exogenous administration of these trophic factors to
the microenvironment of the injured nerve might compensate for the disrupted retrograde
transport system. However, even a brief survey of the literature regarding the known trophic
factors in the peripheral nervous system makes it clear that the native regenerative environment
contains a very complex mixture of these factors. While it is theoretically possible to add any
number of these reagents to a nerve graft, there is an increasing risk of immune response that is
accompanied by increasing FDA regulatory burden as additional factors are added to the
construct. Given these circumstances, it would seem appropriate to target very specific signaling
events for enhancement by the exogenous addition of therapeutic reagents.
Key therapeutic reagents that have been examined, and show promise, and represent
candidates for further investigation as therapeutic additions to our nerve guides include NGF,
BDNF, CNTF, and GDNF. NGF protects sympathetic and sensory neuronal cells from injuryinduced death [101, 127]. There is marked increase in the expression of this growth factor, and its
receptors after axotomy [101, 116, 128]. In our studies, the incorporation of an NGF gradient along
the length of our 3D nerve grafts failed to improve functional recovery beyond that observed
with the un-enhanced version of this construct. One explanation for this result may lie not in the
identity of the NGF, but rather in the dosages delivered and the time frame in which it is
available in our constructs; optimal concentration of this factor appears to be critical [102]. BDNF
expression is also up-regulated after peripheral nerve injury. It promotes survival and outgrowth
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of sympathetic, sensory and motor nerves [101]. Exogenous BDNF administration has shown to
improve functional recovery after peripheral nerve lesions [99, 107, 129]. CNTF is present in high
levels in Schwann cells of intact adult nerves and is decreased after peripheral nerve injuries;
supplementing the regenerative environment with this peptide arrests motor neuron and muscle
degeneration in rodents, thereby promoting the survival of these cells following axotomy [99, 101,
107]

. GDNF enhances DRG neurite elongation in vitro [130] and has a strong neurotrophic effect

on Schwann cells [99]. It is also one of the most potent neuro-protectors of motor neurons [103].
In addition to the trophic factors, the incorporation of biological cues, such as Schwann
cells and / or neural stem cells might also be used to enhance the efficacy of the 3D nerve guide
design [50]. As noted, Schwann cells mediate myelination and express a variety of trophic factors,
and axon adhesion molecules, including laminin, fibronectin, heparan sulfate proteoglycans, and
tenascin [99, 101]. By providing this cell population, it may be possible to completely negate the
need of for the addition of exogenous growth factors and / or other reagents. The caveat to this
approach concerns identifying the source of the Schwann cells to be used and the associated
regulatory hurdles imposed when cell-based therapies are considered.
Given our observation that our guides appear to develop a deficient vascular network, it
is reasonable to propose to add VEGF (vascular endothelial growth factor) to our constructs.
This peptide drives intraneural neo-vasculogenesis [131] and has neuro-protective effects above
and beyond any therapeutic benefits associated with increased vascular development [132]. This
makes this particular peptide a very attractive choice for further investigation. Poor vascular
perfusion in our grafts may represent a key limiting factor in our regenerative environment.
Emergent science in the cell biology of peripheral nerve can be expected to provide new
avenues for the treatment of nerve injury. We believe that efforts should be concentrated on
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developing methods to accelerate axon regeneration and elongation across the lesion site. To
this end, there are several much focused areas of interest for future investigation. For example,
the addition of a physiologically relevant surface to the PCL fibers, in the guise of laminin, can
be expected to enhance the performance of our basic nerve guide design. As noted, VEGF
represents a very attractive candidate that may serve to address multiple regenerative barriers.
We have not explored the use of chondroitinase ABC (chABC) as a supplement in this study.
There is evidence from our morphometric study that axons penetrate into the fiber arrays of our
3D guides slowly during the early stages of regeneration (Chapter 6, Figure 6.7 G, J). This may
be a consequence of growth inhibitory chondroitin sulfate proteoglycans (CSPGs) that
accumulate in response to nerve injury [133]. Treating the vicinity of nerve injuries, over relatively
short intervals of time (days) with the enzyme chondroitinase ABC has been shown to reduce the
burden of these inhibitory factors and accelerate the onset of peripheral nerve regeneration. The
acute nature of the time course needed to effectively administer this enzyme to an injury site
makes it amenable for use in our alginate platform. Adjunct therapies designed to spare the distal
tissues until they are re-innervated provide a secondary therapeutic target that can be exploited to
improve functional outcomes. The electrospinning process and the nature of our novel 3D nerve
guide make it possible to incorporate multiple and synergistic structural, biochemical, and / or
cellular cues into these constructs to modulate the regenerative environment and maximize
functional recovery.
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